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ABSTRACT 
A Dissection of T cell Receptor Signaling Pathways in Primary Human T cells Activated 
in the Rotating-Wall Vessel Bioreactor 
Donald M. Simons 
Peter I. Lelkes, Ph.D. 
 
 
 
One hurdle of long-term manned spaceflight is the reduction in cellular immunity 
experienced by astronauts in the microgravity environment. T lymphocytes, the primary 
effectors of cellular immunity, are unresponsive to mitogenic lectins or T cell receptor 
(TCR) ligation when cultured in vitro during spaceflight.  Responsiveness can be 
partially rescued by directly activating the diacyl glycerol- (DAG) and calcium-signaling 
pathways that lie downstream of the TCR.  Studies using rotating wall vessel (RWV) 
bioreactors as ground-based microgravity analogs have shown that sub-mitogenic doses 
of PMA, a DAG mimetic, can rescue T cell activation in response to mitogenic-lectins 
and -antibodies.  Based on these findings we hypothesized that RWV-culture impairs T 
cell activation by affecting the generation of or response to the DAG second-messenger.  
This hypothesis was investigated by making comparative analyses of TCR-induced signal 
transduction in primary human CD4+ T cells in RWV- and 1-g (static)-culture.     
Our results show that TCR-induced phospholipase Cγ1 (PLCγ1) activation and 
the subsequent generation of DAG is unimpaired in CD4+ T lymphocytes cultured in the 
RWV.  Furthermore, the primary targets of the DAG second-message, the guanyl-
nucleotide replacing protein for RAS (RASGRP) and protein kinase cθ (PKCθ), were 
both activated by cells cultured in the RWV.  Gene expression downstream of these 
enzymes, however, was only induced by T cells cultured in static conditions.  A closer 
inspection of these pathways indicated that during culture in the RWV the extracellular 
ix 
 
regulated kinase (ERK), which is downstream of RASGRP, may become sequestered in 
the cytosol and thus prevented from mediating gene expression in the nucleus.   Based on 
these results we conclude, that altered compartmentalization of ERK prevents T cells 
from becoming activated in the RWV by limiting the activation of key transcription 
factors required for the cell to become activated and enter the cell-cycle. 
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CHAPTER 1: INTRODUCTION 
 
 
 
 2007 marks the 50th anniversary of the Soviet-launched satellite Sputnik 
becoming the first man-made object to orbit the earth.  In response to this event the 
United States government established the National Aeronautics and Space Administration 
(NASA); effectively beginning a space race between the U.S. and Soviet Union.  This 
competition drove rapid progress in both space-flight and –exploration, and the 
intervening years have seen the first manned spaceflights within earth orbit as well as 
extra-orbital flights to the moon.  Future missions planned by NASA—including 
extended lunar/orbital operations and the manned exploration of Mars—will require 
astronauts to spend extended periods in the absence of gravity, and require careful 
consideration of the long-term impact of spaceflight on astronaut health.       
 Orbital missions of up to approximately one-year in length have shown that 
microgravity can have profound effects on astronaut physiology including loss of bone- 
and muscle-mass, shifts in body fluids, and immune suppression37.  The effect of 
microgravity on the immune system has been the subject of a great deal of study, and 
there is a growing body of evidence indicating that the cells mediating acquired immunity 
are adversely affected by conditions encountered during spaceflight.  For the relatively 
short-duration missions that have been undertaken to date, strict sanitary controls and 
pre- and post-flight quarantine of astronauts have done much to minimize the health risks 
arising from decreased immune surveillance during spaceflight.  The maintenance of 
astronaut health during multi-year missions, however, will likely also require astronauts 
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to receive pharmacological or dietary supplements that are capable foe ameliorating the 
immune response during spaceflight.   
 The design of such supplements has been hindered by our limited mechanistic 
understanding of the effects of microgravity on T cell activation and function.  The 
available data strongly implicates a defect in the ability of T cells to respond to antigen-
receptor signals during exposure to microgravity but, to date, this has not been 
demonstrated directly.  The results presented in chapters 4, 5, and 6 of this thesis 
represent a concerted effort to fill this gap in our understanding of the mechanisms that 
prevent T cells from becoming activated in microgravity.  This was accomplished by 
making a comparative analysis of the antigen-receptor signals generated by primary 
human CD4+ T cells cultured at 1-g and in a ground-based microgravity analog, the 
rotating-wall vessel bioreactor.  These data represent the most detailed study of T cell 
signal transduction in microgravity culture to date, and lay the groundwork for the future 
in-flight studies that will be required to fully develop countermeasures for preventing 
immunosenescence during long-term spaceflight.    
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CHAPTER 2: BACKGROUND AND LITERATURE REVIEW 
 
  
 
 The experiments described in this thesis investigate the hypothesis that T 
lymphocytes are unresponsive to antigen-receptor stimulation during culture in the 
rotating-wall vessel bioreactor due to a defect in signal transduction through the diacyl 
glycerol second-messenger pathway.  The purpose of this chapter is to provide the reader 
with the context within which this hypothesis was formulated.  Section 2.1 will provide a 
narrative overview of the immunological processes germane to the topics addressed in the 
remainder of the chaptera.  The final sections of this chapter will provide an extensive 
review of the current literature regarding antigen-receptor signal transduction in T cells 
and also the immune response during spaceflight and microgravity culture.   
2.1 A general overview of the immune system 
 The cells of the immune system, collectively known as leukocytes, are essential 
for host defense against pathogens.  Functionally, the immune responses mediated by 
these cells are broadly categorized as innate or adaptive (a.k.a. acquired).  Innate 
immunity is characterized by a rapid response that is only generally specific, and retains 
no memory of past encounters.  By contrast, acquired immunity arises with slower 
kinetics, but is capable of responding with high specificity to distinct pathogenic 
epitopes, and develops memory of past encounters, which allows for a more rapid, 
specific, and robust response upon re-exposure to a pathogen.  Though phenotypically 
distinct, the two branches of the immune system are functionally interdependent, and 
                                                 
a For a more in depth discussion of the immunological principles outlined in section 2.1 the reader is 
referred to recent text books by Kindt et al. and Mak and Saunders82;100. 
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together are capable of protecting the host from a variety of environmental pathogens and 
parasitic organisms.   
2.1.1 Innate immunity 
 The innate immune system provides the first line of defense against pathogens, 
and is often capable of clearing insulting organisms without the aid of acquired 
immunity.   Innate immune cells are generally of the myeloid lineage and develop in the 
bone marrow, but mature at various sites throughout the body.  Neutrophils, 
macrophages, and dendritic cells (DCs) are the best studied effector cells of innate 
immunity.  Neutrophils are the most abundant leukocyte in peripheral blood (~70-%)108, 
and provide protection against extracellular bacteria at sites of injury/infection.  
Macrophages and DCs are phenotypically diverse and can exist as specialized tissue-
resident cells (e.g. Kupfer cells of the liver or Langerhans cells in the skin) or can 
differentiate from blood-derived monocytes that have been recruited into inflamed 
tissues.  Macrophages and DCs are both phagocytic cells that are capable of acting as 
professional antigen presenting cells (APCs)b for T cells (see later), although the latter is 
the more specialized of the two in this respect.  Macrophages and DCs are exquisitely 
sensitive to environmental cues, and respond to these cues by becoming activated to 
secrete cytokines and/or express surface molecules that dictate the quality of the ensuing 
adaptive immune response.               
 The environmental sensitivity of macrophages and DCs is mediated in part by 
germ-line encoded pattern recognition receptors (PRR).  These receptors recognize 
                                                 
b While it is a gross oversimplification to refer to macrophages (especially) and dendritic cells as though 
their sole function is the presentation of antigen, it is beyond the context of this introductory chapter to 
review the diverse roles these cells play in the innate immune response.    
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evolutionarily conserved motifs that are commonly expressed by many pathogenic 
organisms (e.g. endotoxin by gram negative bacteria or double stranded RNA by many 
viruses), and confer a general degree of specificity to the innate immune response.  In this 
way PRRs discriminate between classes of organisms and provide “danger signals” that 
are essential for the development of an appropriate immune response to pathogens.  An 
essential aspect of danger signals is that they change the context within which cells of the 
adaptive immune system “see” antigen.  Most importantly in this regard, signals 
emanating from PRRs activate DCs causing their maturation and migration to the 
secondary lymphatic tissues where they induce the acquired immune response.        
2.1.2 Adaptive immunity 
 Adaptive immunity is mediated by cells of lymphoid origin (lymphocytes).  The 
hallmark of the major effector cells of acquired immunity, Bc and T lymphocytes, is their 
expression of clonally distributed antigen receptors that confer individual cells with the 
ability to specifically recognize and respond to a single antigenic epitope.  In contrast to 
the PRRs of innate immunity the antigen-receptors of T lymphocytes are not encoded in 
the germ-line, but instead arise from the stochastic recombination of a developing T cells 
DNA.  Recombination of the nascent T cell receptor (TCR) loci produces an enormous 
array of unique receptors, however, only a small fraction of these receptors will be 
represented in the mature antigen-receptor repertoire.  Many genetic recombinations will 
result in non-functional or autoreactive receptors, and T cells undergo stringent selection 
processes during their maturation that ensure the deletion of cells expressing non-useful 
or harmful T cell receptors. 
                                                 
c A discussion of B cells is beyond the scope of this thesis, and these cells will not be described in any 
further detail here 
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 The site of T cell maturation and selection is the thymus.  Lymphoid progenitor 
cells arising in the bone marrow populate this organ via the bloodstream and undergo a 
developmental program that is intimately tied to signal transduction through the T cell 
receptor (fig. 2.1).  Maturing T cells (thymocytes) pass through several phenotypically 
distinct developmental stages that are grossly categorized by expression of the CD4 and 
CD8 co-receptors.  Each of these stages is characterized by a developmental checkpoint 
that requires appropriate signals from the TCR for the continued survival and maturation 
of the cell.  The first of these checkpoints, β-selection, occurs during the double negative 
(DN, CD4-CD8-) stage of thymocyte development, and requires the cells to successfully 
transduce a signal through the pre-TCR.  The second and third checkpoints, positive and 
negative selection, occur just before or during the transition of thymocytes from the 
double positive (DP, CD4+CD8+) to single positive (SP, CD4+ or CD8+) stages of 
development.  Survival of thymocytes at these checkpoints depends on the magnitude of 
the signals transmitted through the TCR; signals that are too weak fail positive selection, 
while those that are too strong fail negative selection.  The ligands that mediate positive 
and negative selection are self-peptides bound to major histocompatibility complexes 
(MHC) on the surface of thymic epithelial- and dendritic-cells.  A consequence of these 
selection processes is that the peripheral TCR repertoire only recognizes antigen in the 
context of an MHC molecule (positive selection), and has been depleted of TCRs that 
recognize self-peptide strongly enough to induce an immune response (negative 
selection).       
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 The small fraction of T cells that survive positive and negative selection 
downregulate one of the co-receptors and mature into either CD4+ helper (TH) cells or 
CD8+ cytotoxic (TC) cells.  These freshly minted (“naïve”) T cells emigrate from the 
thymus to the periphery where they circulate between the blood and peripheral lymphoid 
organs until they are activated by encounter with cognate antigen or eventually become 
senescent and undergo apoptosis.  The CD4+ subset of TH cells are the conductors of the 
acquired immune response.  TH cells are exquisitely sensitive to environmental cues and 
depending on the cytokine milieu within which they are activated can direct an acquired 
immune response mediated by either of the subordinate lymphocyte subsets—TC cells 
(TH1) or B lymphocytes (TH2) —or by inflammatory effectors of the innate immune 
system such as neutrophils (TH17).  CD8+ TC cells are able to specifically recognize and 
kill cells that have become infected with obligate intracellular parasites such as viruses 
and certain bacteria.  Both TH and TC cells are activated in the lymph nodes by 
recognition of cognate peptide-MHC expressed on the surface of an activated DC.  The 
process of antigen recognition induces the formation of a distinct junction between the T 
cell and APC known as the immunological synapse.  This structure is characterized by a 
central region enriched in TCRs and associated signaling molecules surrounded by an 
adhesive ring of the integrin LFA-1 (leukocyte function associated antigen-1) that 
maintains a tight junction between the T cell and APC.  Activation of a T cell results in 
distinct phenotypic and morphological changes culminating in proliferative expansion 
and acquisition of effector function.  Phenotypically, the cell surface-antigens CD69 and 
CD25 are often used to identify activated cells.  CD69 is a c-type lectin that is the earliest 
detectible cell surface-marker of activation.  CD25 is the high-affinity α-chain of the 
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interleukin 2 (IL-2) receptor, and is an essential component of the IL-2-driven 
proliferation of activated T cells.  IL-2 is an autocrine cytokine whose expression is 
induced by signals emanating from the TCR and especially the CD28 co-stimulatory 
receptor whose ligands are only expressed by activated DCs.  A majority of the T cells 
activated during the course of an immune response will become the terminally 
differentiated effector T cells that play a direct role pathogen clearance.  These cells will 
ultimately undergo apoptosis as clearance of the driving antigen causes the immune 
response to contract.  A small number of antigen-specific cells, however, will 
differentiate into long-lived memory cells (TM) that continuously patrol the periphery for 
re-emergence of the offending pathogen(s).  Compared to their naïve counterparts the 
TCRs of TM cells have a lower triggering-threshold and TM are also less reliant on CD28 
co-stimulation for their activation.  As a result some TM cells are capable of immediate 
effector function and can be activated in the periphery by professional APCs other than 
dendritic cells.  Memory T (and B) cells are one of the hallmarks of the acquired immune 
response and provide long-term protection against re-encounter with a pathogenic 
organism.             
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2.2  T cell activation and signaling from the TCR  
2.2.1 Introduction 
 A common requirement of all extracellular sensing mechanisms is the ability to 
convert cell-specific stimuli into cell-specific responses using generic intermediates.  
Differential recognition of stimuli is conferred by the expression of cell-type-specific 
receptors for a given ligand, and specificity in the response to generic signaling pathways 
is due to the epigenetic and proteomic context within which a signal is received.  
Lymphocytes represent an extreme example of this feature since nearly every cell 
expresses a uniquely specific antigen-receptor, but all cells execute the same basic 
genetic program in response to an agonist ligand.  In T cells, the TCR-specific signaling 
pathway converges on the enzyme phospholipase Cγ1 (PLCγ1).  PLCγ1 serves to convert 
the phosphotyrosine-mediated TCR-signal into the lipid-derived second-messengers that 
activate three common signaling pathways: the mitogen activated protein kinase (MAPK) 
pathway, the nuclear factor κ of B cells (NFκB) pathway, and the calcium signaling 
pathway.  Though activated at the membrane, these pathways converge in the nucleus 
and both independently and in concert induce the expression of the genes required for a T 
cell to enter the cell cycle and differentiate into an effector cell.   
 The following section offers an extensive review of the studies that have 
elucidated the biochemical pathways that mediate activation of PLCγ1 in response to 
TCR triggering, and also the means by which the TCR signal is transmitted to the nucleus 
to induce gene expression.  An overall summary of these pathways is illustrated in figure 
2.2, and summaries of the individual pathways are provided in figures 2.4, 2.5, and 2.6.  
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2.2.2 The TCR and TCR-triggering 
 The TCR is a finely tuned sensory apparatus that detects and converts physical 
information (affinity, crosslinking) into a biochemical signal capable of activating the cell 
(fig. 2.3)48;77.  The antigen receptor of conventional T lymphocytes consists of a 
clonotypic T cell receptor comprised of an α- and β-chain dimer that is expressed in a 
complex with a quaternary CD3 molecule (δε2γ) and ζ-chain homodimer.  The TCR 
confers antigen specificity to this complex, and CD3 and the ζ-chains contain specialized 
signaling motifs (immune-receptor tyrosine-based activation motifs, ITAMs) within their 
cytoplasmic tails that signal to the interior of the cell88.  Triggering of the antigen-
receptor signal critically depends on the half-life of the TCR-pMHC interaction22.  In 
response to an agonist ligand, this interaction is of sufficient duration for enzymatic 
activity at the TCR to achieve critical mass and transmit an activating signal to the 
interior of the cell49;51;136.   
 The accumulation of enzymatic activity at the TCR in response to peptide-MHC 
is thought to occur by two interrelated mechanisms.  (1) The src-family tyrosine kinase 
lck constitutively associates with the cytoplasmic tails of the CD-4 and -8 co-receptors, 
and co-receptor binding of MHC localizes lck with the ITAMs of the ζ-chains and CD3, 
allowing their phosphorylation, and (2) the intimate contact between the T cell and APC 
at the MHC-TCR interface excludes molecules with large extracellular domains from the 
contact site—most notably the membrane phosphotyrosine phosphatases (PTPs) CD45 
and CD14825;28;49;64;136.  These two mechanisms reflect the fact that lck, whose activity is 
principally responsible for initiating the TCR signal, is regulated by the balance of 
tyrosine-kinase and -phosphatase activity at the TCR.  Phosphorylation of lck at tyrosine 
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505 by the non-receptor tyrosine kinase csk induces lck to adopt an inactive closed 
conformation119;155.  Dephosphorylation of this site by CD45 allows lck to assume an 
open conformation and trans-autophosphorylate tyrosine 394 to become enzymatically 
active21;46;85;116;119;143.  Dephosphorylation of tyrosine 505 is exclusive to CD45; tyrosine 
394 is dephosphorylated by CD45, but also by a number of other membrane 
phosphatases45;105;161.  In resting cells lck and csk are co-localized in lipid rafts, and PTPs 
are stochastically distributed throughout the membrane17;59.  Due to this arrangement lck 
continuously cycles between the open and closed conformations, and maintains a basal 
level of kinase activity that is kept to a minimum by the promiscuity of membrane PTPs 
for tyrosine 394.  Upon receptor triggering csk is transiently displaced from the lipid rafts 
and lck becomes segregated from membrane PTPs; conditions, which strongly favor the 
open conformation of lck.  The subsequent receptor clustering and coalescence of lipid 
rafts promotes phosphorylation of tyrosine 394 allowing enzymatically active lck to 
accumulate at the TCR and trigger the activating signal27;86;110;157;160.                
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Figure 2.4. Schematic of TCR-proximal signaling.  Table summarizes the functional 
domains that are critical for transmission of the activating signal downstream.  Enzymatic 
activity is indcitaed by arrows.  Protein-protein interactions are shown as diamonds.  
Signals originating with the TCR are in red.  Co-stimulatory signals are in purple.    
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ζ‐chains
ZAP‐70
LAT
SLP‐76 Itk
PLCγ1
IP3
DAG
CD28
PI3K
CD4
Vav1
PIP2
PIP3
p85
component residue/domain
pY505
pY394
SH2
ζ-chains ITAMs
pY493
pY319
SH2-SH2
pY132
pY171
pY191
pY226
pY145
PRR
Vav1 SH2-SH3
pY511
SH2
PH
pY783
pY775
SH2-SH2-SH3
Lck
PLCγ1
Itk
SLP-76
LAT
ZAP-70
All three domains are required for activation of PLCγ1
substrates of Itk; required for the enzymatic activity of PLCγ1
bindis PIP3; may help localize Itk and PLCγ1
binds to pY145 of SLP-76
substrate of lck; Required for enzymatic activation of Itk
Stabilizes the LAT-PLC-Itk-SLP interaction
importance
substrate of csk and CD45; maintains lck in the closed conformation 
autophosphorylation site; resides in the lck activation loop; required for 
enzymatic activity
with pY505, maintains closed conformation; interacts with ZAP-70 in open 
conformation, required for downstream signaling
Docking site for ZAP-70 et al.  
Substrate lck; resides in the ZAP-70 activation loop; required for enzymatic 
activity
Substrate of lck; "locks" ZAP-70 into the active conformation; docking site for 
lck; required for downstream signaling
binds ζ-chain ITAMs; stabilizes active conformation that is "locked" by 
pY319
Substrates of ZAP-70; docking site for gads, grb-2, and Vav-1; required for 
activation of PLCγ1
Substrate of ZAP-70; docking site for PLCγ1; required for activation of PLCγ1
Substrate of ZAP-70; Docking site for Itk; required for optimal activaiton of 
PLCγ1
Docking site for Gads; required for activation of PLC
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2.2.3 Antigen-receptor signaling   
 Triggering of the antigen-receptor transmits an activating signal that passes from 
the TCR to PLCγ1 via the sequential activation of src-, syk-, and tec-family tyrosine 
kinases with each enzyme requiring a progressively more complex assembly of adaptors 
and co-enzymes to function (figure 2.4)146.  The accumulation of enzymatically active lck 
at the TCR in response to agonist ligand results in the phosphorylation of the CD3 and ζ-
chain ITAMs25;64;126.  Phosphorylation of these residues provides docking sites for the 
tandem src homology 2 (SH2) domains of the syk-family kinase ZAP-70 (ζ-chain 
associated protein of 70kDa)25.  The autoinhibited conformation of ZAP-70 is 
destabilized upon binding of the ITAMs, and receptor clustering allows trans-
autophosphorylation, or phosphorylation by lck, of tyrosines 319 and 49350.  The addition 
of phosphate at these residues stabilizes ZAP-70 in the enzymatically active 
conformation and is required for phosphorylation of downstream substrates including 
LAT (linker for activation of T cells) and SLP-76 (SH2-domain containing leukocyte 
protein of 76kDa)24;118;120;166;169;170;176. 
 LAT is a transmembrane adaptor protein that is constitutively targeted to 
cholesterol-rich membrane microdomains (lipid rafts) by palmitoylation of dual cysteine 
residues within its transmembrane domain93;176.  LAT is absolutely essential for the 
transmission of signals from the TCR to downstream pathways.  Thymocytes from LAT-/- 
mice exhibit a severe developmental block at the DN stage of T cell development 
indicating that LAT-/- cells are unable to generate the pre-TCR signals required for 
β−selection177.  LAT contains nine conserved tyrosine residues that are phosphorylated in 
response to TCR ligation, and nucleate the nascent signaling complex at the membrane 
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by serving as docking sites for several SH2-domain containing proteins including PLCγ1, 
growth factor receptor-bound protein 2 (Grb-2), the Grb-2 related adaptor protein (Gads), 
and the P85 regulatory subunit of phosphoinositide 3-kinase (PI3K)74.  Productive TCR 
signaling, however, only appears to absolutely require the tyrosines that recruit PLCγ1 
(Tyr132) and Grb-2/Gads (Tyr171, 191, and 226)92;120;178;179.   Mice expressing LAT with 
tyrosine to phenylalanine (YÆF) substitutions at only these four residues show an 
identical block in T cell development as LAT deficient mice; and conversely LAT-/- bone 
marrow transduced to express LAT containing YÆF mutations in all but these four 
residues exhibited normal T cell development when adoptively transferred into back into 
LAT deficient hosts148;179.   
 In resting T cells the adaptor protein Gads constitutively associates with SLP-76 
in the cytosol via an interaction between the src homology 3 (SH3) domain of Gads and a 
proline rich region (PRR) of SLP-76, and upon TCR ligation this complex is rapidly 
recruited to the membrane by phosphorylated LAT12;76;95;96.  The primary role of Gads is 
to deliver SLP-76 to the membrane, although this role may not be exclusive since 
thymocytes from Gads-/- mice, though unable to activate PLCγ1, are able to 
phosphorylate SLP-76 in response to TCR crosslinking96;173.     
 SLP-76 is absolutely required for productive TCR signal transduction.  
Thymocytes from SLP-76 deficient mice display a complete block in development at the 
double negative stage that is identical to the phenotype of LAT-/- mice, and conditional 
deletion of this molecule after TCR rearrangement or in Jurkat T cells completely blocks 
TCR-induced activation of PLCγ1 and induction downstream signaling 
pathways102;127;172.  Structurally, SLP-76 consists of an SH2 domain, a PRR that interacts 
18 
 
with Gads, and three n-terminal tyrosines (Tyr112, 128, and 145) that are phosphorylated 
by ZAP-70 in response to antigen-receptor stimulation84;166;171.  Each of these domains 
are essential for TCR-induced activation of PLCγ1, although, only the n-terminal 
tyrosines are absolutely required to rescue the defect in thymic development observed in 
SLP-76-/- mice89.  This requirement lies principally in the role tyrosine 145 plays in the 
recruitment of the tec-family kinase Itk (inducible T cell kinase) to the signaling 
complex, as deletion of this residue but not tyrosines 112 and 128 impaired TCR-induced 
PLCγ1 activation in Jurkat T cells58;84. 
 The recruitment of Itk to membrane localized SLP-76 is a two step process 
requiring both the Pleckstrin homology (PH) - and SH2-domains of Itk11.  In resting T 
cells this enzyme is inactive and resides in the cytosol.  TCR triggering results in the 
activation of PI3K, which generates abundant phosphatidyl (3,4,5,)-trisphosphate (PIP3) 
at the membrane and also induces the membrane-recruitment and phosphorylation of 
SLP-76.  The PH domain of Itk specifically recognizes PIP3, and results in the 
translocation of this enzyme to the membrane where phosphorylated SLP-76 provides a 
docking site for the SH2 domain, and recruits Itk into the TCR signaling complex19;150.  
Recruitment to the TCR brings Itk into close proximity with both its activator (lck) and 
primary substrate (PLCγ1)11;62;70;166.  Lck drives Itk activation by phosphorylating 
tyrosine 511, and Itk subsequently induces the enzymatic activity of PLCγ1 by 
phosphorylating this molecule on tyrosine 783 and possiblyd 77581;94;140.  The 
requirement for tec-family kinase activity to complete this final step in the TCR signaling 
                                                 
d Although, to my knowledge, direct evidence for Itk-dependent phosphorylation of tyrosine 775 has not 
been published, two pieces of evidence argue in favor of this interaction (1) the analogous site in PLCγ2, 
Tyr753, is phosphorylated by the tec-family kinase Btk in response to BCR signaling 167, and (2) 
phosphorylation of both Tyr783 and 775 of PLCγ1 is required for its enzymatic activity, and PLCγ1 
activation is abrogated by the absence of the tec-kinases Itk and Rlk 94;140 
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pathway to PLCγ1 is absolute, and although Itk predominantly fills this role in normal T 
cells; a second tec family kinase Rlk (resting lymphocyte kinase) is able to maintain some 
level of inducible PLCγ1 activation in T cells from Itk-/- mice91;94;99;140.  T cells from 
Itk/Rlk double knockout mice, however, are completely unable to activate PLCγ1 and do 
not proliferate in response to TCR ligation140. 
 A common feature of all phospholipase C enzymes is a catalytic domain that is 
split between two conserved sub-domains.  In PLCγ1 the intervening sequence between 
these sub-domains contains two SH2- and one SH3-domain, and although only the N-
terminal SH2 domain is required for recruitment of PLCγ1 to LAT, all three domains are 
required to stabilize this interaction and coordinate the tyrosine phosphorylation of 
PLCγ1 by Itk16;131.  Vav-1, the guanyl-nuceotide exchange factor (GEF) for the rho-
family GTPasese Rac-1, is particularly important in this respect, due to its ability to 
interact with both SLP-76 (directly) and LAT (possibly via Grb-2) as well as the C-
terminal SH2 domain of PLCγ142;124.  The possibility of a PLC-SH2-Vav-SLP interaction 
is particularly attractive, since in addition to forming a bridge between PLCγ1 and SLP-
76, this interaction would ideally position tyrosines 783 and 775 for phosphorylation by 
SLP-bound Itk; a proposition that is supported by the severe impairment in PLCγ1 
activation observed in Vav-1-/- mice16;40;175.  Although there are five tyrosine 
phosphorylation sites within PLCγ1, only 783 and 775 are absolutely required for the 
enzymatic activity of this molecule144.  Once activated, PLCγ1 transmits the TCR signal 
into the interior of the cell by cleaving the membrane phospholipid phosphatidyl inositol 
(4,5)-bisphosphate (PIP2) into the second messengers diacyl glycerol (DAG) and inositol 
(1,4,5) trisphosphate (IP3). 
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2.2.4 TCR signaling to the nucleus 
 The DAG and IP3 generated by PLCγ1 feeds into three major signaling pathways 
that drive immediate-early gene expression and T cell activation.  The primary recipients 
of the DAG second-message are the guanyl-nucleotide releasing protein for the small 
GTPase RAS (RASGRP) and several members of the protein kinase C (PKC) family of 
enzymes, most notably in the context of TCR signaling, PKCθ6;56.  Activation of 
RASGRP by DAG initiates a mitogen activated protein kinase (MAPK) signaling 
cascade that induces gene expression by activating multiple transcription factors 
including Elk-1 and the c-fos sub-unit of the transcription factor activator protein-1 (AP-
1)44.  PKCθ is essential for many aspects of T cell activation, and its activation initiates 
signals that are essential for activation of the NFκB-family of transcription factors 69.  IP3 
is a soluble inducer of calcium signaling, and its release into the cytosol triggers a 
sustained elevation of intracellular calcium that is required for activating members of the 
nuclear factor of activated T cells (NFAT) family of transcription factors.        
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SIGNALING THROUGH DAG PART 1—RASGRP 
 Small GTPases such as RAS act as molecular switches; alternating between active 
and inactive conformations depending on whether they are bound to GTP or GDP 
(guanosine tri- (di-) phosphate) respectively.  The active conformation is induced by 
guanyl-nucleotide exchange factors (GEFs) that catalyze the exchange of GDP for GTP; 
small GTPases will eventually auto-inactivate by hydrolyzing GTP to GDP, but this 
process typically requires catalysis a by a GTPase activating protein (GAP) to occur on a 
physiologically relevant timescale.  Activation of small GTPases occurs at cellular 
membranes, and once activated these molecules serve as platforms for downstream 
signaling.         
 The canonical signaling pathway from receptor tyrosine kinases to RAS involves 
the Grb-2 mediated recruitment of the GEF son of sevenless (SOS) to the receptor.  In 
TCR-induced activation of the RAS/MAPK signaling pathway, however, SOS is 
subordinate to the DAG-responsive GEF RASGRP54;56;135.  RASGRP contains DAG- and 
Ca2+-binding domains, and is rapidly recruited to cellular membranes in response to 
TCR-triggering55;98.  The binding of DAG and phosphorylation by PKCθ induces the 
catalytic activity of RASGRP resulting in a rapid accumulation of RAS-GTP in DAG 
rich membranes134.  GTP-bound RAS recruits the MAP3Ke RAF into an oligomeric 
complex at the membrane that, along with phosphorylation at multiple residues, induces 
RAF to assume an active conformation and phosphorylate MEK113;122.  MEK and the 
extracellular regulated kinase (ERK), the MAP2K and MAPK in this cascade, are 
recruited into this complex by the adaptor protein KSR (kinase-suppressor of RAS).  
                                                 
e MAPK signaling cascades are typified by kinases activating kinases activating kinases, and hence the 
terminology MAPK, MAPK kinase (MAPKK or MAP2K), MAPKK kinase (MAPKKK or MAP3K) etc.  
The MAPNK designation is used here.   
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MEK constitutively associates with both KSR and ERK in the cytosol, and TCR 
triggering unmasks an ERK docking site and DAG binding domain within KSR that 
targets these molecules to RAF at the membrane104.  Membrane-localized RAF 
phosphorylates MEK, inducing its activation, and MEK, in turn, phosphorylates and 
activates the p44 and p42 MAPKs ERK-1 and -2 (ERK-1/2 = ERK unless stated 
otherwise). 
 ERK has diverse downstream targets and the substrate-specificity of this MAPK 
is dictated to a large extent by its sub-cellular localization.  Phosphorylation of ERK 
disrupts the association of this enzyme with MEK, and in the absence of the latter 
molecule’s nuclear export sequence activated ERK preferentially translocates to the 
nucleus2.  Alternatively, ERK can also be targeted to various cytosolic compartments 
through interactions with a number of adaptor proteins128.  In many cases these adaptors 
prevent or inhibit ERK from entering the nucleus and/or re-locating to other cytosolic 
compartments.  For example β-arrestin can stabilize the RAF-MEK-ERK interaction to 
sequester these enzymes at the membrane; similarly the Golgi-membrane adaptor protein 
Sef1 (similar expression to fgf-1) binds MEK and prevents the release of activated ERK 
from the Golgi145;156.  The activity of ERK is unaffected by these interactions, and 
sequestration principally serves to limit the availability of substrates.  The functional 
outcome of RAS/MAPK signaling can therefore vary greatly depending on whether this 
MAPK principally phosphorylates cytosolic or nuclear targets115.    
 In T cells, two important cytosolic targets of ERK are the MAPK activated 
protein kinases (MAPKAPKs) RSK2 and MSK1 (90kDa ribosomal S6 kinase and 
mitogen and stress activated kinase respectively).  The activation of these MAPKAPKs 
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expands the downstream substrates targeted by RAS/MAPK signals including the cyclic 
AMP response element binding protein (CREB) whose activation is critical for 
progression through the cell cycle8;60;117.  Key nuclear substrates of ERK are Elk-1 and 
members of the AP-1 family of transcription factors129.  These molecules are responsible 
for the expression of many immediate-early genes including c-fos and c-Rel, both of 
which are essential for many aspects of T cell activation including the TCR-induced 
secretion of IL-2 and the expression of the high-affinity IL-2 receptor77.           
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Figure 2.6.  A schematic diagram of signal transduction from PKCθ to NFκB.  
Arrows indicate enzymatic activity; diamonds indicate protein-protein interactions.  
Abbreviations and specific details are provided in the text.        
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SIGNALING THROUGH DAG PART 2—PKCθ  
 PKCθ is a member of the novel class of PCKs that require DAG but not Ca2+ for 
their activation.  Although T cells express several PKC isozymes, only the θ isoform 
translocates to the immunological synapse in response to TCR triggering6;112.  This 
translocation is mediated by DAG, and the binding of DAG by PKCθ is thought to 
induce an active conformation that is subsequently stabilized by trans-
autophosphorylation and also phosphorylation by lck and PDK1 (phosphoinositide 
dependent kinase-1) on tyrosine 90 and threonine 538 respectively90;97.  PKCθ is central 
to many aspects of T cell activation including rearrangement of the actin cytoskeleton, 
TCR downmodulation and activation of the transcription factor NFκB, and mutations 
affecting PKCθ cause severe defects in T cell activation138;151;164.   
 Rearrangement of the actin cytoskeleton is essential to T cell activation, and loss 
of function mutations in key cytoskeletal regulatory elements such as the Wiscott-Aldrich 
syndrome protein (WASP) lead to immunodeficiencies arising from impaired T cell 
activation5;13.  In resting T cells WASP resides in the cytosol in an inactive conformation 
that is stabilized by an interaction with the WASP interacting protein (WIP)4.  Upon TCR 
ligation the WIP-WASP complex is indirectly recruited to SLP-76 via the cytoskeletal 
adaptor protein Nck, and the WIP-WASP interaction is disrupted by PKCθ-mediated 
phosphorylation of WIP7;138;174.  The TCR signal also induces tyrosine phosphorylation of 
Vav-1, which subsequently catalyzes the small GTPase CDC42 to exchange GDP for 
GTP, and activate the newly liberated WASP to induce actin polymerization via the Arp-
2/3 complex71.              
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 TCR-engagement by peptide-MHC or mitogenic antibodies leads to receptor 
downregulation.  This process depends upon activation of a dileucine-based receptor-
sorting motif within the CD3 γ-chain53.  Upon recruitment to the TCR, PKCθ activates 
this motif by phosphorylating serine 126 resulting in a rapid loss of TCR expression at 
the cell surface164.   
 The 5-member NFκB-family of transcription factors consists of RelA (p65), 
RelB, c-Rel, NFκB1 (p50) and NFκB2 (p52).  In resting T cells the NFκB family 
members are retained in the cytosol through inhibitory interactions with the inhibitor of 
κB (IκB) proteins61.  Activating signals target the IκB proteins for degradation, allowing 
the NFκB family members to dimerize with one another and translocate to the nucleus 
where they initiate gene expression.  This process is linked to antigen-receptor signaling 
by the PKCθ−mediated activation of the CBM complex (CARMA1, BCL10, and 
MALT1; fig. 2.6)141.  The lipid second-messengers generated in response to TCR-
signaling activate PKCθ and co-localize this enzyme with CARMA1 (caspase-
recruitment domain (CARD)-membrane-associated guanylate kinase (MAGUK) protein 
1)  at the membrane.  PKCθ subsequently phosphorylates CARMA1 on multiple serine 
residues, which are essential for the recruitment of BCL10 (B cell lymphoma 10) and 
MALT1 (mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1) into the 
nascent CBM complex.  These molecules are recruited into the CARMA1 signalosome in 
groups of three, which places MALT1 into a configuration reminiscent of the trimeric 
intracellular domains of ligated tumor necrosis factor receptors (TNFR), and allows the 
recruitment of the ubiquitin ligase TRAF6 (TNFR-associated factor 6) into the complex.  
The ubiquitin-mediated oligomerization cascade initiated by this molecule recruits 
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enzymatic complexes containing the kinases TAK1 (transforming-growth-factor-β 
(TGFβ)-activated kinase 1) and the IκB kinase (IKK)130.  The latter enzyme is a MAP3K 
that constitutively associates with one or more TAK binding proteins (TABs) that contain 
the ubiquitin-binding domains (UBDs) responsible for the association between TAK1 and 
TRAF6165.  IKK is a heterotrimeric complex comprised of two enzymatic, IKK-α, -β, and 
one regulatory, IKKγ, sub-unit.  IKKγ mediates the recruitment of IKK to the CBM 
complex, and IKKβ is subsequently activated by phosphorylation on serine residues 171 
and 181 by TAK107.  Enzymatically active IKKβ phosphorylates the IκB proteins leading 
to their degradation and the release of NFκB family members from inhibition.  The 
NFκB family members liberated by this process form dimers, and translocate to the 
nucleus where they regulate the transcription of genes containing κB elements within 
their promoter sequences.   
SIGNALING THROUGH IP3—CALCIUM AND THE ACTIVATION OF NFATf 
 The IP3 portion of the PLCγ1signal diffuses away from the membrane and is 
bound by specific receptors (IP3R) expressed on the cytosolic face of the endoplasmic 
reticulum (ER).  Triggering of these receptors leads to a transient increase in cytosolic 
calcium due to its release from intracellular stores.  This initial spike in intracellular 
calcium is not sufficient to induce signaling to NFAT, but rather promotes the influx of 
extracellular calcium into the cell by activating calcium-release-activated calcium 
(CRAC)-channels in the plasma membrane.  Opening of the CRAC channels provides the 
sustained elevation of calcium required for activation of NFAT.  The most important 
                                                 
f The work described in this thesis does not address signaling through NFAT and a detailed description of 
the activation and function of this family of transcription factors will not be provided here.  For more 
information regarding NFAT and calcium signaling the reader is referred to excellent reviews by 
Macian101, Crabtree & Olsen41, and Hogan et al.72.   
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transducer of intracellular calcium signals is the small, calcium-binding protein 
calmodulin.  Calmodulin activates the serine phosphatase calcineurin, which then binds 
to and dephosphorylates cytosolic NFAT.  Dephosphorylation of NFAT unmasks a 
nuclear localization sequence resulting in the migration of this transcription factor to the 
nucleus and expression of NFAT-dependent genes (typically in conjunction with AP-1).      
2.3 Immune function, spaceflight and the RWV 
 The first indication of altered immunity during spaceflight was the high incidence 
of infectious disease in astronauts during or just following orbital flight68.  NASA 
addressed this problem by implementing a flight-crew health stabilization program that 
required better sanitary controls for all mission equipment and instituted a period of pre-
flight quarantine for all astronauts10.  The success of this program clearly demonstrated 
that latent or sub-clinical infections could manifest as full-blown illness during 
spaceflight, and set in motion a number of investigations to determine the effects of 
spaceflight on the immune system.  Some of the earliest investigations of this type used 
ex vivo stimulation of peripheral blood mononuclear cells (PBMC) drawn from astronauts 
prior-to and just following spaceflight as an indicator of cellular immunity.  These studies 
found that cells in the peripheral blood of astronauts drawn immediately following 
spaceflight exhibited a decreased ability to proliferate and secrete cytokines in response 
to the T cell mitogen phytohemagglutinin (PHA)43;152.  These results were subsequently 
confirmed in vivo by testing astronauts for delayed-type hypersensitivity (DTH)g 
                                                 
g Delayed-type (a.k.a. type IV) hypersensitivity is a localized inflammatory response mediated by memory 
CD4+ TH1 cells and macrophages (both as APC and part of the cellular infiltrate).  Tests of the DTH 
response are sometimes used as a general indicator of cellular immune function.  These tests are 
administered by subcutaneously injecting small amounts of a recall antigen, and measuring the resulting 
induration at the injection site.          
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reactions to several common recall antigens32.  In these studies, the in-flight DTH-
reactions of ten shuttle astronauts were tested over the course of three missions and found 
to be consistently decreased compared to pre-flight values153.   
 The results of ex vivo studies and DTH testing firmly established that astronauts 
experience a decline in cellular immunity during spaceflight, but offered little 
information about the mechanisms of this decline.  A confounding factor of these studies 
is their inability to separate any direct effects of the spaceflight environment on immune 
cells from indirect effects due to the physical- and psychological-stress placed on 
astronauts during orbital missions34;149.  Although the adverse affect of stress on 
immunity is well established, attempts to correlate the levels of stress hormones in the 
blood or urine of astronauts with the results of ex vivo testing have produced mixed 
results and ground-based studies have done little to clarify the role of stress in 
spaceflight-induced immunosenescence29;80;109;137.  Microgravity, however, has been 
shown to have a profound effect on the activation of immune cells during spaceflight31.   
 The ability of microgravity to directly affect immune cells was first demonstrated 
in a series of experiments conducted during the Spacelab missions that subjected human 
T cells to in vitro culture during spaceflight35.  In these experiments PBMC were shown 
to be unresponsive to stimulation with the T cell mitogen concanavalin A (ConA) unless 
cultured in artificial 1-g conditions produced by an in-flight centrifuge.  Data generated 
during subsequent flights using fluorescently labeled ConA confirmed that this inhibition 
was a genuine cellular phenomenon since receptor capping and agglutination were only 
minimally affected by culture in the microgravity environment36.  Given the requirement 
for monocyte-derived second signals (either soluble or intercellular) to drive lectin-
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mediated T cell activation and IL-2 production, and the minimal cell-substratum 
interactions that take place in microgravity; the loss of ConA-induced T cell proliferation 
during culture in spaceflight was initially thought to be secondary to defects in adherent 
accessory cells such as monocytes9;63;154;163.  This hypothesis quickly fell out of favor, 
however, since PBMC encapsulated in collagen beads prior to launch were still 
functionally defective during spaceflight, and addition of exogenous IL-1, a primary 
cytokine produced by monocytes, or IL-2 was unable to rescue ConA-induced 
proliferation during microgravity culture121;125.  Furthermore, purified T cells that were 
stimulated with bead immobilized antibodies against CD3 and CD28 (stimulus that is 
thought to be independent of accessory cells) also failed to become activated during 
spaceflight67.   
 A common aspect of T cell activation by mitogenic lectins and antibodies is the 
requirement for antigen-receptor signaling from the surface of the cell to the interior.  
The requirement for receptor generated signals can be bypassed using phorbol esters, 
such as phorbol myristate acetate (PMA), and calcium ionophores such as ionomycin, to 
directly activate second-messenger signaling pathways downstream of the TCR.  PMA is 
a structural analog of DAG, and can activate enzymes such as PKCθ that contain a DAG 
binding domain.  Ionomycin generates an increase of intracellular calcium by actively 
shuttling calcium ions across the cell membrane, and activates calcium signaling in a 
manner similar to IP3.  In contrast to the inability of surface mitogens to activate T cells 
during spaceflight, T cells stimulated with PMA and ionomycin during spaceflight were 
fully competent to express the activation marker CD69, and only partially blocked from 
upregulating the high-affinity IL-2 receptor CD2567.  This finding provided the first 
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direct evidence that defective T cell activation in microgravity lie not in the ability of the 
cell to become activated, but rather in the ability of the cell to transduce activating signals 
from the TCR.  Importantly this result also represented the first instance in which a 
phenomenon predicted by ground-based models of microgravity (see below) was tested 
and confirmed in true microgravity.                                  
 The rise in use of ground-based models of microgravity (modeled microgravity, 
MMG) culture has paralleled the need for more mechanistic investigations of the cellular 
phenomena observed during spaceflight.  The increased complexity inherent in these 
types of investigations presents a severe obstacle for in-flight studies given the limited 
opportunities and logistical difficulties of conducting experiments in true microgravity.  
Mechanistic, ground-based studies of T cell activation in microgravity have relied heavily 
on rotating-wall vessel (RWV) bioreactors to mimic the in vitro culture conditions 
experienced by T cells during spaceflight.  The RWV is a zero-headspace suspension-
culture system that utilizes solid-body rotation to randomize the gravitational vector and 
suspend cells in a state of low-shear freefall that effectively reduces the gravitational 
force experienced by cultured cells to 10-2xg83;142;158.  Importantly, the selective inhibition 
of T cell activation in response to receptor-mediated stimulus that is seen in true-
microgravity culture is recapitulated when T cells are stimulated in the RWV33;38;67.   
 The comparative ease of performing experiments in the RWV vs. spaceflight has 
allowed for a much more detailed investigation of the effects of MMG on T cell 
activation.  In accordance with the finding that T cells are unresponsive to mitogenic 
lectins and antibodies during RWV culture, stimulation of T cells with peptide-loaded 
antigen presenting cells or in a mixed lymphocyte reaction also fails to induce T cell 
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proliferation in the RWV38;39;39;67.  Similarly, CD8+ T cells isolated from the lymph nodes 
of immunized mice fail to generate a cytotoxic response to target cells loaded with the 
immunizing peptide after culture for several days in the RWV139.  In accordance with 
observations in true-microgravity, inhibition of T cell function by the RWV was also 
found to be independent of both cell-cell and cell-substrate interactions.  Increasing the 
cell density in the bioreactor to promote cell-cell interactions did not rescue the ability of 
PBMC to proliferate in response to PHA, and conversely, stimulation of PBMC in Teflon 
coated bags that prevent cell-substratum interactions did not significantly hamper T cell 
activation by PHA38.   
 The most compelling evidence to date that T cells experience a specific inhibition 
of activation signaling pathways during culture in MMG comes from two studies that 
measured T cell activation in response to a variety of mitogens during culture in 
RWVs38;67.  In the first study it was shown that both PBMC and purified T cells 
stimulated with PMA + ionomycin proliferated to the same extent in both 1-g and MMG 
conditions38.  This finding was the first demonstration that the inhibited activation of T 
cells in the RWV was due to a disruption of receptor-proximal signals rather than an 
intrinsic defect in the ability of T cells to become activated in the TCR.  The suggestion 
of these results that once the activating signal is delivered T cells should be able to 
function normally in the RWV is supported by the finding that pre-activating PBMC with 
PHA at 1-g allows there proliferation during subsequent culture in the RWV.  The most 
important finding of this study, however, was the finding that co-stimulation with sub-
mitogenic doses of PMA could partially rescue PHA-induced T cell proliferation during 
culture in the RWV   A similar rescue of activation was not observed with ionomycin and 
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the addition of calcium ionophore could not enhance the ability of PMA to rescue T cell 
activation in the RWV indicating that calcium signaling remains intact during MMG 
culture.  The second report of this nature confirmed that sub-mitogenic PMA could 
rescue the activation of PHA-stimulated T cells in the RWV, and extended this result by 
showing that rescue was also observed when mitogenic antibodies were used as the 
stimulus67.  One important aspect of this study was the authors’ use of flow cytometry to 
quantify T cell activation, which clearly demonstrated that PMA fully (or near fully) 
rescued activation in a subset of T cells rather than partially rescued the activation of all 
T cells.  The exact subsets whose activation is rescued, however, is an area that has yet to 
be explored.   
 In summary, the results of both in-flight and ground-based investigations of T cell 
activation in microgravity implicate altered signaling between the TCR and nucleus as 
responsible for failed T cell activation in spaceflight and the RWV.  While this 
conclusion represents considerable progress in our knowledge of this phenomenon, there 
is still a considerable gap in our understanding of the underlying mechanisms of T cell 
signaling that are sensitive to changes in the gravitational force.  Although a number of 
recent studies have provided a degree of mechanistic information using gene arrays and 
single biochemical measurements at various points within the T cell activation pathway, a 
step-by-step investigation of the T cell activation signal itself has yet to be undertaken.  
The studies presented herein were conducted with the goal of making just such an 
investigation, and provide the most detailed accounting to date of the TCR signal as it 
progresses from receptor to nucleus.  The data from these studies indicate that the TCR 
signal itself is unaffected by culture in the RWV, but that DAG-producing co-stimulatory 
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signals may instead be altered in microgravity.  Our results suggest a mechanism for the 
inhibition of T cell activation in the RWV where ERK becomes sequestered in the 
cytosol, and the resulting loss of ERK-induced immediate-early and early gene 
expression including c-fos, c-Rel, and c-myc, abrogates T cell activation. 
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CHAPTER 3: EXPERIMENTAL DESIGN 
 
3.1 Hypothesis and Rationale 
 The studies described in the preceding chapter clearly show that 
 
 
T lymphocytes 
do not suffer from an intrinsic cellular defect during microgravity culture that prevents 
their activation, but rather are inhibited in their capacity to transduce activating signals 
from the surface to the interior of the cell.  The ability of sub-mitogenic PMA to 
ameliorate activation in response to receptor stimulation strongly implicates PLCγ1 
and/or signaling downstream of the DAG second-messenger in this inhibition.  The 
inability of ionomycin to confer a similar enhancement implies that some degree of 
PLCγ1 activity is present in T cells stimulated in microgravity, and that this activity is 
sufficient for productive signaling via IP3 but not DAGh.  These studies form the basis of 
the central hypothesis of this thesis—that T cells are unresponsive to receptor stimulation 
during culture in microgravity and microgravity analogs due to inhibited signaling 
through the DAG second-messenger pathway. 
3.2 Experimental Design   
 There is an abundance of molecular mechanisms that have evolved to convert 
stimuli at a cell’s surface into functional and genetic changes within the interior of the 
cell.  A common theme of these mechanisms is the use of lipid-derived intermediates to 
amplify and transduce signals at the membrane into the interior of the cell.  In T cells 
DAG connects the membrane-proximal signal that activates PLCγ1 with critical 
                                                 
h This conclusion is supported by a report that Jurkat T cells with a greater than 90-% reduction in PLCγ1 
expression were fully competent to induce transcription of an NFAT reporter construct, but inhibited in 
their ability to induce NFκB or AP-1 dependent gene expression75.   
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downstream pathway eased production or 
accumulation of DAG at the membrane, or decreased activation of PKCθ and/or 
n response to antigen-receptor stimulation.  A 
3.2.1 Experimental model 
 The experiments described in this thesis investigate signal transduction by 
primary human CD4  T cells in response to crosslinking of the TCR and CD28 co-
stimulatory molecule (CD3XCD28).  CD4  T cells were chosen for study based on the 
observation that astronauts experience a decrease in delayed-type hypersensitivity during 
spaceflight, and this type of hypersensitivity is primarily mediated by CD4  T cells.  
CD3XCD28 was used as stimulus based on several considerations (1) T cells have been 
insensitive to this stimulus in the RWV, (2) CD3XCD28 
aspect-ratio vessel (HARV)-type RWV as the ground-based model of microgravity 
c as 
s by activating PKCθ and RASGRP.  Decr
RASGRP impairs T cell activation i
reduction in signaling to or from any one of these enzymes could, therefore, result in the 
PMA-sensitive inhibition of T cell activation observed during microgravity culture.  The 
experiments presented in the following three chapters were designed to investigate a 
possible breach in TCR signaling at each of these points during culture in a ground-based 
microgravity analog system, the RWV 
+
+
+
shown (by us and others) to be 
defines the source of activating signals, and allows the precise control of stimulation 
since activating signals are not transmitted until the crosslinking agent is added to the 
cells, and (3) CD3XCD28 allows for the study of a mitogenic signal, rather than just a 
triggering signal as with CD3XCD3. 
 All of the experiments described in this thesis were conducted using a high 
ulture.  The HARV has been extensively validated both in our lab and in the literature 
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a model of microgravity for ground-based studies of T cell activation in microgravity.  
The dual syringe-port design of the HARV is also particularly well suited for the 
experiments carried out during the course of this thesis (see below and chapter 4 
methods).  The terms RWV, HARV, and bioreactor will be used interchangeably 
throughout this document to refer to the HARV-type RWV.            
3.2.2 Special considerations for processing samples from the RWV 
 Many of the experimental methods used in this study make direct measurements 
of the post-translational modifications and oligomerization cascades that transmit an 
ce to the interior of a cell.  These processes are in many 
cells.  Western blots are less 
activating signal from the surfa
cases labile, and generally occur on a timescale of seconds to minutes.  Directly 
measuring these processes required several special considerations to avoid processing 
artifacts due to the requirement that the cells be removed from the RWV at the end of 
each experiment.  This issue was addressed by (1) always stimulating the cells directly in 
the RWV without stopping rotation, and (2) terminating each experiment by removing 
the cells from the RWV directly into 2x fixative or ice-cold buffer (w/phosphatase 
inhibitors), also without stopping rotation. 
3.2.3. Summary of methods   
 The two primary methods used throughout this thesis are flow cytometry and 
Western blots.  The former offers the advantage of making measurements in situ, and 
provides highly quantitative data at the level of individual 
quantitative, and measure the average signal of a bulk population of cells, but provide 
detailed information regarding the proteins generating the signal.  These methods provide 
a complimentary approach to measure signal transduction.  Flow cytometry to make 
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quantitative measurements for statistical calculations and Western blots to verify that the 
signal being quantified derives from the protein under study.   
 The precise details of the experiments carried out during the course of this 
research are provided in the appropriate chapters and are summarized in table 3.1.  A 
common theme shared by each chapter is DAG.  Chapter 1 investigates the transmission 
of the activating signal from the TCR to PLCγ1 that results in the generation of DAG.  
Chapter 2 measures the activation of PKCθ in response to DAG, and the ability of this 
enzyme to induce downstream signaling through the NFκB pathway.  In Chaper 3 the 
ability of RASGRP to respond to DAG and induce MAPK signaling to ERK is examined.  
Taken together, the data from these experiments provides a detailed snapshot of a TCR-
induced mitogenic signal as it progresses from the membrane to the nucleus via the DAG 
second-messenger pathway.             
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Figure 3.1.  Summary of the experimental design for investigating signal transduction 
through the DAG second-messenger pathway during RWV culture.    
  
DAG
CHAPTER 4: TCR ÆPLCγ1
Hypothesis: Inhibited signal transduction from 
activation of PLCγ1 
Readouts: site-specific tyrosine phosphorylation 
of key TCR signaling molecules
Methods: flow cytometry, Western blot
CHAPTER 5: DAGÆPKCΘ
the TCR during RWV culture leads to decreased 
Hypothesis: DAG –induced activation of PKCθ
and/or signaling through NFκB is inhibited by 
culture in the RWV
Readouts: actin polymerization, TCR 
downmodulation, IκB degradation, ICAM-1 
expression
Methods: flow cytometry, Western blot
CHAPTER 6: DAG ÆRASGRP
Hypothesis: DAG –induced activation of 
RASGRP and/or signaling through RAS/MAPK 
is inhibited by culture in the RWV
Readouts: ERK activation and sub-cellular 
localization, CD69 expression
Methods: flow cytometry, Western blots, 
confocal microscopy
enger pathway.
CD4+ T lymphocytes are unresponsive to receptor stimulation in the RWV due to
inhibited signal transduction through the DAG second‐mess
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CHAPTER 4: SIGNALING FROM THE EXTERIOR—TCR TO PLCγ1 
 
 
 
4.1. Introduction 
 Culture of T cells in rotating-wall vessel (RWV) bioreactors abrogates their 
activation in response to mitogenic lectins and antibodies38;132;147.  The activation of 
receptor-stimulated T cells cultured in the RWV can be partially rescued by co-
stimulation with sub-mitogenic doses of phorbol myristate acetate (PMA), and T cells are 
fully responsive to stimulation with mitogenic combinations of PMA and ionomycin38;67.  
PMA and ionomycin directly activate the diacyl glycerol (DAG) and inositol 
trisphosphate (IP3) signaling pathways that lie downstream of phospholipase Cγ1 
(PLCγ1) and the above findings suggest that T cells are defective in their ability to 
activate PLCγ1 during culture in the RWV.                            
 The activation of PLCγ1 in response to TCR-triggering requires the 
phosphotyrosine-mediated assembly of an ad hoc signaling network at the membrane.  In 
resting T cells the antigen receptor is primed to signal but prevented from doing so by a 
tightly regulated equilibrium between the tyrosine-kinase and -phosphatases that regulate 
the src-family kinase lck.  TCR engagement by agonist ligands shifts this equlibrium in 
subs uent tyrosine 
hosphorylation of the adap r proteins LAT and SLP-76 by ZAP-70 promote their 
association and nucleates the assembly of a multimeric complex containing both the tec-
family kinase Itk and PLCγ1.  Upon recruitment into this complex Itk is phosphorylated 
and activated by lck, and in turn phosphorylates PLCγ1 to promote its enzymatic activity.     
favor of activated lck, and lck phosphorylates the ζ-chain ITAMs allowing the syk-family 
kinase ZAP-70 to be recruited to the receptor and activated.  The eq
p to
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  cell 
ctivation, and disruptions in the pathway leading to the activation of this enzyme can 
ogate mitogen-induced T cell growth and cell-cycle entry65.  The 
The TCR-induced induction of PLCγ1 activity is an essential step for T
a
inhibit or completely abr
working hypothesis of the study described in this chapter is that T cells fail to activate 
PLCγ1 in response to TCR-triggering during culture in the RWV due to defective signal 
transduction between the TCR and PLCγ1.  This hypothesis was investigated by making 
a direct comparison of the activating signals produced by CD4+ T cells in response to 
TCR-crosslinking in the RWV and static conditions.  This was accomplished using site-
specific tyrosine phosphorylation of several molecules within the signaling pathway to 
monitor the progression of an activating signal as it is passed from src- (ζ-chain and 
ZAP-70 phosphorylation) to syk- (SLP-76 phosphorylation) and finally to tec-family 
kinases (PLCγ1 phosphorylation).   
 Surprisingly we found that culture in the RWV had no affect on the induction of 
the tyrosine phosphorylation of any of these molecules, and with the exception of Itk 
(which proved to be unquantifiable) we were unable to detect any differences in the 
magnitude of induced phosphotyrosine between static and RWV conditions.  Based on 
the phosphorylation of tyrosine 783 we conclude that PLCγ1 becomes fully activated in 
the RWV, and that the microgravity sensitive mechanisms of T cell activation must lie in 
the DAG-responsive pathways downstream of this enzyme.      
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4. Materials and Methods 
4.2.1 Antibodies and reagents 
2 
 Cells were immunostained for flow cytometry using fluorescently conjugated 
antibodies against phosphorylated tyrosine (pY) residues of the ζ-chain[pY142], ZAP-
70[pY319], Btk[pY551]/Itk[pY511], SLP-76[pY128], and PLCγ1[pY783] that were 
purchased from BD Biosciences (San Jose, CA).  For phospho-specific Western blot 
analysis, unconjugated antibodies against ZAP-70[pY319] and PLCγ1[pY783] were 
purchased from BD and Invitrogen (Carlsbad, CA) respectively.  Pan-specific antibodies 
against ZAP-70 and PLCγ1 were purchased from Cell Signaling Technology (Danvers, 
MA, USA) and Sigma-Aldrich (St. Louis, MO).  HRP-conjugated secondary antibodies 
used for Western blots were polyclonal anti-rabbit or -mouse IgGs raised in goat (Pierce, 
Rockford, IL).  Mouse monoclonal IgG against human CD3 (clone OKT3) and CD28 
(clone CD28.2) purchased from eBioscience (San Diego, CA), and a goat F(ab′)2 against 
c
althy human donors were 
purchased from Biological Specialty Corporation (Colmar, PA, USA).  Untouched CD4+ 
of unwanted cells using the 
CD4+ T cell isolation kit II from Miltenyi Biotec (Auburn, CA, USA).  Briefly, PBMC 
were labeled with magnetic beads according to the manufacturer’s protocol and the 
the F  region of mouse IgG purchased from Upstate (Charlottesville, VA) were used to 
stimulate T cells in these experiments. 
4.2.2 Cell purification and culture 
 PBMC were purified by gradient centrifugation of freshly isolated buffy coats 
over histopaque 1077 (Sigma-Aldrich).  Buffy coats from he
T cells were isolated from PBMC by magnetic depletion 
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unlabeled CD4+ T cells were eluted from the cell suspension using an AutoMACSpro cell 
sorter (Miltenyi Biotec).  Following magnetic enrichment, the cell suspension used in 
these experiments typically contained greater than 86-% CD4+ T cells (see appendix A).  
The purified CD4+ T cells were counted, washed and suspended in RPMI or PBS (w/Ca2+ 
& Mg2+) at a density of 2E6/ml, and incubated at 37 °C/5-% CO2 in a humidified 
incubator for at least 30-minutes prior to experimentation.  
 
 
Figure 4.1. A high aspect ratio vessel (HARV)-type RWV bioreactor.  
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4.2.3 Direct stimulation of T cells within the RWV  
 Signal transduction through the TCR occurs on a timescale of seconds to minutes 
following receptor triggering.  Accordingly our experiments were designed so that the 
cells could be stimulated directly within the dynamic culture environment of the RWV 
(fig. 4.2).  To accomplish this, T cells were first labeled with mouse monoclonal 
antibodies against CD3 and CD28 each at 2.2-μg/ml for 15-minutes on ice.  A portion of 
the labe erred to a 15-ml centrifuge tube (VWR, Bridgeport, NJ) 
for the static control sample, and 9-ml of the cell suspension was used to load a 10-ml 
HARV-type (Synthecon, Houston, TX; fig. 4.1) RWV to capacity under slightly negative 
pressure.  Both the 15-ml tube and the RWV were incubated for 15-minutes at 37 °C for 
5-minutes to allow the cell suspension to reach physiological temperature prior to 
stimulation.  The RWV was rotated at 14-rpm during this period.  The cells were 
subsequently stimulated by direct addition of a 1/10th volume aliquot of anti-mouse IgG 
at 100-μg/ml.  This was achieved without stopping rotation of the HARV by 
simultaneously injecting 0.5-ml of antibody solution into each of the two syringe ports of 
the RWV.  The stimulated cells were incubated at 37 °C and then processed for flow 
cytometry or Western blot as described below.  The final concentration of antibodies in 
g/ml goat anti-
ouse IgG.  A sham-stimulated control was included in all experiments to measure basal 
rosine phosphorylation. 
  
led cells were then transf
stimulated samples was 2-μg/ml each of anti-CD3 and –CD28, and 10-μ
m
ty
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Figure 4.2.  Flowchart of the procedure for stimulating T cells in the RWV.  Purified 
human CD4+ T cells were stimulated in the HARV according to the above diagram.  
Briefly, cells were labeled with anti-CD3 and –CD28 antibodies on ice.  Cells were then 
warmed to 37 °C in the appropriate culture venue, and labeled surface-receptors were 
subsequently crosslinked by direct addition of anti-mouse IgG.  Experiments were 
terminated by the direct addition of 4-% PFA to the cells (2-% final concentration).    
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4.2.4 Sample processing for Immunofluorescent detection of site-specific tyrosine 
phosphorylation by flow cytometry 
  
 For analysis of tyrosine phosphorylation by flow cytometry T cell stimulation was 
terminated by the direct addition of 4-% paraformaldehyde (PFA) to each sample at a 
ratio of 1:1 (i.e. 2-% PFA final).  For T cells stimulated within the RWV, this was 
accomplished by withdrawing 5.5-ml of cell suspension into a 10cc syringe containing 
5.5-ml (exactly ½-full) of 4-% PFA without stopping rotation.  Cells were then processed 
for the detection of site-specific tyrosine phosphorylation by flow cytometry according to 
an optimized procedure based on protocols published by Perez et al, Krutzik et al, and 
Chow et al30;87;123.  Briefly, cells were fixed in 2-% PFA for 10-minutes at 37 °C and then 
permeabilized for at least 30-minutes (and no longer than overnight) in 90-% methanol at 
4 °C.  Cells were then washed and blocked for 30-minutes at room temperature in PBS + 
15-% normal mouse serum (Sigma-Aldrich).  Each sample was then divided into 0.5E6 
cell aliquots that were stained for 60-minutes on ice with fluorescently-conjugated 
antibodies against phospho-specific epitopes of the ζ-chains, ZAP-70, SLP-76 or PLCγ1.  
Cells were then washed and immediately analyzed by flow cytometry. 
 sis of tyrosine phosphorylation by Western blot T cell stimulation was 
he presence of phosphatase 
inhibitors.  For the static control samples this was accomplished by adding 5-ml of ice-
cold PBS + 1 μM Na3VO4 + 5μM EDTA (final) and immediately placing the sample on 
ice.  Cells cultured in the HARV were rapidly removed from the RWV using a 10cc 
syringe and immediately transferred to a 15-ml tube containing 5-ml of PBS + 
4.2.5 Sample processing for detection of phosphorylated proteins by Western blot 
For analy
terminated by rapidly cooling the samples to 4 °C in t
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Na3VO4/EDTA on ice.  The cells were then pelleted and lysed by suspension in lysis 
buffer consisting of 10mM Tris HCl pH7.2, 150mM NaCl, 2mM EDTA, 50mM NaF, 
10mM Na2P4O7, 1mM Na3VO4, 1mM PMSF, 1-% NP-40, and protease inhibitor cocktail 
(Sigma-Aldrich).  Lysates were incubated for 30-minutes on ice, insoluble material was 
pelleted by centrifugation at 13,500xg in a 4 °C microfuge, and supernatants were stored 
at -80 °C until analysis by Western blot.  The protein concentration of lysates was 
measured using a BCA assay kit (Pierce) following the manufacturer’s recommended 
protocol scaled down by a factor of four. 
 Following electrophoresis, gels were soaked for at least 10-minutes in tris/glycine 
transfer buffer to leach SDS from the gels, and were electrotransferred to 0.45-μm PVDF 
minutes to overnight in TBST + 10-% BSA (for phospho-specific Westerns) or TBST + 
5% non-fat dry milk (non-phospho Westerns).  Membranes were probed with primary 
antibodies overnight at 4 °C at the manufacturer’s recommended dilution.  Antigen-
specific signal was subsequently revealed with HRP-conjugated secondary antibodies and 
4.2.6 SDS-PAGE & Western blots 
 Protein lysates prepared as described in section 4.2.5 were denatured for SDS-
PAGE by boiling for 5-minutes in 1x Laemmli buffer containing 10-% β-
mercaptoethanol.  Fifteen-μg per lane of total protein was loaded onto pre-made 5-15-% 
polyacrylamide gels (Biorad, Hercules, CA), and lysates were separated by SDS-PAGE 
at a constant voltage of 200 V for ~2-hrs in a Biorad mini-protean tetracell using a 
tris/glycine buffer system. 
membranes (Millipore, Billerica, MA, USA) for 60-minutes at 4 °C and 100V.  
Membranes were blotted as follows.  Briefly, membranes were washed and blocked 60-
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enhanced chemiluminescent (ECL, Pierce) exposure of autoradiography film.  Digital 
images were made from the autoluminographs of each blot and band-intensities were 
quantified densitometrically using ImageJ software (NIH, Bethesda, MD).   
 To control for variations in loading all phospho-specific blots were stripped of 
antibody, washed, and incubated as above with pan-specific antibodies to ZAP-70 or 
PLCγ1.  PVDF membranes were stripped of antibody by incubation in Restore Western 
blot stripping buffer (Pierce) for 30-minutes at room temperature on an orbital shaker.  
These conditions were previously verified to completely strip both primary and 
 4.2.8 Statistical analyses 
secondary antibodies from the membrane.   
4.2.7 Flow Cytometry 
Quantitative analysis of immunofluorescent staining was performed using a BD 
FACSCanto flow cytometer.  At least 30,000 events were collected for all experimental 
samples.  Data were acquired using BD FACSDiva software, and analyzed using FlowJo 
(Treestar, Ashland, OR).   
 All statistical calculations were performed using InStat by GraphPad software 
(San Diego, CA).  Data from individual experiments were normalized to the unstimulated 
sample and expressed as the fold-increase over unstimulated cells for all statistical 
comparisons.  A one way ANOVA with Tukey post-test was used to make comparisons 
between the unstimulated, static, and RWV sample for each molecule tested.  A p-value 
of less than 0.05 was considered statistically significant.   
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4.3. Results 
 To quantitatively measure TCR signaling we used fluorescently labeled 
antibodies to monitor the TCR-inducible phosphorylation of tyrosine 142 of the ζ-chains 
-chai
rker for lck activity and tyrosine 128 of SLP-
e cytoskeletal adaptor protein Nck171) was used as a surrogate 
 319 of ZAP-70, 511 of Itk, and 783 of PLCγ1 are all required 
for enzymatic activity of these molecules and mutation of these sites prevents or inhibits 
activation of PLCγ1 in response to TCR triggering52;70;81.  
sphorylation of all signaling 
nditions and during culture in 
the RWV (fig. 4.3, see figure legend for significance levels).  We did not observe RWV 
(ζ ns[pY142]), tyrosine 319 of ZAP-70 (ZAP70[pY319]), tyrosine 128 of SLP-76 
(SLP76[pY128]), tyrosine 511 of Itk (Itk[pY511]), and tyrosine 783 of PLCγ1 
(PLCγ1[pY783]) by flow cytometry.  These molecules and tyrosine residues were chosen 
based on their necessity for continuation of the TCR signal downstream to PLCγ1 and/or 
their utility as a marker of upstream enzymatic activity.  In the latter category tyrosine 
142 of the ζ-chains serves as a surrogate ma
76 (the docking site for th
marker for both ZAP-70 enzymatic activity and phosphorylation of SLP-76 on tyrosine 
145 (the docking site for Itk150) since an appropriate antibody to this site was not 
available at the time these experiments were performed.  In the former category 
phosphorylation of tyrosine
 4.3.1 Measurement of site-specific tyrosine phosphorylation by flow cytometry 
 Flow cytometry was used to quantify intracellular staining of purified CD4+ T 
cells by fluorescently labeled phospho-epitope-specific monoclonal antibodies.  
Crosslinking of the TCR and CD28 for 5-minutes induced highly reproducible and 
significant increases in the site-specific tyrosine pho
molecules examined except Itk (see below) in both static co
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culture to significantly alter the tyrosine phosphorylation of any of the molecules 
amin
residue was typically detected in response to CD3XCD28, the magnitude of this increase 
nd was 
ex ed compared to culture under static conditions.   
 The most receptor-proximal site analyzed was tyrosine 142 of the ζ-chains, which 
lies within the 2nd ITAM of this molecule.  Receptor crosslinking typically resulted in a 
1.8-fold increase in the median fluorescence intensity (MFI) of staining over 
unstimulated cells and near identical results were obtained when the cells were stimulated 
in the RWV.  This result corresponds well with the 1.5-fold increase in phosphorylation 
of ZAP-70 at tyrosine 319 observed in both static and RWV conditions after receptor 
crosslinking.  Tyrosine 128 of SLP-76 was the most strongly induced phospho-epitope 
examined here, typically exhibiting a greater than 2-fold increase in response to receptor 
stimulation in both culture venues.  By contrast tyrosine 783 of PLCγ1 was the least 
sensitive to receptor crosslinking.  Although significantly increased in both static and 
RWV conditions, phosphorylation of this epitope was typically only 10-% greater than in 
unstimulated cells with no detectable difference between culture venues. 
 Measurement of Itk activation by phosphorylation at tyrosine 511 ultimately 
proved to be unsuccessful (data not shown).  While an increase in phosphorylation at this 
was highly variable, both between experiments and between conditions, a
therefore statistically indistinguishable from unstimulated cells.  The antibody itself was 
raised against Bruton’s tyrosine kinase (BTK) which is expressed by B cells, but not T 
cells.  The manufacturer of this antibody (BD) reports that it also cross-reacts with Itk 
phosphorylated on tyrosine 511.  However, based on supporting information provided by 
BD tech support it is likely that this claim is based purely on the ability of this antibody 
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to detect inducible phosphorylation (by flow) in pervanadate stimulated Jurkat T cells.  
While Itk is the major tec kinase involved in TCR signaling, it is not the only tec kinase 
expressed by T cells.  T cells also express (at least) the tec kinase family members rlk and 
tec, and it is likely that detection of these molecules confounded our measurements of 
inducible itk phosphorylation11.         
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Figure 4.3. Site-specific tyrosine phosphorylation of select TCR signaling 
molecules.  Purified CD4+ T cells were stimulated for 5-minutes by CD3XCD28 in a 
RWV or static conditions.  Cells were then immunostained with the indicated antibodies 
and analyzed by flow cytometry.  A.  The MFI of staining normalized to the MFI of 
unstimulated (unst) cells.  Data are means ± SD of 5-independent experiments.  
***p<0.001, **p<0.01, *p<0.05, N.S. = p>0.05  B.  Representative flow data showing 
histograms from one of five experiments.    
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4.3.2 Measurement of site-specific tyrosine phosphorylation by Western blot 
 To verify the results obtained by flow cytometry, identical experiments were 
conducted, and the cells were lysed and intracellular proteins were analyzed by Western 
blot using antibodies against ZAP70[pY319] and PLCγ1[pY783].  A semi-quantitative 
analysis of these data was performed by making densitometric measurements of the 
protein-bands detected by blotting for the activated enzymes and normalizing this value 
to the total enzyme present as determined from reprobing the blots with the 
corresponding pan-specific antibodies.  
 Lysates of T cells stimulated in both the RWV and static conditions were enriched 
in ZAP70[pY319] compared to lysates from unstimulated cells (fig. 4.4b).  Densitometric 
measurements of these blots were in qualitative agreement with the data we obtained by 
flow cytometry—showing a consistent increase in ZAP-70[pY319] expression in 
response to stimulation in both static and RWV conditions (fig. 4.4a).   
 Western blots for PLCγ1 confirmed that phosphorylation of this enzyme on 
tyrosine 783 is not inhibited by culture in the RWV.  In our hands, however,  this 
molecu
on to be decreased in the RWV compared to 
 
le was subject to high basal levels of tyrosine phosphorylation, and due to this, 
only two of the four experiments in which PLCγ1[pY783] was examined resulted in a 
quantifiable upregulation pY783 (fig. 4.4a).  In both cases, however, tyrosine 783 of 
PLCγ1 was phosphorylated to a similar extent in the RWV and static conditions.  
Importantly, in the remaining experiments, we found that PLCγ1[pY783] was expressed 
to the same extent in stimulated and unstimulated cells regardless of culture venue, and 
we never observed PLCγ1[pY783] expressi
static or unstimulated cells (fig. 4.4  and data not shown). 
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Figure 4.4. Site-specific tyrosine phosphorylation of ZAP-70 and PLCγ1.  Purified 
CD4+ T cells were stimulated for 5-minutes in a RWV or under static conditions.  The 
cells were then lysed and analyzed by Western blot.  Blots were probed for ZAP-
70[pY319] (pZAP70) or PLCγ1[pY783] (pPLCγ1), stripped and re-probed with pan-
specific antibodies for each enzyme.  A.  Autoluminographs were digitally scanned and 
the optical density (OD) of protein bands was calculated using ImageJ.  Each filled 
symbol represents the OD of phospho-specific staining normalized to pan-specific 
staining for an independent experiment.  Horizontal Bars represent the mean value for all 
experiments.  B.  Autoluminographs of phospho- and pan-specific Western blots from 
one representative experiment for each enzyme.      
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4.4 Conclusions 
 The data presented here provide a high fidelity snapshot of a mitogenic signal as it 
passes from the T cell receptor to PLCγ1, and refute the hypothesis that culture in the 
RWV inhibits receptor-proximal signal transduction.  Our results clearly show TCR-
inducible tyrosine-phosphorylation of the ζ-chains, ZAP-70, SLP-76, and PLCγ1 in 
response to TCR ligation in the RWV.  Importantly the magnitude of tyrosine 
phosphorylation of each of these molecules was indistinguishable between culture venues 
indicating that T cells “see” the stimulus with the same affinity/avidity in the RWV and 
static conditions.   Phosphorylation of PLCγ1 tyrosine 783 indicates that this enzyme is 
activated during culture in the RWV, and that there should be equal concentrations of 
PLCγ1-generated DAG in the membranes of cells stimulated in the RWV and static 
conditions.  These results indicate that the microgravity sensitive mechanisms that are 
responsible for failed T cell activation in the RWV lie in the DAG-responsive signaling 
pathways downstream of PLCγ1.     
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CHAPTER 5: SIGNALING TO THE INTERIOR—PKCΘ TO NFκB 
 
 
 responsible for the recruitment of this enzyme to the 
at promotes the subsequent 
tyrosine and serine phosphorylations required for enzymatic activity112.  At the membrane 
PKCθ undergoes trans-autophosphorylation as well as phosphorylation by lck and the 
constitutively active kinase PDK-1, which is recruited to the membrane by PI3K-
generated PIP390;97.  Activated PKCθ has many substrates including WIP, the adaptor 
protein CARMA1, and the CD3γ-chain69.  PKCθ-mediated phosphorylation of WIP 
disrupts an inhibitory interaction between this molecule and WASP allowing the latter to 
induce actin polymerization71.  CARMA1 is a cytosolic adaptor protein that is inducibly 
recruited to the membrane in response to TCR ligation, and its phosphorylation by PKCθ 
 
5.1 Introduction 
 T lymphocytes cultured in rotating-wall vessel (RWV) bioreactors are fully 
competent to activate PLCγ1 in response to TCR ligation, yet exhibit a PMA sensitive 
defect in their response to mitogenic lectins and antibodies.  These results indicate that 
PMA rescues T cell activation in the RWV by acting on downstream pathways rather 
than by compensating for inadequate DAG production at the membrane.  One of the 
primary downstream targets of DAG (and hence PMA) is the novel PKC isozyme, PKCθ.  
PKCθ has a diverse role in T cell activation, and acts both directly to modify cellular 
morphology and also indirectly by inducing and/or enhancing the downstream signaling 
pathways that regulate gene expression103.   
 TCR-induced activation of PKCθ requires both tyrosine kinase activity and lipid-
derived second-messengers.  DAG is
membrane and also mediates a conformational change th
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nucleate cation 
f NFκB family members to the nucleus141.  The interaction between CARMA1 and 
ecules to the immunological synapse where PKCθ plays a role 
 term
ex iments reported in this chapter consider this 
of these experiments show that CD4  T cells activate PKCθ in response to TCR-ligation 
in the RWV, but only weakly signal through the NFκB pathway and fail to express genes 
under the control of this transcription factor.           
s the CBM-complex leading to the degradation of IκB proteins and translo
o
PKCθ localizes these mol
in inating the TCR signal by phosphorylating a di-leucine sorting motif in the 
cytoplasmic tail of the CD3γ chain resulting in downmodulation of the TCR53;103;164.   
 T cells from PKCθ-/- mice exhibit defective activation in response to antigen-
receptor stimulation that is only mildly responsive to exogenous IL-2, which is similar to 
the activation phenotype of T cells cultured in the RWV38;151.  As would be expected, 
PKCθ-/- T cells are unresponsive to phorbol esters, so it is unlikely that culture in the 
RWV blocks the function of PKCθ.  RWV-culture may, however, decrease the 
responsiveness of PKCθ to DAG or make this enzyme less efficient in activating 
downstream signaling pathways.  The per
possibility by investigating the hypothesis that TCR-stimulation fails to activate T cells in 
the RWV due to decreased signaling through PKCθ-mediated pathways.  This hypothesis 
was investigated by measuring three aspects of PKCθ function in response to TCR 
ligation: (1) polymerization of the actin cytoskeleton, (2) downregulation of the TCR, and 
(3) induction of signaling to and activation of the transcription factor NFκB.  The results 
+
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5.2 Materials and Methods 
 
 For receptor stimulation, mouse monoclonal IgG against CD3 (OKT3) and CD28 
(CD28.1) from eBioscience (San Diego, CA) were crosslinked with a goat F(ab′)  
specific to the Fc region of mouse IgG (Upstate, Charlottesville, VA).  Cells urf
 
5.2.1 Antibodies and reagents 
2
 were s ace 
5.2.2 Cell isolation and culture 
 Buffy coats from healthy human donors were purchased from Biological 
Specialty Corporation (Colmar, PA, USA) and PBMC were purified by gradient 
tec (Auburn, CA, USA).  In these 
MC were labeled with magnetic beads according to the manufacturer’s 
pension using an 
stained for flow cytometry using fluorescently conjugated antibodies to CD3, CD4, and 
ICAM-1 (CD54) purchased from eBioscience.  For Western blotting, antibody against 
IκB was purchased from Cell Signaling Technology (Danvers, MA), β-actin and HRP-
conjugated donkey anti-goat were from Abcam (Cambridge, MA), and HRP-conjugated 
donkey anti-rabbit was from Pierce (Rockford, IL).  For staining of f-actin a TRITC-
conjugate of phalloidin was purchased from Sigma-Aldrich (St. Louis, MO).   
centrifugation over histopaque 1077 (Sigma-Aldrich).  For experiments that required 
culture of PBMC for 48-hrs the cells were cultured in RPMI supplemented with 2mM L-
glutamine, 50-μg/ml penicillin/streptomycin (all from Mediatech, Herndon, VA, USA), 
and 10-% heat-inactivated FBS (HyClone, Logan, UT).  For some experiments untouched 
CD4+ T cells were further purified by magnetic depletion of unwanted cells using the 
CD4+ T cell isolation kit II from Miltenyi Bio
experiments PB
protocol and the unlabeled CD4+ T cells were eluted from the cell sus
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Auto ACSpro cell sorter (MilteM nyi Biotec).  Following magnetic enrichment the cell 
uspension used in these experiments typically contained greater than 80-% CD4+ T cells 
(see appendix A).  Purified CD4  T cells were washed and suspended in PBS (w/Ca2+ & 
Mg2+) at a density of 2E6/ml, and incubated at 37 °C/5-% CO2 in a humidified incubator 
for at least 30-minutes prior to experimentation. 
containing 
either 8-μg/ml PHA, 1-ng/ml PMA, 8-μg/ml PHA and 1-ng/ml PMA, or anti-CD3, -
CD28, and anti-mouse IgG antibodies at 2-, 2-, and 20-μg/ml respectively.  A portion of 
s
+
5.2.3 Stimulation and RWV culture 
 In short-term experiments that examined the inducible polymerization of f-actin 
or degradation of IκB in the RWV, purified CD4+ T cells were stimulated as described in 
section 2.3 of chapter 4.  In experiments that measured TCR and ICAM-1 expression 
after 48-hrs of culture the cells were stimulated as follows.  PBMC were suspended at a 
density of 2E6/ml in culture media and mixed with an equal volume of media 
each suspension was then used to fill a 10-ml HARV to capacity, and the remaining cells 
were cultured in a T-25 flask.  The final concentration of PHA and PMA was 4-μg/ml 
and 0.5-ng/ml respectively, and anti-CD3 and -CD28 were used at final concentrations of 
1-μg/ml each with goat anti-mouse IgG at 10-μg/ml.  The final cell density was 1E6/ml 
in all experiments.  Sham-stimulated cells cultured in a T-25 flask were included in all 
experiments.  Cells were cultured for 48-hrs in a humidified incubator at 37 °C/5-% CO2.  
HARVs were rotated at 14-rpm 
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5.2.4 Processing and staining for measurement of f-actin by flow cytometry 
 Experiments that analyzed CD3XCD28-induced f-actin polymerization were 
terminated after 5-minutes of stimulation by direct addition of 4-% paraformaldehyde 
(PFA) to the cells as described in the previous chapter (section 4.2.4).  Cells were fixed 
for 20-minutes in 2-% PFA at 37 °C and then stored overnight at 4 °C in PFA.  Cells 
were subsequently stained with a TRITC-conjugate of the fungal toxin phalloidin 
according to the protocol in appendix C.  Briefly, the cells were washed 3 times with PBS 
and permeabilized for 5-minutes in PBS + 0.1-% Triton X-100.  Cells were washed an 
additional 3 times and incubated for 30-minutes in PBS + TRITC phalloidin at 0.5-μg/ml.  
Cells were washed a final three times in PBS and immediately analyzed by flow 
cytometry    
 until analysis by flow cytometry.  All steps were on ice 
and storage was at 4 °C protected from light.  Samples were never stored longer than 3-
  
5.2.5 Surface staining for flow cytometry 
 PBMC that were stimulated for 48-hrs in RWV or static conditions were removed 
from each culture venue, washed once with PBS + 5mM EDTA, and counted using a 
hemacytometer.  Half a million cells from each condition were subsequently surface 
stained according to the protocol in appendix C.  Briefly, the cells were washed three 
times with PBS + 1-% BSA or FBS (FACSwash), stained for 30-minutes with 
fluorescently conjugated antibodies at the manufacturer’s recommended dilution in 
FACSwash + 2-% mouse serum (Sigma-Aldrich), washed thrice more with FACSwash, 
and fixed and stored in 1-% PFA
days prior to analysis.  
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5.2.6 Western blot analysis of IκB degradation 
 For analysis of IκB degradation aliquots of 1- to 2-million cells from each 
condition were removed from the culture venues after increasing durations of stimulation 
for analysis by Western blot.  For the static samples cells were withdrawn from the 
sample tube using a 1-ml micropipette.  For RWV samples, a 3- or 5-ml syringe was used 
to withdraw 1E6 cells from one of the HARV syringe ports while a second syringe was 
used to inject an equal volume of PBS into the opposite syringe port.  This resulted in a 
gradual dilution of the cells contained in the RWV, and increasing sample volumes were 
withdrawn at each timepoint to maintain 1E6 cell aliquots.  To precisely control the 
amount of cell suspension withdrawn from the HARV at each timepoint, syringes were 
pre-filled with ice cold PBS so that addition of the desired volume of suspension would 
chapter 4.  Briefly, cells were pelleted and lysed by resuspension in lysis buffer 
ysis by W
concentration of lysates was determined using a BCA assay kit (Pierce) following the 
  
exactly fill the syringe to capacity.  Rotation of the HARVs was not stopped at any point 
during the experiment.   
 Aliquots were processed for Western blot analasis as described in section 2.5 of 
consisting of 10mM Tris HCl pH7.2, 150mM NaCl, 2mM EDTA, 50mM NaF, 10mM 
Na2P4O7, 1mM Na3VO4, 1mM PMSF, 1-% NP-40, and protease inhibitor cocktail 
(Sigma) for 30- to 45-minutes on ice.  Lysates were cleared of insoluble material by 
centrifugation and stored at -80 °C until anal estern blot.  The protein 
manufacturer’s recommended protocol scaled down by a factor of four. 
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 SDS-PAGE and Western blotting were performed as described in section 2.6 of 
5.2.7 Flow Cytometry 
 Quantitative analysis of immunofluorescent staining was performed using a BD 
(San Jose, CA) FACSCanto flow cytometer.  At least 30,000 events were collected for 
experimental samples.  For all experiments that required multi-color staining the 
appropriate compensation controls were included to avoid spectral overlap between 
fluorophores.  Flow data were collected using BD FACSDiva software, and analyzed 
with FlowJo (Treestar, Ashland, OR, USA). 
Chapter 4.  Briefly, 5-μg of each lysate was separated by SDS-PAGE, and blotted to 
PVDF membranes (Millipore, Billerica, MA).  Membranes were subsequently probed for 
IκB, stripped and reprobed for β-actin as a loading control.  Specific antibody binding to 
the blots was revealed using HRP-conjugated secondary antibodies and ECL exposure of 
autoradiography film.  Digital scans of the resulting autoluminographs were quantified 
using ImageJ software (NIH, Bethesda, MD).  
5.2.8 Statistical analysis 
 All statistical calculations were performed using InStat by GraphPad software 
(San Diego, CA).  A two tailed Student’s T test or one way ANOVA with Tukey post-test 
were used to test samples for statistical significance as appropriate.  For all numerical 
comparisons a p value of less than 0.05 was considered statistically significant.             
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5.3 Results  
  
+
toxin phalloidin.  In preliminary experiments carried out under static conditions we found 
 
5.3.1 Actin polymerization 
 The ability of purified CD4  T cells to polymerize f-actin in response to 
CD3XCD28 stimulation was investigated using flow cytometry to measure the 
fluorescence intensity of staining by a TRITC-conjugate of the f-actin-specific fungal 
that an increase in f-actin was detectable as early as one-minute following receptor 
r 3-minutes and had begun to decline by 10-minutes of 
imula
d cells (figure 5.1b).  This observation was 
confirmed numerically using the median fluorescence intensity of staining for statistical 
comparisons between samples.  Over the course of five independent experiments we 
found that CD3XCD28-stimulation significantly increased TRITC-phalloidin staining in 
both the RWV or static conditions compared to unstimulated cells (Fig. 5.1a; p<0.05, 
static; p<0.01, RWV; N = 5).  Although there was a slight trend for increased f-actin 
staining in the RWV, difference in the MFI of staining between static and RWV samples 
were not statistically significant.   
 
crosslinking, peaked afte
st tion (see Appendix C.4).  For the purpose of this study, later timepoints were not 
considered and a 5-minute stimulation period was used to compare actin polymerization 
in the RWV and static conditions.   
 When CD4+ T cells were stimulated by CD3XCD28 for 5-minutes we observed a 
consistent increase in the fluorescence intensity of f-actin staining in both the RWV and 
in static conditions compared to unstimulate
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  Figure 5.1.  Actin polymerization by CD4+ T cells.  Purified CD4+ T cells were 
stimulated for 5-minutes at 37 °C by CD3XCD28 in a RWV or under static conditions.  
Unstimulated (Unst) cells were cultured in parallel as a control for basal f-actin 
expression.  Following stimulation, the cells were fixed, permeabilized, and stained with 
TRITC-conjugated phalloidin to label actin filaments (f-actin).  Staining was then 
analyzed by flow cytometry.  A.  The MFI of TRITC-phalloidin staining normalized to 
the staining of unstimulated cells.  Data are means ± SD of five independent experiments.  
*p<0.05 vs. unst; **p<0.01 vs. unst.  B.  Histograms of the fluorescence intensity of 
TRTIC-phalloidin staining from a single representative experiment.  
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5.3.2 TCR downmodulation 
 In preliminary experiments, CD4+ and CD8+ cells in PBMC cultures were 
routinely observed to significantly reduce their expression of CD3 after 48-hrs of 
stimulation by CD3XCD28.  After 96-hrs, expression of CD3 by both subsets of T cells 
was approximately equal to cells that were cultured in the absence of stimulation for the 
same duration.  Based on these observations an endpoint measurement of TCR 
expression at 48-hrs following stimulation was chosen to compare the ability of T cells to 
downmodulate the TCR in static and RWV conditions.  For these experiments T cells 
the CD4+ population 
as a whole was reduced by 35-% compared to the unstimulated control.  The percentage 
of CD4+/CD3+ cells in the RWV was significantly reduced compared to both stimulated 
and unstimulated cells cultured under static conditions (fig. 5.2a; p<0.01, p<0.001, 
respectively; N = 4).  In the RWV the percentage of CD4+ cells that expressed CD3 after 
48-hrs of stimulation was typically less than 10-%, and was accompanied by a ~40-% 
reduction in the MFI of CD3 staining by these cells compared to unstimulated controls. 
were stimulated in PBMC culture, and flow cytometry was used to detect 
immunostaining of the TCR/CD3 complex expressed by CD4+ cells.       
 We found that when PBMC were left unstimulated for 48-hrs in either a tissue 
culture flask or RWV nearly 100-% of CD4+ T cells maintained uniformly high 
expression of the TCR (fig. 5.2 and data not shown).  Receptor crosslinking in both 
culture venues resulted in a significant reduction in CD3 expression by CD4+ PBMC (fig. 
5.2b; p<0.001, N = 4).  When PBMC were stimulated in a tissue culture flask 
approximately 20-% of CD4+ T cells expressed (or re-expressed) CD3 at levels 
comparable to unstimulated cells, and the MFI of CD3 staining by 
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Figure 5.2.  Activation-induced downregulation of the TCR by CD4  T cells.  Human 
PBMC were stimulated by CD3XCD28 and cultured in a RWV or tissue-culture flask at 
37 °C/5-% CO2 in a humidified incubator.  Unstimulated (Unst) cells cultured for the 
duration in a tissue culture flask were used as a control.  After 48-hrs of culture the cells 
were immunostained for CD4 and CD3 and analyzed by flow cytometry.  A.  The MFI of 
CD3 staining by CD4  lymphocytes.  Data are means ± SD of four independent 
experiments.  ***p<0.001 vs. unst; **p<0.01 static vs. RWV.  B.  Histogram of the 
fluorescence intensity of CD3 staining by CD4  lymphocytes from a representative 
experiment.    
+
+
+
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5.3.3 IκB degradation    
 To investigate the ability of CD4+ T cells to activate PKCθ-dependent NFκB 
signaling during culture in the RWV we used Western blots to measure the degradation 
of IκBα in response to CD3XCD28 stimulation.  Under static conditions, receptor 
crosslinking resulted in an ~80-% decrease in IκBα expression by 30-minutes post-
stimulation, and expression of this molecule had not fully recovered after stimulation for 
180-minutes, which was the latest timepoint examined in these experiments (fig. 5.3, 
+
 
  
table 5.1).  When purified CD4  T cells were stimulated by CD3XCD28 in the RWV loss 
of IκBα was minimal and occurred with delayed kinetics (fig. 5.3).  These cells did not 
exhibit a decrease in IκBα during the first 45-minutes following stimulation and when 
the experiment was terminated after 60-minutes IκB expression had decreased by less 
than 15-%  of its initial value (table 5.1).     
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Figure 5.3.  TCR-induced IκB degradation by purified CD4  T cells.  Purified CD4  
T cells were stimulated by CD3XCD28 for the indicated durations in a RWV or under 
static conditions.  Cells were then lysed and assayed for IκB expression by Western blot.  
All blots were reprobed for β-actin as a control for loading. The data shown here are 
digital scans of the autoluminographs from Western blotting of lysates from cells 
stimulated in the RWV or static conditions.  Numerical data from these experiments are 
summarized in table 5.1.     
+ +
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5.3.4 ICAM-1 expression 
 NFκB plays a dominant role in the regulation of the immune cell adhesion 
molecule-1 (ICAM-1 a.k.a. CD54) and the upregulation of this molecule by T cells in 
response to TCR ligation can be used as an indicator of NFκB—dependent gene 
expression26;106;133.  To investigate the possibility that RWV-culture prevents or inhibits 
PBMC culture, and also rescued ICAM-1 expression by a 
significant fraction of T cells cultured in the RWV (fig. 5.4; p<0.01, N = 3).  The 
percentage of T cells that upregulated ICAM-1 in response to PMA co-stimulation in the 
RWV was comparable to that of cells stimulated in static conditions with PHA alone, but 
was slightly reduced compared to cells stimulated with PHA+PMA in static conditions, 
although this difference failed to reach statistical significance (fig. 5.4a).  Stimulation 
with PMA alone is capable of inducing T cells to express ICAM-1.  The dose of PMA 
used in these experiments, however, was insufficient to induce NFκB-mediated gene 
expression, as ICAM-1 upregulation in response to stimulation with PMA alone was 
never observed regardless of culture venue (fig. 5.4).   
 
  
mitogen-induced activation of NFκB the expression of ICAM-1 by T cells in response to 
PHA and/or PMA stimulation was measured using flow cytometry.   
 Stimulation of PBMC for 48-hrs with PHA under static conditions induced 60-% 
of T cells, on average, to upregulate ICAM-1 (fig. 5.4a).  Stimulation with this mitogen 
did not, however, induce ICAM-1 expression by T cells cultured in the RWV (fig. 5.4a).  
Co-stimulation with sub-mitogenic PMA under static conditions enhanced the expression 
of ICAM-1 by T cells in 
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Figure 5.4.  TCR-induced ICAM-1 expression by CD3  T cells in PBMC culture.  
Human PBMC were stimulated with the indicated mitogens for 48-hrs in a RWV or T 
flask.  Cells were then immunostained for CD3 and ICAM-1 (CD54) and analyzed by 
flow cytometry.  A.  The percentage of CD54  T cells from three experiments.  Each 
filled symbol represents an independent experiment.  Horizontal bars are the means of all 
experiments.  Unst = unstimulated.  B. Histograms of the fluorescence intensity of CD54 
staining by CD3  T cells for a representative experiment.  The gate used to determine 
CD54  cells is shown on each plot.      
+
+
+
+
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5.4 Conclusion 
 The results presented in this chapter demonstrate that PKCθ is activated during 
culture in the RWV.  Importantly, our data define a break in the TCR-induced signal 
between PKCθ and the induction of NFκB-mediated gene expression, and offer the first 
hints of a mechanism for inhibition where the TCR-induced signaling machinery is 
activated at the membrane, and possibly in the cytoplasm, but is unable to productively 
communicate with the nucleus.  This conclusion is supported by our finding that re-
expression of the TCR following receptor triggering either does not occur, or occurs with 
severely delayed kinetics during culture in the RWV (see fig. 5.2).  Based on these data 
alone it is difficult to determine if the broken signal is directly due to defects in signaling 
to NFκB, or secondary to defective MAPK signaling.  Although degradation of IκB was 
attenuated in the RWV it was not abolished, so it remains a possibility that NFκB family 
members enter the nucleus, but encounter an inhospitable transcriptional environment 
due to the absence of transcription factors induced by the RAS/MAPK signaling 
pathway.    
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CHAPTER 6: SIGNALING TO THE INTERIOR—RASGRP TO ERK 
 
 
 induces RAS/MAPK signaling by recruiting to the membrane and activating 
e guanyl-nucleotide exchange factor for RAS, RASGRP55.  At the membrane RASGRP 
ctivates the small G protein RAS by catalyzing the exchange of GDP for GTP, and 
ng cascade that activates the 
p44 and p42 MAPKs ERK-1 and ERK-2i.  The functional outcome of RAS/MAPK 
signaling depends both on the enzymatic- and spatial-regulation of ERK, and the 
activation of this enzyme at the plasma- versus the Golgi-membrane is thought to be 
particularly important role in directing the response of a T cell to signals emanating from 
                                                
 
6.1 Introduction 
 T lymphocytes do not express activation markers, secrete cytokines, or enter the 
cell cycle and proliferate in response to antigen-receptor stimulation during culture in 
RWV bioreactors132;147.  Although T cells are responsive to phorbol esters such as PMA 
in the RWV, our results have shown that TCR-induced activation of PLCγ1 is unaltered 
by culture in the RWV.  Similarly, RWV-culture does not inhibit the TCR-induced 
activation of PKCθ.  The subsequent induction of NFκB-regulated gene expression 
downstream of PKCθ, however, is blocked by culture in the RWV.  The available data 
regarding this defect indicates that the IκB molecule is degraded during culture in the 
RWV, albeit weakly and with delayed kinetics, which raises the possibility that the loss 
of gene expression downstream of PCKθ could be secondary to defective signaling 
through the RAS/MAPK signaling pathway.   
 DAG
th
a
GTP-bound RAS subsequently initiates the MAPK signali
 
i The term ERK will be used to collectively refer to both ERK isoforms throughout this chapter 
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the TC hered 
ctivated ERK that is free to enter the nucleus or become localized to a number of 
y a variety of adaptor proteins and molecular scaffolds129.  The 
+ V or static conditions.  The 
R47;115.  The plasma membrane serves as a platform for generating untet
a
cytosolic compartments b
Golgi membrane functions as a platform for generating a tethered population of activated 
ERK molecules that are constrained to Golgi-proximal targets and therefore unable to 
activate nuclear substrates156.  A number of ERK’s nuclear substrates are essential for 
executing the genetic program that leads to T cell activation and altered induction and/or 
compartmentalization of this enzyme by microgravity provides an attractive mechanistic 
explanation for the insensitivity of T cells to mitogenic lectins and antibodies during 
culture in the RWV.  
 Based on the mechanism proposed above we hypothesized that altered signaling 
through the RAS/MAPK pathway prevents the activation of T cells cultured in the RWV.  
We investigated this hypothesis by comparing both the enzymatic and spatial regulation 
of ERK in CD4  T cells stimulated by CD3XCD28 in the RW
results reported here clearly demonstrate that ERK becomes activated in response to 
receptor stimulation in the RWV.  Less clear, however, is the sub-cellular localization of 
enzymatically active ERK.  Our data indicate that ERK may become sequestered in the 
cytosol and prevented from entering the nucleus during culture in the RWV.  A 
possibility that is supported by the inability of T cells to express the RAS-induced 
immediate-early gene CD69 in response to TCR stimulation in the RWV.      
  
75 
 
6.2 Materials and Methods   
 
 
6.2.1 Antibodies and reagents 
 For receptor stimulation, mouse monoclonal IgG against CD3 (OKT3) and CD28 
(CD28.1) from eBioscience (San Diego, CA) were crosslinked with a goat F(ab′)2 
specific to the Fc region of mouse IgG (Upstate, Charlottesville, VA).  Cells were surface 
stained for flow cytometry using fluorescently conjugated antibodies to CD3, CD4, and 
CD69 purchased from eBioscience. For Western blotting, antibodies against pan-ERK 
(rabbit polyclonal) and ERK (mouse IgG; clone E10) dually phosphorylated at threonine 
202 and tyrosine 204 (ppERK) were purchased from Cell Signaling Technology 
(Danvers, MA), and HRP-conjugated donkey anti-rabbit and –mouse IgG were from 
Pierce (Rockford, IL).  Intracellular detection of ppERK by flow cytometry was 
performed using a monoclonal rabbit IgG (clone 197G2) purchased from Cell Signaling 
Technology, and Alexafluor488-conjugated goat anti-rabbit IgG (Invitrogen, Carlsbad, 
CA).  For confocal microscopy, Alexafluor647-conjugated monoclonal mouse IgG and 
unconjugated rabbit IgG against ppERK (clones E10 and 197G2 respectively) were 
purchased from Cell Signaling Technology.  The Alexa488-conjugated rabbit anti-giantin 
antibody used in these experiments was purchased from Covance (Princeton, NJ), and 
Alexafluor594-conjugated wheat germ agglutinin (WGA) was purchased from 
Invitrogen. 
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6.2.2 Cell isolation and culture  
Buffy coats from healthy human donors were purchased from Biological 
Specialty Corporation (Colmar, PA, USA) and PBMC were purified by gradient 
centrifugation over histopaque 1077 (Sigma-Aldrich).  For experiments that required 
culture of PBMC for 24-hrs; cells were cultured in RPMI supplemented with 2mM L-
glutamine, 50-μg/ml penicillin/streptomycin (all from Mediatech, Herndon, VA, USA), 
and 10-% heat-inactivated FBS (HyClone, Logan, UT, USA).  For some experiments 
untouched CD4+ T cells were further purified by magnetic depletion of unwanted cells 
using the CD4+ T cell isolation kit II from Miltenyi Biotec (Auburn, CA, USA).  In these 
experiments PBMC were labeled with magnetic beads according to the manufacturer’s 
protocol and the unlabeled CD4+ T cells were eluted from the cell suspension using an 
AutoMACSpro cell sorter (Miltenyi Biotec).  Following magnetic enrichment the cell 
suspensions used for Western blotting contained greater than 85-% CD4+ T cells in all 
experiments and those used for confocal microscopy were ~80-% CD4+ T cells (see 
appendix A).  Purified CD4+ T cells were counted using a hemacytometer, washed and 
suspended in PBS (w/Ca2+ & Mg2+) at a density of 2E6/ml, and incubated at 37 °C/5-% 
CO  in a humidified incubator for at least 30-minutes prior to experimentation. 
hort-term experiments that examined the inducible phosphorylation and 
localization of ERK in the RWV, purified CD4+ T cells were stimulated as described in 
section 2.3 of chapter 4.  In experiments that measured CD69 expression after 24-hrs of 
culture the cells were stimulated as follows.  PBMC were suspended at a density of 
2E6/ml in culture media and mixed with an equal volume of media containing either 8-
 
2
6.2.3 Stimulation and RWV culture 
 In s
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μg/m  PHA, 1-ng/ml PMA, or 8l -μg/ml PHA and 1-ng/ml PMA.  A portion of each 
 
6.2.4 Sample processing for analysis of ERK phosphorylation by Western blot  
 Samples were processed for analysis of ERK phosphorylation by Western blot as 
described in section 2.5 of chapter 4.  Briefly, experiments were terminated by rapidly 
cooling the samples to 4 °C in the presence of phosphatase inhibitors.  The cells were 
then pelleted and lysed by suspension in lysis buffer consisting of 10mM Tris HCl pH7.2, 
150mM NaCl, 2mM EDTA, 50mM NaF, 10mM Na2P4O7, 1mM Na3VO4, 1mM PMSF, 
1-% NP-40, and protease inhibitor cocktail (Sigma-Aldrich) for 30-minutes on ice.  
Lysates were cleared of insoluble material by centrifugation, and supernatants were 
stored at -80 °C until analysis by Western blot.  The protein concentration of lysates was 
determined using a BCA assay kit (Pierce) following the manufacturer’s recommended 
o r.  
  
suspension was then used to load a 10-ml HARV to capacity, and the remaining cells 
were cultured in a T-25 flask.  Sham-stimulated cells cultured in a T-25 flask were 
included as controls.  For all experiments the final concentration of each mitogen was 4-
μg/ml and 0.5-ng/ml PHA and PMA respectively, and the final cell density was 1E6/ml. 
Cells were cultured for 24-hrs in a humidified incubator at 37 °C/5-% CO2.  HARVs 
were rotated at 14-rpm in all experiments. 
protoc l scaled down by a factor of fou
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c
P
p
b
o ageJ software (NIH, Bethesda, MD).  
y flow 
cytometry    
 Samples were processed for analysis of ERK phosphorylation by flow cytometry 
as described in section 2.4 of chapter 4.  Briefly, experiments were terminated by the 
direct addition of 4-% paraformaldehyde (PFA) to each sample and the cells were 
incubated at 37 °C for 10-minutes.  Cells were subsequently pelleted, permeabilized with 
90-% methanol, and immunostained with an unconjugated rabbit anti-ppERK according 
to the procedure outlined in chapter 4 (section 2.4) modified to include an additional 30-
minute incubation with Alexafluor488-conjugated goat anti-rabbit IgG diluted to 1:2000 
in phospho-stain buffer.  Following this incubation, cells were washed twice with PBS 
and analyzed by flow cytometry.    
  
.2.5 SDS-PAGE and Western blotting  
SDS-PAGE and Western blotting were performed as described in section 2.6 of 
hapter 4.  Briefly, 5-μg of each lysate was separated by SDS-PAGE, and blotted to 
VDF membranes (Millipore, Billerica, MA).  Membranes were subsequently probed for 
pERK, stripped and reprobed for total ERK as a loading control.  Specific antibody 
inding was revealed by ECL (Pierce) exposure of autoradiography film.  Digital images 
f autoluminographs were quantified using Im
6.2.6 Sample processing and staining for analysis of ERK phosphorylation b
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6.2.7 Staining of cells for confocal microscopy 
at 4 °C in 2-% PFA, and 100-% methanol was added to each sample for a final 
concentration of 90-%.  All samples were stored overnight in 90-% methanol, and then 
mples were stored at 4 °C protected from light until 
icroscope. 
  
 Cells were stained for analysis by confocal microscopy using the phospho-
specific flow cytometry staining protocol described above with slight modification to 
account for WGA staining.  Briefly, experiments were terminated by direct addition of 
PFA, and cells were fixed for 10-minutes at 37 °C.  Cells were then washed three times 
with PBS + phosphatase inhibitors (pwash), and stained for 30-minutes on ice with WGA 
at 10-ug/ml.  Cells were washed two additional times in pwash, post-fixed for 20-minutes 
stained as described in section 2.4 of chapter 4 with Alexafluor488-conjugated anti-
giantin antibody and Alexafluor647-conjugated anti-ppERK antibody at 1:500 and 1:10 
dilutions in pwash + 10-% mouse serum (pstain, Sigma-Aldrich) respectively or 
unconjugated rabbit anti-ppERK antibody at 1:50 in pstain.  In the latter case, an 
additional 30-minute incubation in Alexafluor488-conjugated goat anti-rabbit at 1:1000 
in pstain was included for secondary detection of ppERK.  10-μl of cell suspension from 
each sample was then mixed 1:1 with Vectashield hardmount (Vector Labs, Burlingame, 
CA) containing DAPI to counterstain nuclei, transferred to a glass microscope slide, and 
covered with a glass coverslip.  Sa
analysis by laser scanning confocal microscopy using a Leica TCS SP2 m
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6.2.8 Surface staining of cells for flow cytometry 
6.2.9 Flow cytometry 
 Quantitative analysis of immunofluorescent staining was performed using a BD 
(San Jose, CA) FACSCanto flow cytometer.  At least 30,000 events were collected for 
experimental samples.  For all experiments that required multi-color staining the 
6.2.8 Statistical analysis 
 All statistical calculations were performed using InStat by GraphPad software 
(San Diego, CA).  A two tailed Student’s T test or one way ANOVA with Tukey post-test 
were used to test samples for statistical significance as appropriate.  For all comparisons a 
p value of less than 0.05 was considered statistically significant.              
 PBMC that were stimulated for 24-hrs in RWV or static conditions were removed 
from each culture venue, washed once with PBS + 5mM EDTA, and counted using a 
hemacytometer.  Half a million cells from each condition were subsequently surface 
stained according to the protocol in appendix C.  Briefly, the cells were washed three 
times with PBS + 1-% BSA or FBS (FACSwash), stained for 30-minutes with 
fluorescently conjugated antibodies at the manufacturer’s recommended dilution in 
FACSwash + 2-% mouse serum (Sigma-Aldrich), washed thrice more with FACSwash, 
and fixed and stored in 1-% PFA until analysis by flow cytometry.  All steps were on ice 
and storage was at 4 °C protected from light.  Samples were never stored longer than 3-
days prior to analysis. 
appropriate compensation controls were included to avoid spectral overlap between 
fluorophores.  Flow data were collected using BD FACSDiva software, and analyzed 
using FlowJo (Treestar, Ashland, OR, USA). 
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6.3 Results 
  
6.3.1 ERK-1/2 activation 
 Dual phosphorylation of ERK on threonine 202 and tyrosine 204 is sufficient to 
induce the enzymatic activity of this MAPK.  In preliminary experiments the percentage 
of cells expressing dually phosphorylated ERK (ppERK) was found to peak after 5-
minutes of stimulation by CD3XCD28 (appendix C.3), and this timepoint was used for 
analysis of ERK phosphorylation. 
 Using Western blots to probe lysates of CD4  T cells stimulated in the RWV or 
static conditions for the expression of phosphorylated and total ERK we found that 
CD3XCD28 stimulation induced robust phosphorylation of ERK regardless of culture 
venue (fig. 6.2a).  On average, receptor crosslinking induced a greater fraction of ERK-1 
osphorylated compared to ERK-2 (Fig 6.1 a & b).  The 
agnit
this molecule showed high levels of basal 
xpression of phosphorylated ERK-1 was 
evident in both static and RWV conditions, the high variation between experiments 
 
 
+
molecules to become ph
m ude of this increase over unstimulated cells, however, was almost twice as great 
for ERK-2 compared to ERK-1 (Table 6.1).  The inducible phosphorylation of ERK-2 
was statistically significant in both static and RWV conditions compared to unstimulated 
control samples (p<0.001 by ANOVA; N = 4), but no difference was detected between 
the two culture venues (fig. 6.1b).  The inducible phosphorylation of ERK-1 was subject 
to greater variation and in some experiments 
phosphorylation, and although inducible e
obscured the statistical significance of these differences (fig. 6.1a).  
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 Figure 6.1. ERK-1/2 phosphorylation by CD4  T cells—numerical data.  Purified 
CD4  T cells were stimulated for 5-minutes by CD3XCD28 in a RWV or under static 
conditions.  Cells were then lysed and analyzed by Western blot using antibodies specific 
to pan- and phosphorylated-ERK-1 and -2.  Band intensities were quantified 
Densitometrically and the ppERK signal was normalized to the total ERK signal to 
facilitate comparisons between experiments.  A. Phosphorylation of the p44 MAPK 
ERK-1.  B. Phosphorylation of the p42 MAPK ERK-2.  Filled symbols represent 
independent experiments.  Bars are the mean of all experiments.   
  
+
+
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Figure 6.2. ERK-1/2 phosphorylation by CD4  T cells—representative data.  Purified 
CD4  T cells were stimulated for 5-minutes by CD3XCD28 in a RWV or under static 
conditions.  Cells were then lysed and analyzed by Western blot or fixed and analyzed by 
flow cytometry.  A. Autoluminographs of representative phospho- and pan-ERK-1/2 
Western blots.  B. Histograms of the fluorescence intensity of ppERK staining as 
measured by flow cytometry.          
+
+
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 In two later experiments we were able to use flow cytometry to measure ERK 
phosphorylation within intact cells (fig. 6.2b).  Although there were too few replicates to 
p RK 
 To visualize the sub-cellular localization of ppERK we stained the plasma 
utinin (WGA) and the Golgi 
with a fluorescently labeled antibody against the Golgi-resident protein giantin.  Nuclei 
were counterstained with DAPI (false-colored as magenta in many of the images shown 
here).  ppERK was visualized in relation to these structures using either a fluorescently 
conjugated anti-ppERK antibody, or an unconjugated antibody with secondary detection 
(see below).   
  
  
make quantitative statistical comparisons the flow cytometry data were largely in 
agreement with data obtained by Western blot.  In both experiments we found that 
ppERK was upregulated by cells cultured in both static and RWV conditions, and that the 
magnitude (MFI) of this increase was roughly equal between culture venues.   
6.3.2. Sub-cellular localization of p E
membrane with a fluorescent-conjugate of wheat germ aggl
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Figure 6.3.  Sub-cellular localization of ppERK in CD4+ T cells.  Purified CD4+ T 
cells were stimulated for 10-minutes by CD3XCD28 in a RWV or under static 
conditions.  Cells were then fixed and processed for laser-scanning confocal microscopy 
with staining for the membrane (RED, wheat germ agglutinin), the Golgi (BLUE, 
giantin), ppERK (GREEN), and the nucleus (MAGENTA, DAPI).  NOTE: staining for 
Golgi, ppERK and the nucleus are false colored to aid in visualization.  Unstimulated 
(unst) cells were included as a control for basal ERK phosphorylation.  With the 
exception of B1 all images are a single 1-μm z-slice through the cell.  All images are 
from a single experiment, and each panel shows representative cell(s) from the indicated 
condition.  Arrows indicate capped regions of the membrane.  Arrowheads indicate 
patches of ppERK staining that occur outside of capped membrane regions.  A1: 
Unstimulated cells cultured in static conditions.  B1: A z-projection through an entire cell 
illustrating that the membrane, nucleus, and Golgi can clearly be distinguished from one 
another.  A2:  A cell stimulated under static conditions.  Diffuse ppERK signal can be 
observed at the membrane in this image and a small amount of ppERK appears to be 
localized to the Golgi.   A3:  A pair of cells stimulated in a RWV.  Several very distinct 
patches of ppERK signal that are not noticeably associated with a capped region of the 
membrane are visible in this image.  B2:  A cell stimulated under static conditions.  A  
capped region of this cells membrane is prominent in this image, and virtually all of the 
ppERK signal is co-localized with this region of the membrane.  B3:  A cell stimulated in 
a RWV.  Capping of the membrane can be seen at two distinct locations on the surface of 
this cell.  Similar to its static counterpart, virtually all of the ppERK signal in this cell is 
co-localized with the capped membrane regions.      
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 As expected the resting CD4+ T cells used in these experiments were typically 
less than 10-μm in diameter, had large nuclei, and very little cytoplasm.  Using the 
markers described above we were able to clearly distinguish between the nucleus, Golgi, 
and membrane (fig. 6.3 image B1).  In unstimulated cells we did not detect significant 
ppERK expression at any of these structures or in the cytoplasm (fig. 6.3 image A1).  In 
agreement with our data collected by Western blot, phosphorylation of ERK was 
apparent in cells that were stimulated with CD3XCD28 for 10-minutes in both static 
conditions and in the RWV (fig. 6.3 images A2 & A3; B2 & B3 respectively).  
Concomitant staining for ppERK, the Golgi, and the membrane revealed that ppERK was 
predominantly expressed at the membrane in both culture venues.  The distribution of 
membrane-localized ppERK was also similar between static and RWV conditions, and 
was typically found in discrete non-uniformly distributed patches of membrane and 
especially in regions that appeared to be sites of receptor capping (fig 6.3 arrows).  
Surprisingly, we observed very little ppERK in the cytosol or in the nucleus, and rarely if 
ever co-localized with the Golgi in either culture venue (6.3 images A2 and A3).   
 In preliminary experiments we found that immunostaining with the fluorescently 
conjugated ppERK antibody used in the above experiments resulted in a very low signal 
to noise ratio.  We therefore chose to stain an aliquot of each sample with an 
unconjugated ppERK antibody to verify our data.  This allowed for amplification of the 
ppERK signal by secondary detection, but at the expense of staining for Golgi since both 
giantin and ppERK antibodies were raised in rabbit.  In agreement with the above results 
very little ppERK was detected in unstimulated cells, and inducible ppERK staining was 
readily observed in both static- and RWV-cultured cells stimulated for 10-minutes with 
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CD3XCD28 (fig. 6.4). The pattern of ppERK sub-cellular localization revealed by this 
antibody, however, differed from the results shown in figure 6.3.  Not only were there 
discrete patches of ppERK staining at the membrane in both RWV and static conditions 
(fig. 6.4 images B2 & B3), but using this antibody we also found significant amounts of 
intracellular ppERK in cells from both conditions (fig. 6.4 images A2 & A3).  At the 
membrane, ppERK was localized to discrete patches of the plasma membrane and 
especially at regions that appeared to be capped by the crosslinking antibodies.  In some 
of the stimulated samples ruffling of the membrane was apparent, and ppERK staining 
appeared to trace the contours of the ruffles (fig. 6.4 images B2 & B3).  By contrast the 
distribution of ppERK within the cell appeared to differ between the RWV and static 
conditions (fig. 6.4 images A2 & A3).  Most notably, in static conditions there was a 
small fraction of ppERK that appeared to have tanslocated into the nucleus, whereas in 
the RWV there was a substantial amount of ppERK in the cytosol, but relatively very 
little of this enzyme in the nucleus.   
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Figure 6.4.   Sub-cellular localization of ppERK in CD4+ T cells.  Purified CD4+ T 
cells were stimulated for 10-minutes by CD3XCD28 in a RWV or under static 
conditions.  Cells were then fixed and processed for laser-scanning confocal microscopy 
with staining of the membrane (RED, wheat germ agglutinin), ppERK (GREEN), and 
the nucleus (BLUE, DAPI).  Unstimulated (unst) cells were included as a control for 
basal ppERK phosphorylation.  All images are a single 1-μm z-slice through the cell.  
A1-A3 and B1-B3 are two independent experiments.  Each panel shows a representative 
cell from one experiment.  Arrows indicate capped regions of the membrane.  A1 & A2: 
Unstimulated cells cultured in static conditions.  A2: A cell stimulated in static 
conditions.  ppERK is visible both at a capped region of membrane (arrow) and also 
diffusely distributed throughout the nucleus.  A3: A cell stimulated in a RWV.  Two 
mall capped regions of the membrane that are co-localized with ppERK are visible in 
 prominent.  Note that there 
appears to be very little nuclear localized ppERK compared to the static sample from this 
experiment (A2).  B2:  A cell stimulated in static conditions.  Both capping and ruffling 
of this cells' membrane are apparent in this image.  Some ppERK appears to be present in 
the nucleus, but the majority of staining follows the contour of the membrane.  B3:  A 
cell stimulated in a RWV.  The cellular morphology and distribution of ppERK are very 
similar to the static sample from this experiment although membrane ruffling is more 
apparent than capping in this image.  There appears to be slightly less ppERK in the 
nucleus of this cell compared to its static counterpart.               
s
this image (arrows).  ppERK staining in the cytoplasm is
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6.3.3 CD69 expression 
 CD69 is the product of an immediate-early gene whose expression is directly 
regulated by transcription factors downstream of RAS23;44.  TCR-induced upregulation of 
CD69 was therefore used as a reporter of productive signaling through the RAS/MAPK 
pathway to the nucleus.  In preliminary experiments we found that with respect to 
activation markers such as CD69, PHA- and CD3XCD28-stimulation yield identical 
results, and the former was used as stimulus in the experiments reported in this section.       
 Stimulation of PBMC for 24-hrs with PHA induced CD69 expression by ~75-% 
of CD4+ T cells cultured under static conditions, but failed to induce expression of this 
molecule by CD4+ PBMCs cultured in the RWV (fig. 6.4a).  Sub-mitogenic PMA co-
stimulation was able to rescue PHA-induced CD69 expression by CD4+ T cells in the 
RWV and was nearly as effective at inducing CD4+ T cells to express CD69 in the RWV 
as in static conditions (fig. 6.4a; p = 0.1218; N = 3), although the magnitude of CD69 
expressed by RWV-cultured cells was still significantly less than their counterparts 
cultured in static conditions (fig. 6.4b; p = 0.0472; N = 3).  Even at the sub-mitogenic 
dose used in these experiments PMA alone was nearly as potent an inducer of CD69 
expression as PHA, and somewhat surprisingly this effect was not significantly inhibited 
by culture in the RWV (p = 0.6518, %-CD69+ cells; p = 0.3899, CD69 MFI; N = 3).  
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Figure 6.4.  CD69 expression by CD4+ T cells.  Human PBMC were stimulated with th
indicated mitogens or left unstimulated (unst) as a control and cultured for 24-hrs in
RWV or under static conditions.  Cells were then immunostained for CD4 and CD69 
analyzed by flow cytometry.  A.  Percentages of CD4+ cells that were also CD69+. 
MFI of CD69 staining by CD4+/CD69+ T cells.  Each filled symbol represents an
independent experiment.  Horizontal bars are the mean of all experiments.       
e 
 a 
and 
 B.  
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6.4 Conclusions 
 The results presented in this chapter demonstrate that receptor stimulation of 
CD4+ T cells in the RWV induces robust signaling through the RAS/MAPK pathway to 
activate both the p44 and p42 MAPKs ERK-1 and ERK-2.  Nonetheless, T cells 
stimulated within the RWV fail to express immediate-early genes regulated by 
transcription factors downstream of ERK.  Our data suggest that this disconnect between 
MAPK signaling and gene expression may be due to sequestration of activated ERK in 
of genes critical for activation of the cell.  In support of this hypothesis PMA at a dose 
his finding 
indicates that rather than boosting the magnitude of RAS/MAPK signaling, co-
stimulation with PMA facilitates the entry of ERK into the nucleus.  An intriguing 
possibility in this regard is that PMA shifts the activation of RAS from the Golgi to the 
plasma-membrane in the RWV, and thus generates a pool of mobile RAS that can 
subsequently translocate into the nucleus and mediate gene expression.           
  
the cytosol leading to its exclusion from nucleus during culture in the RWV.  According 
to this model the abortive activation of T cells in the RWV is due to the failure of ERK-
activated transcription factors such as Elk-1 and AP-1 (via c-fos) to induce the expression 
sufficient for rescue of PHA-induced T cell proliferation was able to promote the 
expression of an immediate-early gene directly downstream from RAS.  T
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CHAPTER 7: DISCUSSION & FUTURE EXPERIMENTS 
 
 
“What are the molecular and genetic mechanisms that are affected by space flight 
related environments (e.g., radiation, microgravity, stress, isolation, sleep 
deprivation, extreme environments, nutritional deficiency, and social interactions) 
that can result in the loss of immunoregulation/immune tolerance and/or affect 
innate/acquired immunity, respectively?”  
or.  These 
plied T cells were unable to 
transduce activating signals from the TCR in microgravity culture, and test the hypothesis 
that the defect in TCR signaling lies in the generation of DAG, or in the pathways that are 
activated in response to this second-messenger.   
  
 
7.1 Introduction 
 The National Aeronautics and Space Administration’s goals of manned 
exploration of mars and multiyear sojourns to lunar and orbital stations will require 
careful consideration of the physiological consequences of long-term spaceflight.  The 
Bioastronautics Critical Path Roadmap outlines these concerns and identifies the essential 
research questions that must be answered to address them1.  With regard to the decline in 
astronaut immunity during spaceflight this document proposes the question:  
 The research presented in this thesis directly addresses this question by making a 
detailed investigation of antigen-receptor signal transduction in primary human CD4+ T 
cells cultured in a microgravity analog, the rotating-wall vessel bioreact
investigations stem from previous findings that strongly im
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7.2. Signa
 The activation of T lymphocytes in both true- and modeled microgravity culture 
reat detail using a battery of different mitogens to show that T 
t in antigen-
receptor sig
TCR li
recruitm
recepto
measur tion of several of these molecules in 
response to receptor crosslinking with CD3 and CD28 monoclonal antibodies.   
Furthermore, the signals transduced by cells cultured in the RWV were identical in 
magnitude to those of T cells stimulated under static conditions.  The lack of any defect 
in the TCR signal was surprising given the similar activation-phenotypes of T cells 
cultured in the RWV and T cells lacking key components of the TCR signaling pathway 
such as LAT or Itk .     
ling from the TCR to PLCγ1 
has been investigated in g
cells fail to undergo blast formation, express activation markers, secrete cytokines, or 
proliferate in response to stimuli that lie upstream of the T cell receptor, but become fully 
activated (i.e. express CD25 and proliferate) when stimulated with mitogenic 
combinations of phorbol ester and calcium ionophore38;67.  Based on these reports and 
preliminary data produced in our own lab we hypothesized that during culture in 
spaceflight or ground-based microgravity analogs T cells experience a defec
nal transduction leading to sub-optimal activation of PLCγ1 in response to 
gation.  Signaling between the TCR and PLCγ1 is mediated by the sequential 
ent and activation of a number of tyrosine kinases and adaptor molecules at the 
r-proximal plasma membrane.  We therefore investigated the above hypothesis by 
ing the site-specific tyrosine phosphoryla
 In these studies we found that primary human CD4+ T cells were fully competent 
to transduce activating signals to PLCγ1 during RWV-culture (see figure 4.1).  
92;140
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 The above data suggest that either (1) the antigen-receptor signal is not sustained 
gnal.  A 
by cells cultured in the RWV or that (2) culture in the RWV impinges upon signaling 
pathways downstream of the DAG second-messenger.  Although the former possibility 
cannot be explicitly ruled out in the absence of data from longer timepoints, the similarity 
in magnitude of inducible ZAP-70 and ζ-chain phosphorylation in the RWV and static 
conditions favors the latter explanation.  The initial TCR signal is subject to negative 
feedback from the lck-associated phosphotyrosine phosphatase SHP-1, and for a TCR-
induced signal to persist beyond the initial encounter with a ligand it must be potent 
enough to induce MAPK signaling to ERK.  ERK subsequently phosphorylates lck and 
disrupts the interaction with SHP-1, abolishing negative feedback on the antigen-receptor 
signal3.  The affinity of a TCR for its ligand, and thus its potency to transduce activating 
signals has been shown to directly correlate with the magnitude of tyrosine 
phosphorylation of ZAP-70 and ζ-chains47.  In light of this observation our data imply 
that TCR-stimulation is equally as potent in the RWV as in static conditions, and should 
therefore be of sufficient strength to overcome negative feedback on the si
consequence of this conclusion is that even if the TCR-signal is quenched at later 
timepoints, this quenching would be secondary to defects within the MAPK signaling 
pathway rather than a direct result of altered receptor-proximal signaling.   
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7 Signaling from PKCθ to NFκB 
 Our initial finding that T cells are unimpaired in their ability to activate PLCγ1 
during culture in the RWV led us to shift the focus of this study to the downstream 
pathways activated by the DAG second-messenger.  PKCθ is one of the primary 
downstream targets of DAG, and we began our investigation by measuring several 
aspects of T cell activation mediated by this enzyme.   
 Based on the CD3XCD28-induced mobilization of the actin cytoskeleton and 
downmodulation of the TCR, our data clearly show that primary human CD4+ T cells 
activate PKCθ during culture in the RWV (see figs. 5.1 & 5.2).  PKCθ-function impinges 
on each of the major TCR-induced activation pathways, but is only absolutely required 
for signaling to NFκB151.  Our data indicate that despite activation of PKCθ, degradation 
of IκBα was only weakly induced and did not result in the expression of the NFκB target 
gene ICAM-1 (see figs. 5.3 & 5.4).  Although the former result should be interpreted with 
caution due to the small sample size, the latter clearly illustrates the failure of T cells 
stimulated within the RWV to express genes under the transcriptional control of NFκB.   
 Importantly, the results described above define a break in the TCR signaling 
θ
.3. 
pathway downstream of PKC  but prior to the induction of ICAM-1 gene expression.  
Given the provisional nature of the IκB data, however, it is unclear whether this break is 
upstream or downstream of immediate-early gene expression.  TCR-induced expression 
of ICAM-1 is highly dependent on the activation of NFκB family members, and is most 
strongly induced by the c-Rel-RelA (p65) NFκB heterodimer20;133.  RelA is constitutively 
expressed by T cells and translocates to the nucleus within 30-minutes of TCR triggering 
as part of the p65-NFκB1 (p50) complex responsible for NFκB-mediated immediate-
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early gene expression111.  c-Rel is also constitutively expressed albeit at lower levels; 
anslo
 canonical NFκB pathway, and 
Bα d
tr cation of this molecule to the nucleus, however, requires de novo protein synthesis, 
since basal c-Rel protein is not associated with IκBα162.   
 Our data suggest two possible scenarios by which defects in NFκB signaling 
could prevent ICAM-1 expression during culture in the RWV.  In the first scenario, 
RWV-culture directly inhibits signaling through the
Iκ oes not become degraded to allow NFκB proteins access to the nucleus.  In the 
second scenario, inhibition of ICAM-1 expression is secondary to defects in other 
pathways that prevent de novo synthesis of c-Rel.  Expression of c-Rel requires the 
activation of both AP-1 and NFAT-family transcription factors, and a loss of TCR-
induced c-Rel expression would require that signaling to one or both of these proteins be 
defective during microgravity culture65;66.  Based on preliminary evidence, it appears that 
the activation of NFAT is intact during culture in the RWV; the activation of AP-1, 
however, is questionable and will be addressed in more detail in the next section.   
7.4. Signaling from RASGRP to ERK 
 RASGRP is the second major target of DAG, and we concluded our studies by 
examining TCR-induced signaling through this molecule during culture in the RWV.  
RASGRP activates the small GTPase RAS, and sets in motion the MAPK signaling 
cascade that leads to the activation of ERK.  Two principle aspects of ERK regulation are 
its phosphorylation on threonine 202 and tyrosine 204, and its sub-cellular localization.  
Dual phosphorylation is sufficient to induce the enzymatic activity of this molecule, and 
also disrupts the constitutive association of MEK and ERK allowing the latter enzyme to 
translocate into various sub-cellular compartments128.  
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  In our experiments we found that culture in the RWV did not prevent CD4+ T 
lymphocytes from activating either ERK-1 or -2 in response to CD3XCD28 stimulation 
(see figs. 6.1 & 6.2).  The sub-cellular distribution of these enzymes was less clear, but 
+ 23
 these 
molecules.  Like all immediate-early genes, CD69 does not require de novo protein 
se to PMA is downstream of 
RAS-activated transcription factors—expression of constitutively active RAS has the 
expression of calcium-independent immediate-early genes such as CD69 and presumably 
our data suggest that activated ERK may become sequestered in the cytosol during 
culture in the RWV (see fig. 6.4, image A3).  This finding would indicate that ERK has 
limited access to nuclear substrates during culture in the RWV; a conclusion that is 
supported by the finding that the RAS-induced immediate-early gene CD69 was not 
expressed by PHA-stimulated CD4 T cells cultured in the RWV (see fig. 6.5) .  The 
lack of CD69 expression despite ERK activation is similar to what we observed for 
ICAM-1 expression in relation to PKCθ, however, in contrast to ICAM-1, the expression 
of CD69 could be induced by sub-mitogenic PMA in the absence of other stimuli in both 
the RWV and static conditions.   
 The differential sensitivity of T cells to PMA with respect to the expression of 
CD69 and ICAM-1 stems from differences in the transcriptional regulation of
synthesis for its expression57.  Expression of CD69 in respon
same effect on CD69 expression as PMA, and dominant-negative RAS abrogates the 
PMA-induced expression of CD6923;44.  Efficient upregulation of ICAM-1 requires 
transcription of c-Rel, which is itself under the transcriptional control of AP-1, and, 
importantly, NFAT65.  These observations imply that, on its ownj, PMA can induce the 
                                                 
j
20-ng/ml vs. the 0.5-ng/ml used here) can induce the expression o
mechanisms studied here, including ICAM-1, without the need o
 On its own and at the dose required for rescue of proliferation in the RWV; higher doses of PMA (10- to 
f many of the molecules and 
f a second mitogenic signal.   
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the AP-1 subunits c-fos and c-Jun, but that expression of NFAT dependent genes such as 
c-Rel requires a mitogen such as PHA to provide calcium mediated signals to NFAT77.  
This conclusion raises the intriguing possibility that T cells fail to become activated in the 
RWV due to a block in signaling to the nucleus through the RAS/MAPK pathway, and 
that PMA rescues activation by allowing activated ERK to enter the nucleus and activate 
transcription factors required for the expression of immediate early genes downstream of 
RAS/MAPK.   
+
7.5. A Model of TCR-Signaling in the RWV 
 In the preceding sections we have begun to establish a model of TCR-induced 
signaling during culture in the RWV.  According to this model CD3XCD28-stimulated 
CD4  T cells activate PLCγ1, ERK, and PKCθ, yet fail to enter the cell cycle or 
proliferate due to a failure in RAS-induced immediate-early gene expression secondary to 
ERK becoming sequestered in the cytosol.  According to this model PMA rescues T cell 
activation in the RWV by facilitating the nuclear translocation of ERK where it can 
mediate the expression of immediate-early genes by activating a number of nucleus-
resident transcription factors such as Elk-1.  Several of the immediate-early genes 
induced by these molecules are themselves transcription factors, including c-fos and c-
Rel, whose expression is absolutely required to execute the genetic program of T cell 
activation.     
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 A major issue that is not addressed by the model proposed above is the means by 
which ERK is prevented from entering the nucleus.  One possible mechanism is that ERK 
becomes sequestered at the Golgi in response to TCR-ligation in the RWV.  Important in 
this regard, is the finding that the integral Golgi-membrane protein Sef1 binds to MEK 
and stabilizes the MEK-ERK interaction without perturbing the enzymatic activity of 
ERK.  This interaction allows ERK to phosphorylate cytosolic targets such as RSK, but 
prevents the activation of nuclear substrates such as the transcription factor Elk-1156.   
 Sequestration of ERK at the Golgi is an attractive hypothesis to explain the loss of 
T cell activation in the RWV since partitioning of ERK into this compartment has been 
reported to play a significant role in determining the functional outcome of TCR signals 
during thymic selection.  Specifically, Daniels, et al. found that TCR signaling by 
thymocytes in response to cognate peptide (full agonist) activated RASGRP, RAS, and 
ERK at the membrane, whereas weakly agonistic peptides activated these molecules in 
the cytoplasm; presumably at the Golgi .  This finding complements a number of earlier 
studies that demonstrated a role for both the duration and the strength of ERK signaling 
in thymic selection .  Although these studies did not examine the sub-cellular 
distribution of ERK and Daniels et al. did not investigate the extended kinetics (>10-min) 
of ERK activation; their combined results imply that weak-agonists result in long-
duration low-magnitude ERK signals at the Gogli.  In support of this conclusion Mark 
Philip’s group has demonstrated that in many cell types transient RAS activation occurs 
exclusively at the plasma membrane, but that RAS can be activated with slower kinetics 
for longer durations at the Golgi, and in Jurkat T cells RAS activation at the Golgi occurs 
as a result of low-grade TCR-stimulation14;122. Although we did not observe the same 
47
73
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Golgi/membrane exclusivity as the studies discussed above, our data do provide limited 
evidence that activated ERK may be expressed predominantly in the cytosol during 
culture in the RWV.  Our observation of both cytosolic and membrane-localized ppERK 
likely reflects the fact that we are measuring changes in the sub-cellular localization of 
ERK due to phenomena that are downstream of a fully agonistic TCR signal, rather than 
due to a decrease in the magnitude of TCR-proximal signaling.   
 What remains to be addressed is the mechanism by which culture in the RWV 
                                                
causes a TCR-signal that is demonstrably agonistic at the level of PLCγ1 to become 
weakly agonistic at the level of ERK.  In this regard, a crucial hint can be found by noting 
that an analogous situation is observed in the activation of the leukemic T cell line Jurkat.  
Similar to primary T cells cultured in the RWV, Jurkat T cells generate robust antigen-
receptor signals and induce PLCγ1-activity in response to TCR ligation, but are unable to 
become activatedk without PMA co-stimulation168.  Interestingly, a recent report 
demonstrated that Jurkat T cells generate distinct patterns of DAG signaling in response 
to CD3XCD28 stimulation in the presence or absence LFA-1 co-stimulation114.  The 
authors’ of this study found that the PLCγ1-derived DAG produced in response to 
CD3XCD28 was sufficient to activate RASGRP at the Golgi, but that phospholipase D2 
(PLD2)-derived DAG produced in response to LFA-1 co-stimulation was required to 
activate RASGRP at the plasma membrane.   
 Given the importance of compartmentalized RAS/MAPK signaling in 
determining the functional outcome of TCR triggering it is interesting to hypothesize that 
PMA co-stimulation of CD3XCD28-activated Jurkat T cells results in a redistribution of 
 
k Activation of Jurkat T cells is defined as the ability to produce IL-2 
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RASGRP between the Golgi and plasma membrane similar to LFA-1 co-ligation.  In T 
cells, inducible RAS activation at the plasma membrane, but not at the Golgi, is tightly 
regulated by the antagonistic functions of RASGRP and the GTPase activating protein 
(RASGAP) CAPRI (Ca2+-promoted RAS inactivator)115.  The cleavage of PIP2 by PLCγ1 
recruits both of these enzymes to the plasma membrane—RASGRP through DAG and 
CAPRI via increased levels of intracellular calcium—where they become activated and 
mpet
 to become activated, and the second is that 
ture
                                                
co itively regulate the activation state of RAS.  In CD3XCD28-stimulated Jurkat T 
cells conditions at the membrane favor CAPRI in this equilibrium.  Co-stimulation 
through LFA-1 activates phospholipase D2 (PLD2), which generates “IP3-free” DAG 
from phosphatidylcholinel, thereby boosting DAG levels at the membrane without the 
concomitant rise in intracellular calcium seen with PIP2-derived DAG.  It would appear, 
then, that in Jurkat T cells LFA-1 co-stimulation generates conditions at the membrane 
that favor RASGRP activation over CAPRI, and allow activated RAS to accumulate at 
the membrane and signal to ERK.  PMA co-stimulation could act in a similar manner 
since this molecule also acts as an IP3-free source of DAG that would be expected to 
favor activated RAS at the membrane. 
 The applicability of the mechanism proposed above to T cells cultured in the 
RWV depends on the validity of two assumptions.  The first is that CD3XCD28-
stimulated T cells require an outside-in signal
cul  in the RWV inhibits or prevents the delivery of this signal.  Contrary to the first of 
these assumptions, it has been suggested that stimulation of T cells with CD3XCD28 is 
independent of intercellular interactions.  It should be noted, however, that this is not a 
 
l The generation of DAG by this route requires first the cleavage of phosphatidylcholine into phosphatidic 
acid (PA) and choline by PLD2.  The constitutively active and ubiquitously expressed enzyme phosphatidic 
acid phosphatase (PAP) subsequently converts PA into DAG.   
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universally accepted conjecture (P. Katsikis, personal communication).  The 
conduciveness of high cell-density for T cell activation by CD3XCD28 (G. Koretzky, 
personal communication), and the near ubiquitous expression of LFA-1 and its ligand 
ICAM-1 by cells of the immune system also favors the argument that intercellular 
interactions are required for T cell activation by mitogenic antibodies.. A possible 
mechanism by which the RWV could perturb intercellular adhesion-mediated outside-in 
signaling is the dynamic culture environment within the bioreactor.  Although culture in 
the RWV does not disrupt the aggregation of PBMC in response to surface mitogens 
(unpublished observation), the cells in these aggregates are subject to a continuous low-
level of fluid shear force.  The ability of fluid shear to modulate cellular function is well 
established and the possibility of a role for fluid shear forces in the activation phenotype 
of T cells in the RWV is supported by the recent finding that fluid shear can modulate the 
cross-talk between chemokine receptors and LFA-1 on T cells and neutrophils78.  It is 
feasible then, that fluid forces present within the RWV prevent T cell activation by subtly 
altering inside-out signals that are required for the cells to respond to surface-receptor 
stimulation.   
 In summary, based on our data we have proposed a model (figure 7.1) to explain 
the loss of T cell activation in the RWV where subtle changes in the quality of 
intercellular adhesions alter the DAG content of the plasma membrane and inhibit MAPK 
signaling to the nucleus.  According to this model, fluid-shear forces present in the RWV 
alter outside-in signals originating with LFA-1m, and thereby limit the amount of IP3-free 
                                                 
m Although transmission of this signal need not be exclusive to LFA-1, nor is it necessarily constitutive (or 
inducible for that matter), integrins are responsive to many stimuli including PKCs, and calcium.  
Constitutive expression could set up RASGRP-friendly membranes, whereas inducible expression could 
act to bolster PLCγ1-generated DAG. 
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DAG present in the plasma membrane.  The plasma membrane of cells cultured in the 
RWV is therefore less favorable for the generation of RAS-GTP, and cannot be used as a 
platform to generate activated ERK that is free to enter the nucleus and phosphorylate 
transcription factors that are essential for activating the cell.  Ultimately it is the failure to 
express immediate-early genes regulated by these transcription factors including c-fos, c-
Rel, and c-myc that prevents T cells from becoming activated in microgravity.  PMA co-
stimulation rescues T cell activation in the RWV by providing an IP3-free “DAG” signal 
similar to LFA-1 that restores the ability of cells to use the plasma membrane as a 
platform for MAPK signaling to the nucleus.   
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Figure 7.1. A model of T cell signal transduction in the RWV.  TCR Signals induce 
RAS (and hence ERK) at both the plasma- and Golgi-membranes in static culture, but 
only at the Golgi-membrane in the RWV. Phosphatidic acid (PA); phosphatidic acid 
phosphatase (PAP); diacyl glycerol (DAG); phospholipase D2 (γ1) (PLD2 (γ1 )); 
guanyl-nuceotide replacing protein (GRP); Ca2+ promoted RAS inactivator (CAPRI). 
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7.6 Comparisons of the Proposed Model to the Literature 
 The central tenet of the model we have proposed to explain the failure of T cells 
to become activated in the RWV is that the failure of ERK to enter the nucleus and 
activate gene expression completely abrogates T cell activation.  In support of this 
hypothesis ectopic targeting of ERK to the cytosol abrogates growth factor induced gene 
expression and cell cycle entry by serum-stimulated fibroblasts18.  A corollary of our 
model is that the activation of cyotosolic ERK   substrates should be unaffected by 
culture in the RWV.  This prediction is at odds, however, with a recent report that human 
T cells stimulated with ConA and anti-CD28 antibody in a random positioning machine 
(RPM)n did not phosphorylate the cyclic AMP response element binding (CREB)15.  
CREB is a target of the MAPK activated protein kinases RSK and MSK79;117.  Our model 
predicts that CREB should be phosphorylated during culture in microgravity since RSK 
and MSK are prominent cytosolic targets of ERK60.  Although this discrepancy could 
arise from differences in stimulus (ConA + αCD28 vs. CD3XCD28) or duration of 
stimulation (30-minutes vs. 5-minutes); an Alternative explanation is that in addition to 
preventing the migration of ERK into the nucleus sequestration of ERK at the Golgi may 
also inhibit phosphorylation of RSK/MSK.  Such an interpretation is in line with our 
hypothesis that the plasma membrane is a platform for generating mobile ERK that can 
translocate into various sub-cellular compartments, whereas ERK activated at the Golgi 
membrane remains sequestered in this compartment, and is supported by a recent report 
showing that the ERK-mediated phosphorylation of RSK2 requires the association of 
59.  both enzymes with the cytosolic scaffold PEA-15 (protein enriched in astrocytes-15)1
                                                 
n The RPM is a recent ground-based model of microgravity that, similar to the RWV, produced modeled 
microgravity based on the principle of a randomized gravitational vector.   
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According to this interpretation a reduction in CREB phosphorylation would be due to 
e lim
  
th ited pool mobile ERK that could bind PEA-15 and activate RSK. 
  Regardless of whether T cells are capable of activating RSK/MSK in response to 
TCR ligation in the RWV, it is unlikely that the microgravity induced defect in T cell 
activation is due to a loss of CREB-activaty alone.  T cells from knock-in mice 
expressing a dominant-negative form of CREB undergo G1 arrest and activation-induced 
cell death in response to mitogenic stimulation, and these defects can largely be rescued 
by exogenous IL-28.  Although murine T cells cultured in the RWV undergo activation 
induced cell death, this is not the case with human T cells, and more importantly T cells 
from both species undergo cell-cycle arrest in G0 and are completely unresponsive to IL-
2, exogenous or otherwise, during culture in the RWV39;68;132;147.     
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7.7. Future Experiments 
 The experiments described in this thesis made a step by step investigation TCR-
7.7.1. Measurement of immediate-early gene expression 
 Transcriptional profiling of several immediate-early genes by RT-PCR would 
greatly strengthen the results and presented here.  The experiment described here tests the 
hypothesis that PMA rescues activation in the RWV by allowing ppERK access to the 
sion. The ideal (not most 
economical) experiment two test this hypothesis would have two stimuli (CD3XCD28 
and CD3XCD28 + PMA), two conditions (static and RWV), and one control 
(unstimulated).  Cells from each condition would be harvested for mRNA and RT-PCR 
would be used to measure the expression of c-fos, c-Jun, IκBα and p50, and c-Rel as 
indicators of transcriptional activity from Elk-1, ATF2-cJun, p50/p52 and p50/p65 NFκB 
dimers, and AP-1/NFAT respectively.  Expected results would be that none of these 
genes or at most only IκBα and p50 are expressed in the RWV in the absence of PMA, 
and all are expressed in the presence of PMA.  These genes should all have similar 
kinetics (±30-minutes), and the ideal timepoint should be determined empirically prior to 
beginning experiments in earnest.    
induced signaling from the receptor to the nucleus.  The steps were necessarily large to 
cover the broad scope of this project, and future experiments will fill in the gaps between 
steps.  All of the experiments described in the section below require that the purified 
CD4+ T cells be stimulated by CD3XCD28 as indicated in the materials and methods 
section of chapter 4.  Similarly the details performing experiments in HARVs can be 
found in the same section and chapter.        
nucleus where it promotes immediate-early gene expres
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7.7.2. Phosphorylation of nuclear vs. cytosolic ERK substrates 
ic ERK substrates.  ELK-1 would be a good 
candidate for a nuclear target.  This molecule constitutively resides within the nucleus 
bound to target DNA, but unable to induce transcription until phosphorylated by ERK.  
For the latter protein it may help to make a nuclear protein extract.  The expected result 
would be that lysates from T cells stimulated in the RWV contain phosphorylated RSK, 
but not ELK-1, and when PMA is used as co-stimulus in the RWV phosphorylated ELK-
1 can be detected in lysates             
e le of 5- to 10-minutes can be used, but this should 
 This experiment investigates the hypothesis that activated ERK is prevented from 
entering the nucleus in response to mitogenic stimulation in the RWV, and that PMA co-
stimulation allows nuclear entry of ERK.  The experimental setup (stimuli and 
conditions) are identical to those outlined in section 7.7.2.  A stimulation time of 10-
minutes should be used and then lysates of each sample should be made and analyzed by 
Western blot.  Ribosomal S6 kinase (RSK) would be a good choice for cytosolic targets 
as it is one of the more prominent cytosol
7.7.3. Nuclear translocation of p65 and NFAT 
 The results presented in this thesis suggest imply that NFAT becomes activated 
and translocates to the nucleus in the RWV.  Whether the same is true for p65 is less 
clear.  These experiments investigate the hypothesis that T cells stimulated in the RWV 
mobilize both NFAT and p65-containing NFκB family members to the nucleus, but fail 
to activate many genes necessary for activation in the absence of an AP-1 family 
transcription factor.  In this set of experiments immunofluorescence will be used to study 
the sub-cellular localization of these molecules following stimulation in the RWV or 
static conditions.  For NFAT1 a tim sca
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be determined empirically.  Measurement of p50 translocation should occur on a 
mesca
 
                 
  
ti le of 30- to 45-minutes.  These experiments should be analyzed using a standard 
fluorescence microscope. 
112 
 
LIST OF REFERENCES 
 
 
 1.  Bioastronautics Critical Path Roadmap. http://bioastroroadmap.nasa.gov/index.jsp . 2-9-
2005. Houston, TX, NASA.  
 2.  Adachi M, Fukuda M, Nishida E: Two co-existing mechanisms for nuclear import of 
MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J 
18:5347-5358, 1999 
 3.  Altan-Bonnet G, Germain RN: Modeling T cell antigen discrimination based on feedback 
control of digital ERK responses. PLoS Biol 3:e356, 2005 
 4.  Anton IM, Jones GE: WIP: a multifunctional protein involved in actin cytoskeleton 
regulation. Eur J Cell Biol 85:295-304, 2006 
 5.  Badour K, Zhang J, Siminovitch KA: The Wiskott-Aldrich syndrome protein: forging the 
link between actin and cell activation. Immunol Rev 192:98-112, 2003 
 6.  Baier G, Telford D, Giampa L, Coggeshall KM, Baier-Bitterlich G, Isakov N, Altman A: 
Molecular cloning and characterization of PKC theta, a novel member of the protein 
kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol 
Chem 268:4997-5004, 1993 
 7.  Barda-Saad M, Braiman A, Titerence R, Bunnell SC, Barr VA, Samelson LE: Dynamic 
molecular interactions linking the T cell antigen receptor to the actin cytoskeleton. Nat 
Immunol 6:80-89, 2005 
 8.  Barton K, Muthusamy N, Chanyangam M, Fischer C, Clendenin C, Leiden JM: Defective 
thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-
negative form of CREB. Nature 379:81-85, 1996 
 9.  Bechler B, Cogoli A, Cogoli-Greuter M, Muller O, Hunzinger E, Criswell SB: Activation 
of microcarrier-attached lymphocytes in microgravity. Biotechnol Bioeng 40:991-996, 
1992 
113 
 
 10.  Bennie C.Wooley, Gary W.McCollum: Flight crew health stabilization program, in 
Richard S.Johnston, Lawrence F.Dietlein, Charles A.Berry (eds): Biomedical Results of 
Apollo. NASA-SP 368 , chap 6. Washington, DC, 1975, pp 141-149 
 11.  Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL: Tec family kinases in T 
lymphocyte development and function. Annu Rev Immunol 23:549-600, 2005 
 12.  Berry DM, Nash P, Liu SK, Pawson T, McGlade CJ: A high-affinity Arg-X-X-Lys SH3 
binding motif confers specificity for the interaction between Gads and SLP-76 in T cell 
signaling. Curr Biol 12:1336-1341, 2002 
 13.  Billadeau DD, Nolz JC, Gomez TS: Regulation of T-cell activation by the cytoskeleton. 
Nat Rev Immunol 7:131-143, 2007 
 14.  Bivona TG, Perez DC, I, Ahearn IM, Grana TM, Chiu VK, Lockyer PJ, Cullen PJ, 
Pellicer A, Cox AD, Philips MR: Phospholipase Cgamma activates Ras on the Golgi 
apparatus by means of RasGRP1. Nature 424:694-698, 2003 
 15.  Boonyaratanakornkit JB, Cogoli A, Li CF, Schopper T, Pippia P, Galleri G, Meloni MA, 
Hughes-Fulford M: Key gravity-sensitive signaling pathways drive T-cell activation. 
FASEB J 2005 
 16.  Braiman A, Barda-Saad M, Sommers CL, Samelson LE: Recruitment and activation of 
PLCgamma1 in T cells: a new insight into old domains. EMBO J 25:774-784, 2006 
 17.  Brdicka T, Pavlistova D, Leo A, Bruyns E, Korinek V, Angelisova P, Scherer J, 
Shevchenko A, Hilgert I, Cerny J, Drbal K, Kuramitsu Y, Kornacker B, Horejsi V, 
Schraven B: Phosphoprotein associated with glycosphingolipid-enriched microdomains 
(PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein 
tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med 
191:1591-1604, 2000 
 18.  Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssegur J: Nuclear translocation 
of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene 
expression and cell cycle entry. EMBO J 18:664-674, 1999 
114 
 
 19.  Bunnell SC, Diehn M, Yaffe MB, Findell PR, Cantley LC, Berg LJ: Biochemical 
interactions integrating Itk with the T cell receptor-initiated signaling cascade. J Biol 
Chem 275:2219-2230, 2000 
 20.  Bunting K, Rao S, Hardy K, Woltring D, Denyer GS, Wang J, Gerondakis S, Shannon 
MF: Genome-wide analysis of gene expression in T cells to identify targets of the NF-
kappa B transcription factor c-Rel. J Immunol 178:7097-7109, 2007 
 21.  Byth KF, Conroy LA, Howlett S, Smith AJ, May J, Alexander DR, Holmes N: CD45-null 
transgenic mice reveal a positive regulatory role for CD45 in early thymocyte 
development, in the selection of CD4+CD8+ thymocytes, and B cell maturation. J Exp 
Med 183:1707-1718, 1996 
 22.  Carreno LJ, Gonzalez PA, Kalergis AM: Modulation of T cell function by TCR/pMHC 
binding kinetics. Immunobiology 211:47-64, 2006 
 23.  Castellanos MC, Munoz C, Montoya MC, Lara-Pezzi E, Lopez-Cabrera M, de Landazuri 
MO: Expression of the leukocyte early activation antigen CD69 is regulated by the 
transcription factor AP-1. J Immunol 159:5463-5473, 1997 
 24.  Chan AC, Dalton M, Johnson R, Kong GH, Wang T, Thoma R, Kurosaki T: Activation 
of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte 
antigen receptor function. EMBO J 14:2499-2508, 1995 
 25.  Chan AC, Irving BA, Fraser JD, Weiss A: The zeta chain is associated with a tyrosine 
kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa 
tyrosine phosphoprotein. Proc Natl Acad Sci U S A 88:9166-9170, 1991 
 26.  Chen CC, Manning AM: Transcriptional regulation of endothelial cell adhesion 
molecules: a dominant role for NF-kappa B. Agents Actions Suppl 47:135-141, 1995 
 27.  Choudhuri K, van der Merwe PA: Molecular mechanisms involved in T cell receptor 
triggering. Semin Immunol 19:255-261, 2007 
 28.  Choudhuri K, Wiseman D, Brown MH, Gould K, van der Merwe PA: T-cell receptor 
triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature 
436:578-582, 2005 
115 
 
 29.  Chouker A, Thiel M, Baranov V, Meshkov D, Kotov A, Peter K, Messmer K, Christ F: 
Simulated microgravity, psychic stress, and immune cells in men: observations during 
120-day 6 degrees HDT. J Appl Physiol 90:1736-1743, 2001 
 30.  Chow S, Hedley D, Grom P, Magari R, Jacobberger JW, Shankey TV: Whole blood 
fixation and permeabilization protocol with red blood cell lysis for flow cytometry of 
intracellular phosphorylated epitopes in leukocyte subpopulations. Cytometry A 67:4-17, 
2005 
 31.  Cogoli A: The effect of hypogravity and hypergravity on cells of the immune system. J 
Leukoc Biol 54:259-268, 1993 
 32.  Cogoli A: Gravitational physiology of human immune cells: a review of in vivo, ex vivo 
and in vitro studies. J Gravit Physiol 3:1-9, 1996 
 33.  Cogoli A, Cogoli-Greuter M: Activation and Proliferation of Lymphocytes and Other 
Mammalian Cells in Microgravity, in Bonting SL (ed): Advances in Space Biology and 
Medicine, chap 2. Greenwich, CT, 1997, pp 33-79 
 34.  Cogoli A, Gmunder FK: Gravity Effects on Single Cells: Techniques, Findings, and 
Theory, in Cogoli A (ed): Advances in Space Biology and Medicine, Greenwich, CT, 
1991, pp 183-248 
 35.  Cogoli A, Tschopp A, Fuchs-Bislin P: Cell sensitivity to gravity. Science 225:228-230, 
1984 
 36.  Cogoli-Greuter M, Sciola L, Spano A, Meloni MA, Pippia P, Cogoli A: Lymphocyte 
movements and interactions in microgravity. J Gravit Physiol 2:117-118, 1995 
 37.  Committee on the Longitudinal Study of Astronaut Health: Review of NASA's 
Longitudinal Study of Astronaut Health. Washington, DC, The National Academies 
Press, 2004, 
 38.  Cooper D, Pellis NR: Suppressed PHA activation of T lymphocytes in simulated 
microgravity is restored by direct activation of protein kinase C. J Leukoc Biol 63:550-
562, 1998 
116 
 
 39.  Cooper D, Pride MW, Brown EL, Risin D, Pellis NR: Suppression of antigen-specific 
lymphocyte activation in modeled microgravity. In Vitro Cell Dev Biol Anim 37:63-65, 
2001 
 40.  Costello PS, Walters AE, Mee PJ, Turner M, Reynolds LF, Prisco A, Sarner N, 
Zamoyska R, Tybulewicz VL: The Rho-family GTP exchange factor Vav is a critical 
transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. Proc 
Natl Acad Sci U S A 96:3035-3040, 1999 
 41.  Crabtree GR, Olson EN: NFAT signaling: choreographing the social lives of cells. Cell 
109 Suppl:S67-S79, 2002 
 42.  Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR: Phosphotyrosine-
dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. 
Nature 385:169-172, 1997 
 43.  Crucian BE, Cubbage ML, Sams CF: Altered cytokine production by specific human 
peripheral blood cell subsets immediately following space flight. J Interferon Cytokine 
Res 20:547-556, 2000 
 44.  D'Ambrosio D, Cantrell DA, Frati L, Santoni A, Testi R: Involvement of p21ras 
activation in T cell CD69 expression. Eur J Immunol 24:616-620, 1994 
 45.  D'Oro U, Ashwell JD: Cutting edge: the CD45 tyrosine phosphatase is an inhibitor of Lck 
activity in thymocytes. J Immunol 162:1879-1883, 1999 
 46.  D'Oro U, Sakaguchi K, Appella E, Ashwell JD: Mutational analysis of Lck in CD45-
negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol 
Cell Biol 16:4996-5003, 1996 
 47.  Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D, Holmberg K, Werlen G, 
Hollander GA, Gascoigne NR, Palmer E: Thymic selection threshold defined by 
compartmentalization of Ras/MAPK signalling. Nature 444:724-729, 2006 
 48.  Davis MM, Krogsgaard M, Huse M, Huppa J, Lillemeier BF, Li QJ: T cells as a self-
referential, sensory organ. Annu Rev Immunol 25:681-695, 2007 
117 
 
 49.  Davis SJ, van der Merwe PA: The kinetic-segregation model: TCR triggering and 
beyond. Nat Immunol 7:803-809, 2006 
 50.  Deindl S, Kadlecek TA, Brdicka T, Cao X, Weiss A, Kuriyan J: Structural basis for the 
inhibition of tyrosine kinase activity of ZAP-70. Cell 129:735-746, 2007 
 51.  Denny MF, Patai B, Straus DB: Differential T-cell antigen receptor signaling mediated 
by the Src family kinases Lck and Fyn. Mol Cell Biol 20:1426-1435, 2000 
 52.  Di B, V, Mege D, Germain V, Pelosi M, Dufour E, Michel F, Magistrelli G, Isacchi A, 
Acuto O: Tyrosine 319, a newly identified phosphorylation site of ZAP-70, plays a 
critical role in T cell antigen receptor signaling. J Biol Chem 274:6285-6294, 1999 
 53.  Dietrich J, Backstrom T, Lauritsen JP, Kastrup J, Christensen MD, von Bulow F, Palmer 
E, Geisler C: The phosphorylation state of CD3gamma influences T cell responsiveness 
and controls T cell receptor cycling. J Biol Chem 273:24232-24238, 1998 
 54.  Dower NA, Stang SL, Bottorff DA, Ebinu JO, Dickie P, Ostergaard HL, Stone JC: 
RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat 
Immunol 1:317-321, 2000 
 55.  Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC: RasGRP, a Ras guanyl 
nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. Science 
280:1082-1086, 1998 
 56.  Ebinu JO, Stang SL, Teixeira C, Bottorff DA, Hooton J, Blumberg PM, Barry M, 
Bleakley RC, Ostergaard HL, Stone JC: RasGRP links T-cell receptor signaling to Ras. 
Blood 95:3199-3203, 2000 
 57.  Eichler W, Ruschpler P, Wobus M, Drossler K: Differentially induced expression of C-
type lectins in activated lymphocytes. J Cell Biochem Suppl Suppl 36:201-208, 2001 
 58.  Fang N, Motto DG, Ross SE, Koretzky GA: Tyrosines 113, 128, and 145 of SLP-76 are 
required for optimal augmentation of NFAT promoter activity. J Immunol 157:3769-
3773, 1996 
 59.  Fragoso R, Ren D, Zhang X, Su MW, Burakoff SJ, Jin YJ: Lipid raft distribution of CD4 
depends on its palmitoylation and association with Lck, and evidence for CD4-induced 
118 
 
lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J Immunol 
170:913-921, 2003 
 60.  Frodin M, Gammeltoft S: Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in 
signal transduction. Mol Cell Endocrinol 151:65-77, 1999 
 61.  Ghosh S, Karin M: Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl:S81-S96, 
2002 
 62.  Gibson S, August A, Kawakami Y, Kawakami T, Dupont B, Mills GB: The 
EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is 
required for optimal activation of EMT. J Immunol 156:2716-2722, 1996 
 63.  Gmunder FK, Kiess M, Sonnenfeld G, Lee J, Cogoli A: Reduced lymphocyte activation 
in space: role of cell-substratum interactions. Adv Space Res 12:55-61, 1992 
 64.  Goldsmith MA, Weiss A: Isolation and characterization of a T-lymphocyte somatic 
mutant with altered signal transduction by the antigen receptor. Proc Natl Acad Sci U S A 
84:6879-6883, 1987 
 65.  Grumont R, Lock P, Mollinari M, Shannon FM, Moore A, Gerondakis S: The mitogen-
induced increase in T cell size involves PKC and NFAT activation of Rel/NF-kappaB-
dependent c-myc expression. Immunity 21:19-30, 2004 
 66.  Grumont RJ, Gerondakis S: Murine c-rel transcription is rapidly induced in T-cells and 
fibroblasts by mitogenic agents and the phorbol ester 12-O-tetradecanoylphorbol-13-
acetate. Cell Growth Differ 1:345-350, 1990 
 67.  Hashemi BB, Penkala JE, Vens C, Huls H, Cubbage M, Sams CF: T cell activation 
responses are differentially regulated during clinorotation and in spaceflight. FASEB J 
13:2071-2082, 1999 
 68.  Hawkins WR, Ziegelschmid JF: Clinical Aspects of Crew Health, in  Biomedical Results 
of Apollo. NASA-SP 368 , Washington, DC, 1975, pp 43-81 
 69.  Hayashi K, Altman A: Protein kinase C theta (PKCtheta): a key player in T cell life and 
death. Pharmacol Res 55:537-544, 2007 
119 
 
 70.  Heyeck SD, Wilcox HM, Bunnell SC, Berg LJ: Lck phosphorylates the activation loop 
tyrosine of the Itk kinase domain and activates Itk kinase activity. J Biol Chem 
272:25401-25408, 1997 
 71.  Higgs HN, Pollard TD: Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome 
protein (WASp) stimulates actin nucleation by Arp2/3 complex. J Cell Biol 150:1311-
1320, 2000 
 72.  Hogan PG, Chen L, Nardone J, Rao A: Transcriptional regulation by calcium, 
calcineurin, and NFAT. Genes Dev 17:2205-2232, 2003 
 73.  Hogquist KA: Signal strength in thymic selection and lineage commitment. Curr Opin 
Immunol 13:225-231, 2001 
 74.  Horejsi V, Zhang W, Schraven B: Transmembrane adaptor proteins: organizers of 
immunoreceptor signalling. Nat Rev Immunol 4:603-616, 2004 
 75.  Irvin BJ, Williams BL, Nilson AE, Maynor HO, Abraham RT: Pleiotropic contributions 
of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated 
signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line. Mol Cell 
Biol 20:9149-9161, 2000 
 76.  Ishiai M, Kurosaki M, Inabe K, Chan AC, Sugamura K, Kurosaki T: Involvement of 
LAT, Gads, and Grb2 in compartmentation of SLP-76 to the plasma membrane. J Exp 
Med 192:847-856, 2000 
 77.  Iwashima M: Kinetic perspectives of T cell antigen receptor signaling. A two-tier model 
for T cell full activation. Immunol Rev 191:196-210, 2003 
 78.  Iwashima M, Takamatsu M, Yamagishi H, Hatanaka Y, Huang YY, McGinty C, 
Yamasaki S, Koike T: Genetic evidence for Shc requirement in TCR-induced c-Rel 
nuclear translocation and IL-2 expression. Proc Natl Acad Sci U S A 99:4544-4549, 2002 
 79.  Kaiser M, Wiggin GR, Lightfoot K, Arthur JS, Macdonald A: MSK regulate TCR-
induced CREB phosphorylation but not immediate early gene transcription. Eur J 
Immunol 37:2583-2595, 2007 
120 
 
 80.  Kaur I, Simons ER, Castro VA, Ott CM, Pierson DL: Changes in monocyte functions of 
astronauts. Brain Behav Immun 2005 
 81.  Kim HK, Kim JW, Zilberstein A, Margolis B, Kim JG, Schlessinger J, Rhee SG: PDGF 
stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation 
on tyrosine residues 783 and 1254. Cell 65:435-441, 1991 
 82.  Kindt TJ, Goldsby RA, Osborne BA: Kuby Immunology (ed 6th). New York, W.H. 
Freeman & Company, 2007 
 83.  Klaus DM: Clinostats and bioreactors. Gravit Space Biol Bull 14:55-64, 2001 
 84.  Koretzky GA, Abtahian F, Silverman MA: SLP76 and SLP65: complex regulation of 
signalling in lymphocytes and beyond. Nat Rev Immunol 6:67-78, 2006 
 85.  Koretzky GA, Picus J, Thomas ML, Weiss A: Tyrosine phosphatase CD45 is essential for 
coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 346:66-68, 
1990 
 86.  Krogsgaard M, Li QJ, Sumen C, Huppa JB, Huse M, Davis MM: Agonist/endogenous 
peptide-MHC heterodimers drive T cell activation and sensitivity. Nature 434:238-243, 
2005 
 87.  Krutzik PO, Irish JM, Nolan GP, Perez OD: Analysis of protein phosphorylation and 
cellular signaling events by flow cytometry: techniques and clinical applications. Clin 
Immunol 110:206-221, 2004 
 88.  Kuhns MS, Davis MM, Garcia KC: Deconstructing the form and function of the 
TCR/CD3 complex. Immunity 24:133-139, 2006 
 89.  Kumar L, Pivniouk V, de la Fuente MA, Laouini D, Geha RS: Differential role of SLP-
76 domains in T cell development and function. Proc Natl Acad Sci U S A 99:884-889, 
2002 
 90.  Lee KY, D'Acquisto F, Hayden MS, Shim JH, Ghosh S: PDK1 nucleates T cell receptor-
induced signaling complex for NF-kappaB activation. Science 308:114-118, 2005 
121 
 
 91.  Liao XC, Littman DR: Altered T cell receptor signaling and disrupted T cell development 
in mice lacking Itk. Immunity 3:757-769, 1995 
 92.  Lin J, Weiss A: Identification of the minimal tyrosine residues required for linker for 
activation of T cell function. J Biol Chem 276:29588-29595, 2001 
 93.  Lindquist JA, Simeoni L, Schraven B: Transmembrane adapters: attractants for 
cytoplasmic effectors. Immunol Rev 191:165-182, 2003 
 94.  Liu KQ, Bunnell SC, Gurniak CB, Berg LJ: T cell receptor-initiated calcium release is 
uncoupled from capacitative calcium entry in Itk-deficient T cells. J Exp Med 187:1721-
1727, 1998 
 95.  Liu Q, Berry D, Nash P, Pawson T, McGlade CJ, Li SS: Structural basis for specific 
binding of the Gads SH3 domain to an RxxK motif-containing SLP-76 peptide: a novel 
mode of peptide recognition. Mol Cell 11:471-481, 2003 
 96.  Liu SK, Fang N, Koretzky GA, McGlade CJ: The hematopoietic-specific adaptor protein 
gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. 
Curr Biol 9:67-75, 1999 
 97.  Liu Y, Witte S, Liu YC, Doyle M, Elly C, Altman A: Regulation of protein kinase Ctheta 
function during T cell activation by Lck-mediated tyrosine phosphorylation. J Biol Chem 
275:3603-3609, 2000 
 98.  Lorenzo PS, Beheshti M, Pettit GR, Stone JC, Blumberg PM: The guanine nucleotide 
exchange factor RasGRP is a high -affinity target for diacylglycerol and phorbol esters. 
Mol Pharmacol 57:840-846, 2000 
 99.  Lucas JA, Atherly LO, Berg LJ: The absence of Itk inhibits positive selection without 
changing lineage commitment. J Immunol 168:6142-6151, 2002 
 100.  Mac TW, Saunders ME: The Immue Response: Basic and Clinical Principles. San Diego, 
Academic Press, 2006 
 101.  Macian F: NFAT proteins: key regulators of T-cell development and function. Nat Rev 
Immunol 5:472-484, 2005 
122 
 
 102.  Maltzman JS, Kovoor L, Clements JL, Koretzky GA: Conditional deletion reveals a cell-
autonomous requirement of SLP-76 for thymocyte selection. J Exp Med 202:893-900, 
2005 
 103.  Manicassamy S, Gupta S, Sun Z: Selective function of PKC-theta in T cells. Cell Mol 
Immunol 3:263-270, 2006 
 104.  McKay MM, Morrison DK: Integrating signals from RTKs to ERK/MAPK. Oncogene 
26:3113-3121, 2007 
 105.  McNeill L, Salmond RJ, Cooper JC, Carret CK, Cassady-Cain RL, Roche-Molina M, 
Tandon P, Holmes N, Alexander DR: The differential regulation of Lck kinase 
phosphorylation sites by CD45 is critical for T cell receptor signaling responses. 
Immunity 27:425-437, 2007 
 106.  Medeiros RB, Burbach BJ, Mueller KL, Srivastava R, Moon JJ, Highfill S, Peterson EJ, 
Shimizu Y: Regulation of NF-kappaB activation in T cells via association of the adapter 
proteins ADAP and CARMA1. Science 316:754-758, 2007 
 107.  Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa 
M, Mann M, Manning A, Rao A: IKK-1 and IKK-2: cytokine-activated IkappaB kinases 
essential for NF-kappaB activation. Science 278:860-866, 1997 
 108.  Mestas J, Hughes CC: Of mice and not men: differences between mouse and human 
immunology. J Immunol 172:2731-2738, 2004 
 109.  Mills PJ, Meck JV, Waters WW, D'Aunno D, Ziegler MG: Peripheral leukocyte 
subpopulations and catecholamine levels in astronauts as a function of mission duration. 
Psychosom Med 63:886-890, 2001 
 110.  Molina TJ, Kishihara K, Siderovski DP, van Ewijk W, Narendran A, Timms E, 
Wakeham A, Paige CJ, Hartmann KU, Veillette A, .: Profound block in thymocyte 
development in mice lacking p56lck. Nature 357:161-164, 1992 
 111.  Molitor JA, Walker WH, Doerre S, Ballard DW, Greene WC: NF-kappa B: a family of 
inducible and differentially expressed enhancer-binding proteins in human T cells. Proc 
Natl Acad Sci U S A 87:10028-10032, 1990 
123 
 
 112.  Monks CR, Kupfer H, Tamir I, Barlow A, Kupfer A: Selective modulation of protein 
kinase C-theta during T-cell activation. Nature 385:83-86, 1997 
 113.  Moodie SA, Willumsen BM, Weber MJ, Wolfman A: Complexes of Ras.GTP with Raf-1 
and mitogen-activated protein kinase kinase. Science 260:1658-1661, 1993 
 114.  Mor A, Campi G, Du G, Zheng Y, Foster DA, Dustin ML, Philips MR: The lymphocyte 
function-associated antigen-1 receptor costimulates plasma membrane Ras via 
phospholipase D2. Nat Cell Biol 9:713-719, 2007 
 115.  Mor A, Philips MR: Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 
24:771-800, 2006 
 116.  Mustelin T, Coggeshall KM, Altman A: Rapid activation of the T-cell tyrosine protein 
kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc Natl Acad Sci U S A 
86:6302-6306, 1989 
 117.  Muthusamy N, Leiden JM: A protein kinase C-, Ras-, and RSK2-dependent signal 
transduction pathway activates the cAMP-responsive element-binding protein 
transcription factor following T cell receptor engagement. J Biol Chem 273:22841-
22847, 1998 
 118.  Negishi I, Motoyama N, Nakayama K, Nakayama K, Senju S, Hatakeyama S, Zhang Q, 
Chan AC, Loh DY: Essential role for ZAP-70 in both positive and negative selection of 
thymocytes. Nature 376:435-438, 1995 
 119.  Palacios EH, Weiss A: Function of the Src-family kinases, Lck and Fyn, in T-cell 
development and activation. Oncogene 23:7990-8000, 2004 
 120.  Paz PE, Wang S, Clarke H, Lu X, Stokoe D, Abo A: Mapping the Zap-70 
phosphorylation sites on LAT (linker for activation of T cells) required for recruitment 
and activation of signalling proteins in T cells. Biochem J 356:461-471, 2001 
 121.  Pellis NR, Goodwin TJ, Risin D, McIntyre BW, Pizzini RP, Cooper D, Baker TL, 
Spaulding GF: Changes in gravity inhibit lymphocyte locomotion through type I 
collagen. In Vitro Cell Dev Biol Anim 33:398-405, 1997 
124 
 
 122.  Perez DC, I, Bivona TG, Philips MR, Pellicer A: Ras activation in Jurkat T cells 
following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs 
only on the Golgi apparatus. Mol Cell Biol 24:3485-3496, 2004 
 123.  Perez OD, Nolan GP: Simultaneous measurement of multiple active kinase states using 
polychromatic flow cytometry. Nat Biotechnol 20:155-162, 2002 
 124.  Perez-Villar JJ, Whitney GS, Sitnick MT, Dunn RJ, Venkatesan S, O'Day K, Schieven 
GL, Lin TA, Kanner SB: Phosphorylation of the linker for activation of T-cells by Itk 
promotes recruitment of Vav. Biochemistry 41:10732-10740, 2002 
 125.  Pippia P, Sciola L, Cogoli-Greuter M, Meloni MA, Spano A, Cogoli A: Activation 
signals of T lymphocytes in microgravity. J Biotechnol 47:215-222, 1996 
 126.  Pitcher LA, van Oers NS: T-cell receptor signal transmission: who gives an ITAM? 
Trends Immunol 24:554-560, 2003 
 127.  Pivniouk V, Tsitsikov E, Swinton P, Rathbun G, Alt FW, Geha RS: Impaired viability 
and profound block in thymocyte development in mice lacking the adaptor protein SLP-
76. Cell 94:229-238, 1998 
 128.  Rajalingam K, Schreck R, Rapp UR, Albert S: Ras oncogenes and their downstream 
targets. Biochim Biophys Acta 1773:1177-1195, 2007 
 129.  Raman M, Chen W, Cobb MH: Differential regulation and properties of MAPKs. 
Oncogene 26:3100-3112, 2007 
 130.  Rawlings DJ, Sommer K, Moreno-Garcia ME: The CARMA1 signalosome links the 
signalling machinery of adaptive and innate immunity in lymphocytes. Nat Rev Immunol 
6:799-812, 2006 
 131.  Rhee SG: Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 
70:281-312, 2001 
 132.  Ritz BW, Lelkes PI, Gardner EM: Functional recovery of peripheral blood mononuclear 
cells in modeled microgravity. FASEB J 20:305-307, 2006 
125 
 
 133.  Roebuck KA, Finnegan A: Regulation of intercellular adhesion molecule-1 (CD54) gene 
expression. J Leukoc Biol 66:876-888, 1999 
 134.  Roose JP, Mollenauer M, Gupta VA, Stone J, Weiss A: A diacylglycerol-protein kinase 
C-RasGRP1 pathway directs Ras activation upon antigen receptor stimulation of T cells. 
Mol Cell Biol 25:4426-4441, 2005 
 135.  Roose JP, Mollenauer M, Ho M, Kurosaki T, Weiss A: Unusual interplay of two types of 
Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in 
lymphocytes. Mol Cell Biol 27:2732-2745, 2007 
 136.  Rudd CE, Barber EK, Burgess KE, Hahn JY, Odysseos AD, Sy MS, Schlossman SF: 
Molecular analysis of the interaction of p56lck with the CD4 and CD8 antigens. Adv Exp 
Med Biol 292:85-96, 1991 
 137.  Sams C, D'Aunno D, Feeback DL: The Influence of Environmental Stress on Cell-
Mediated Immune Function, in Lane HW, Sauer RL, Feeback DL (eds): Isolation: NASA 
Experiments in Closed-Environment Living, San Diego, CA, 2004, pp 357-368 
 138.  Sasahara Y, Rachid R, Byrne MJ, de la Fuente MA, Abraham RT, Ramesh N, Geha RS: 
Mechanism of recruitment of WASP to the immunological synapse and of its activation 
following TCR ligation. Mol Cell 10:1269-1281, 2002 
 139.  Sastry KJ, Nehete PN, Savary CA: Impairment of antigen-specific cellular immune 
responses under simulated microgravity conditions. In Vitro Cell Dev Biol Anim 37:203-
208, 2001 
 140.  Schaeffer EM, Debnath J, Yap G, McVicar D, Liao XC, Littman DR, Sher A, Varmus 
HE, Lenardo MJ, Schwartzberg PL: Requirement for Tec kinases Rlk and Itk in T cell 
receptor signaling and immunity. Science 284:638-641, 1999 
 141.  Schulze-Luehrmann J, Ghosh S: Antigen-receptor signaling to nuclear factor kappa B. 
Immunity 25:701-715, 2006 
 142.  Schwarz RP, Goodwin TJ, Wolf DA: Cell culture for three-dimensional modeling in 
rotating-wall vessels: an application of simulated microgravity. J Tissue Cult Methods 
14:51-57, 1992 
126 
 
 143.  Seavitt JR, White LS, Murphy KM, Loh DY, Perlmutter RM, Thomas ML: Expression of 
the p56(Lck) Y505F mutation in CD45-deficient mice rescues thymocyte development. 
Mol Cell Biol 19:4200-4208, 1999 
 144.  Serrano CJ, Graham L, DeBell K, Rawat R, Veri MC, Bonvini E, Rellahan BL, Reischl 
IG: A new tyrosine phosphorylation site in PLC gamma 1: the role of tyrosine 775 in 
immune receptor signaling. J Immunol 174:6233-6237, 2005 
 145.  Shaul YD, Seger R: The MEK/ERK cascade: from signaling specificity to diverse 
functions. Biochim Biophys Acta 1773:1213-1226, 2007 
 146.  Simeoni L, Smida M, Posevitz V, Schraven B, Lindquist JA: Right time, right place: the 
organization of membrane proximal signaling. Semin Immunol 17:35-49, 2005 
 147.  Simons DM, Gardner EM, Lelkes PI: Dynamic culture in a rotating-wall vessel 
bioreactor differentially inhibits murine T-lymphocyte activation by mitogenic stimuli 
upon return to static conditions in a time-dependent manner. J Appl Physiol 100:1287-
1292, 2006 
 148.  Sommers CL, Menon RK, Grinberg A, Zhang W, Samelson LE, Love PE: Knock-in 
mutation of the distal four tyrosines of linker for activation of T cells blocks murine T 
cell development. J Exp Med 194:135-142, 2001 
 149.  Sonnenfeld G: Space flight, microgravity, stress, and immune responses. Adv Space Res 
23:1945-1953, 1999 
 150.  Su YW, Zhang Y, Schweikert J, Koretzky GA, Reth M, Wienands J: Interaction of SLP 
adaptors with the SH2 domain of Tec family kinases. Eur J Immunol 29:3702-3711, 1999 
 151.  Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, Gandhi L, Annes J, 
Petrzilka D, Kupfer A, Schwartzberg PL, Littman DR: PKC-theta is required for TCR-
induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 
404:402-407, 2000 
 152.  Taylor GR, Dardano JR: Human cellular immune responsiveness following space flight. 
Aviat Space Environ Med 54:S55-S59, 1983 
127 
 
 153.  Taylor GR, Janney RP: In vivo testing confirms a blunting of the human cell-mediated 
immune mechanism during space flight. J Leukoc Biol 51:129-132, 1992 
 154.  Taylor GR, Neale LS, Dardano JR: Immunological analyses of U.S. Space Shuttle 
crewmembers. Aviat Space Environ Med 57:213-217, 1986 
 155.  Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Horejsi V, Schraven B, Rolstad B, 
Mustelin T, Tasken K: Release from tonic inhibition of T cell activation through transient 
displacement of C-terminal Src kinase (Csk) from lipid rafts. J Biol Chem 276:29313-
29318, 2001 
 156.  Torii S, Kusakabe M, Yamamoto T, Maekawa M, Nishida E: Sef is a spatial regulator for 
Ras/MAP kinase signaling. Dev Cell 7:33-44, 2004 
 157.  Trautmann A, Randriamampita C: Initiation of TCR signalling revisited. Trends Immunol 
24:425-428, 2003 
 158.  Unsworth BR, Lelkes PI: Growing tissues in microgravity. Nat Med 4:901-907, 1998 
 159.  Vaidyanathan H, Opoku-Ansah J, Pastorino S, Renganathan H, Matter ML, Ramos JW: 
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad 
Sci U S A 104:19837-19842, 2007 
 160.  van Oers NS, Lowin-Kropf B, Finlay D, Connolly K, Weiss A: alpha beta T cell 
development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. 
Immunity 5:429-436, 1996 
 161.  Veillette A, Caron L, Fournel M, Pawson T: Regulation of the enzymatic function of the 
lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 
domains. Oncogene 7:971-980, 1992 
 162.  Venkataraman L, Wang W, Sen R: Differential regulation of c-Rel translocation in 
activated B and T cells. J Immunol 157:1149-1155, 1996 
 163.  Vine JB, Geppert TD, Lipsky PE: T4 cell activation by immobilized phytohemagglutinin: 
differential capacity to induce IL-2 responsiveness and IL-2 production. J Immunol 
141:2593-2600, 1988 
128 
 
 164.  von Essen M, Nielsen MW, Bonefeld CM, Boding L, Larsen JM, Leitges M, Baier G, 
Odum N, Geisler C: Protein kinase C (PKC) alpha and PKC theta are the major PKC 
isotypes involved in TCR down-regulation. J Immunol 176:7502-7510, 2006 
 165.  Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, Chen ZJ: TAK1 is a ubiquitin-
dependent kinase of MKK and IKK. Nature 412:346-351, 2001 
 166.  Wardenburg JB, Fu C, Jackman JK, Flotow H, Wilkinson SE, Williams DH, Johnson R, 
Kong G, Chan AC, Findell PR: Phosphorylation of SLP-76 by the ZAP-70 protein-
tyrosine kinase is required for T-cell receptor function. J Biol Chem 271:19641-19644, 
1996 
 167.  Watanabe D, Hashimoto S, Ishiai M, Matsushita M, Baba Y, Kishimoto T, Kurosaki T, 
Tsukada S: Four tyrosine residues in phospholipase C-gamma 2, identified as Btk-
dependent phosphorylation sites, are required for B cell antigen receptor-coupled calcium 
signaling. J Biol Chem 276:38595-38601, 2001 
 168.  Weiss A, Wiskocil RL, Stobo JD: The role of T3 surface molecules in the activation of 
human T cells: a two-stimulus requirement for IL 2 production reflects events occurring 
at a pre-translational level. J Immunol 133:123-128, 1984 
 169.  Williams BL, Irvin BJ, Sutor SL, Chini CC, Yacyshyn E, Bubeck WJ, Dalton M, Chan 
AC, Abraham RT: Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen 
receptor-dependent phospholipase C-gamma1 and Ras activation. EMBO J 18:1832-
1844, 1999 
 170.  Williams BL, Schreiber KL, Zhang W, Wange RL, Samelson LE, Leibson PJ, Abraham 
RT: Genetic evidence for differential coupling of Syk family kinases to the T-cell 
receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol Cell Biol 
18:1388-1399, 1998 
 171.  Wu JN, Koretzky GA: The SLP-76 family of adapter proteins. Semin Immunol 16:379-
393, 2004 
 172.  Yablonski D, Kuhne MR, Kadlecek T, Weiss A: Uncoupling of nonreceptor tyrosine 
kinases from PLC-gamma1 in an SLP-76-deficient T cell. Science 281:413-416, 1998 
129 
 
 173.  Yoder J, Pham C, Iizuka YM, Kanagawa O, Liu SK, McGlade J, Cheng AM: 
Requirement for the SLP-76 adaptor GADS in T cell development. Science 291:1987-
1991, 2001 
 174.  Zeng R, Cannon JL, Abraham RT, Way M, Billadeau DD, Bubeck-Wardenberg J, 
Burkhardt JK: SLP-76 coordinates Nck-dependent Wiskott-Aldrich syndrome protein 
recruitment with Vav-1/Cdc42-dependent Wiskott-Aldrich syndrome protein activation at 
the T cell-APC contact site. J Immunol 171:1360-1368, 2003 
 175.  Zhang R, Alt FW, Davidson L, Orkin SH, Swat W: Defective signalling through the T- 
and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 
374:470-473, 1995 
 176.  Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE: LAT: the ZAP-70 
tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92:83-92, 
1998 
 177.  Zhang W, Sommers CL, Burshtyn DN, Stebbins CC, DeJarnette JB, Trible RP, Grinberg 
A, Tsay HC, Jacobs HM, Kessler CM, Long EO, Love PE, Samelson LE: Essential role 
of LAT in T cell development. Immunity 10:323-332, 1999 
 178.  Zhang W, Trible RP, Zhu M, Liu SK, McGlade CJ, Samelson LE: Association of Grb2, 
Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect 
of LAT tyrosine mutations on T cell angigen receptor-mediated signaling. J Biol Chem 
275:23355-23361, 2000 
 179.  Zhu M, Janssen E, Zhang W: Minimal requirement of tyrosine residues of linker for 
activation of T cells in TCR signaling and thymocyte development. J Immunol 170:325-
333, 2003 
 
 
 
130 
 
APPENDIX A: PURITY OF CD4+ T CELLS USED IN EXPERIMENTS 
 
 
 
 A majority of the experiments described in this thesis made use of purified 
populations of CD4+T cells.  Since these studies examined antigen-receptor signaling, it 
was necessary to obtain a population of untouched T cells.  This was accomplished using 
monoclonal antibodies to label the unwanted population of cells with magnetic beads, so 
that they could be depleted by magnetic separation.  A caveat is that the purified 
population of cells can be significantly contaminated by unwanted cells if there are more 
cells to be depleted than there are antibodies to deplete them.  When using this technique 
it is therefore important to verify that experimental data is not confounded by an 
insufficiently purified population of cells. 
 In every experiment conducted over the course of this project the purity of the 
tested cell population was verified during experimental processing.  Briefly, cells were 
stained with antibodies against CD3 and CD4 following standard protocol and analyzed 
by flow cytometry (fig. A.1).  To avoid biasing the results the percentage of CD4+ T cells 
was determined by gating on the CD3+/CD4+ cells without prior gating for lymphocytes, 
and a backgate was then used to verify that these cells were of lymphoid origin.  Debris 
was excluded from these calculations either a priori by setting a FSC threshold-trigger 
during data acquisition, or during analysis using an exclusion gate to remove events 
below a set FSC value.   Using this method, we found that our PBMC preps contained on 
average 30-% CD4+ T cells and that enrichment typically returned a population of cells 
that was ~80-% CD4+ T cells (fig. A.2).  The purity of cells used in each experiment 
reported in this thesis can be found in tables A.1 through A.7 at the end of this appendix.    
131 
 
Figure A.1. Gating strategy for determining the purity of magnetically purified 
CD4+ T cells.  PBMC isolated by gradient centrifugation of human buffy coats were 
enriched for CD4+ T cells by negative selection on an AutoMACSpro.  The cells were 
subsequently immunostained for CD3 and CD4 and analyzed by flow cytometry.  The 
data shown here are representative of greater than 20 experiments.   
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Figure A.2. Percentages of CD3+/CD4+ T cells in cell suspensions before and after 
sorting.  Human CD4+ T cells were purified and analyzed as described in the figure A.1.  
Each dot represents a single experiment.  Horizontal bars are the mean of all experiments.  
The samples grouped under “buffy coats in analysis” are the subset of all buffycoats that 
were used to conduct the experiments reported in this thesis. 
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Experiment pre-sort post-sort enrichment cells in  cells out recovery
PhD#5 34.0 92.8 173% 60 16.1 27%
PhD#6 22.5 83.5 270% 60 11.2 19%
PhD#7 24.6 83.3 238% 60 11.4 19%
PhD#8 40.7 94.4 132% 60 19.8 33%
PhD#9 40.5 94.5 133% 60 19.7 33%
average 32.5 89.7 189% 60 15.6 26%
std dev 8.6 5.8 63% 0 4.2 7%
Table A.1. Purity of CD4+ cells for measurement of phosphotyrosine by flow cytometry
%-CD4+ cells total cells x 106
Experiment pre-sort post-sort enrichment cells in  cells out recovery
PhD#27 51.2 91.2 78% 180 62.0 34%
PhD#28 31.8 85.9 170% 160 46.5 29%
PhD#29 33.2 83.4 151% 160 46.0 29%
average 38.7 86.8 133% 167 51.5 31%
std dev 10.9 4.0 49% 12 9.1 3%
Table A.2. Purity of CD4+ cells for detection of phosphorylated ZAP-70 by Western blot
%-CD4+ cells total cells x 106
  
Experiment pre-sort post-sort enrichment cells in  cells out recovery
PhD#25 23.0 87.0 278% 160 15.5 10%
PhD#26 17.0 74.0 335% 160 21.0 13%
PhD#27 51.2 91.2 78% 180 62.0 34%
PhD#28 31.8 85.9 170% 160 46.5 29%
PhD#29 33.2 83.4 151% 160 46.0 29%
average 31.2 84.3 203% 164 38.2 23%
std dev 13.0 6.4 103% 8.9 19.4 11%
Table A.4. Purity of CD4+ cells for measurement of actin polymerization by flow cytometry
%-CD4+ cells total cells x 106
Experiment pre-sort post-sort enrichment cells in  cells out recovery
PhD#23a 29.4 91.9 213% 160 35.0 22%
PhD#28 31.8 85.9 170% 160 46.5 29%
average 30.6 88.9 192% 160 40.8 25%
std dev 1.7 4.3 30% 0 8.1 5%
Table A.3. Purity of CD4+ cells for detection of phosphorylated PLCγ1 by Western blot
%-CD4+ cells total cells x 106
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Experiment pre-sort post-sort enrichment cells in  cells out recovery
PhD#34 26.0 77.0 196% 140 28.0 20%
PhD#35 18.0 85.0 372% 140 11.5 8%
average 22.0 81.0 284% 140 19.8 14%
std dev 5.7 5.7 124% 0 11.7 8%
Table A.7. Purity of CD4+ cells for measurement of ppERK by confocal microscopy
%-CD4+ cells total cells x 106
Experiment pre-sort post-sort enrichment cells in  cells out recovery
PhD#23a 29.4 91.9 213% 160 35.0 22%
PhD#25 23.0 87.0 278% 160 15.5 10%
PhD#27 51.2 91.2 78% 180 62.0 34%
PhD#28 31.8 85.9 170% 160 46.5 29%
average 33.9 89.0 185% 165 39.8 24%
std dev 12.2 3.0 84% 10 19.6 11%
Table A.6. Purity of CD4+ cells for detection of phosphorylated ERK by Western blot
%-CD4+ cells total cells x 106
Experiment pre-sort post-sort enrichment cells in  cells out recovery
PhD#18 37.1 90.1 143% 120 29.6 25%
PhD#29 33.2 83.4 151% 160 46.0 29%
PhD#31 36.8 81.5 121% 80 28.6 36%
average 35.7 85.0 139% 120 34.7 30%
std dev 2.2 4.5 15% 40 9.8 6%
Table A.5. Purity of CD4+ cells for detection of IκB by Western blot
%-CD4+ cells total cells x 106
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APPENDIX B: OPTIMIZATION OF CONDITIONS 
 
 
 
B.1. Optimal concentration of stimulating antibodies for TCR signaling 
experiments 
  
 In many of the experiments presented in this thesis T cell antigen-receptor signals 
were triggered by crosslinking the TCR and CD28 co-stimulatory molecule.  This was 
accomplished by first labeling the cells with mouse monoclonal antibodies against CD3 
and CD28, and subsequently crosslinking these antibodies with a goat F(ab′)2 specific to 
the Fc region of mouse IgG.  The optimal stimulating dose of antibodies was determined 
by crosslinking the TCRs of purified CD4+ T cells with several concentrations of 
antibodies and measuring the inducible tyrosine phosphorylation of the ζ-chains, ZAP-70 
and SLP-76.  We observed peak tyrosine phosphorylation of these three molecules when 
between 1- and 2-μg/ml each of CD3 and CD28 were crosslinked with a 10-ug/ml of 
anti-mouse IgG (fig. B.1).  Based on these observations a dose of 2-μg/ml each of CD3 
and CD28, and 10-μg/ml goat anti-mouse was used to stimulate purified CD4+ T 
cells for measurements of signal transduction.   
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Figure B.1. Titration of CD3XCD28 antibodies for stimulation of CD4+ T cells.  
Purified human CD4+ T cells were labeled for 15-minutes on ice with anti-CD3 and –
CD28 mouse monoclonal antibodies each at the indicated concentration.  The antibodies 
were then crosslinked with a goat anti-mouse IgG at 10-ug/ml for 5-minutes at 37 °C.  
The cells were then fixed and processed for phospho-specific flow cytometry with 
immunostaining for site-specific tyrosine phosphorylation of the indicated molecules.  
Data are the median fluorescence intensity of staining (MFI). 
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B.2 Kinetics of TCR signal transduction 
 Signal transduction in response to TCR-triggering occurs on a timescale of 
seconds to minutes, and it is therefore critical that measurements of inducible tyrosine 
phosphorylation be made at appropriate timepoints.  The kinetics of tyrosine 
phosphorylation in our system were determined based on immunostaining for 
phosphorylated ZAP-70.  Briefly, purified human CD4+ T cells were stimulated by 
CD3XCD28 at the optimal dose, and at several timepoints aliquots of the cell suspension 
were fixed and processed for flow cytometry (fig. B.2).  These data showed that although 
the percentage of pZAP-70+ cells continued to increase after 5-minutes, the MFI of 
staining had peaked by this time and exhibited very little increase at 10-minutes.  Based 
on these data an experimental timepoint of 5-minutes was chosen for analysis of 
tyrosine phosphorylation to ensure that measurements were made during the 
ascending phase of the signaling processes. 
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Figure B.2. Kinetics of ZAP-70 phosphorylation by CD3XCD28-stimulated CD4+ T 
cells.  Purified human CD4+ T cells were stimulated by CD3XCD28 for the indicated 
durations using 2-μg/ml of each antibody crosslinked by 10-μg/ml goat anti-mouse.  At 
each timepoint an aliquot of cells was fixed and processed for flow cytometry with 
staining for phosphorylated ZAP-70.  Greater than 30,000 events were collected for each 
timepoint.     
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B.3 Kinetics of ERK phosphorylation 
 To determine the optimal timepoint for measurements of ERK phosphorylation 
the kinetics of this enzyme’s induction were determined by flow cytometry.  Briefly, 
Cells were stimulated by CD3XCD28 and at several timpoints aliquots of the cell 
suspension were fixed and processed for flow cytometry with immunostaining for 
ppERK.  Our data show that the maximum percentage of cells expressing phosphorylated 
ERK was reached by 5-minutes of stimulation, and that, although the percentage of 
ppERK+ cells had plateaued by 10-minutes, the amount of ppERK expressed by positive 
cells continued to increase (fig. B.3).  Based on these data we measured ppERK 
phosphorylation by Western blot and flow cytometry after 5-minutes in culture to 
maximize the number of ppERK+ cells analyzed, but for confocal microscopy a 
timepoint of 10-minutes was used in an attempt to maximize the positive signal.  
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Figure B.3. Kinetics of ERK phosphorylation by CD3XCD28-stimulated CD4+ T 
cells.  Purified human CD4+ T cells were stimulated by CD3XCD28 for the indicated 
durations using 2-μg/ml of each antibody crosslinked by 10-μg/ml goat anti-mouse.  At 
each timepoint an aliquot of cells was fixed and processed for flow cytometry with 
staining for phosphorylated ERK.  Greater than 30,000 cells were collected for each 
timepoint.   
141 
 
 B.4 Kinetics of actin polymerization 
 The response of the actin cytoskeleton to TCR stimulation is highly dynamic, and 
can involve cycles of both polymerization and depolymerization.  Inducible actin 
polymerization was therefore measured at several early timepoints to locate the peak of 
the immediate actin response to receptor crosslinking.  In these experiments purified 
primary CD4+ T cells were labeled for 15-minutes on ice with mouse monoclonal 
antibodies against CD3 and CD28 each at 2-μg/ml.  The cells were then incubated for an 
additional 15-minutes on ice with a goat anti-mouse IgG at 10-μg/ml, and then placed in 
a 37 °C water bath.  Aliquots of the cell suspension were removed after 1-, 3-, and 10-
minutes, fixed for 20-minutes at 37 °C, and processed for phalloidin staining of actin 
filaments according to the protocol in appendix C.  The cells were subsequently analyzed 
by flow cytometry and the MFI of f-actin staining was used to determine the peak 
response (fig. B.4). These data showed that the peak response occurred after 3-minutes of 
stimulation and was significantly decreased by 10-minutes.  A timepoint of 5-minutes 
was used in all experiments in this thesis that measured actin polymerization.  This 
choice represents a compromise between the peak cytoskeletal response at 3-
minutes, and the peak response in the phosphotyrosine signal at 5-minutes, since 
these analyses were required to share samples.                  
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Figure B.4. Kinetics of TCR-induced actin polymerization in primary CD4+ T cells.  
Purified CD4+ T cells were stimulated for the indicated duration with CD3XCD28 at 37 
°C, and subsequently fixed and processed for staining with TRITC-conjugated phalloidin 
according to standard protocol.  The cells were then analyzed by flow cytometry and the 
MFI of TRITC phalloidin staining was used to assess the kinetics of f-actin 
polymerization in response to TCR ligation (A).  Representative data from one of two 
experiments is shown in B.   
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B.5. Determination of optimal PHA dose for activating T cells in PBMC culture 
 Phytohemagglutinin (PHA) is a mitogenic lectin derived from the red kidney 
bean.  PHA binds tetravalently to glycosylated residues of cell surface-receptors and is a 
potent T cell mitogen when applied to preparations of peripheral blood mononuclear 
cells.  In several experiments presented throughout this thesis PHA was used to activate T 
cells during culture in the RWV.  The dose of PHA used in these experiments was chosen 
to achieve maximal T cell proliferation after 48-hrs of culture.  This dose was determined 
by stimulating freshly isolated human PBMC for 48-, 72-, and 96-hrs with a range of 
PHA doses and pulsing the cells with 1-μCi 3H-thymidine during the last 4-hrs of each 
timepoint.  Incorporation of 3H-thymidine into newly synthesized DNA was then 
measured with a scintillation counter.  Based on these measurements a dose of 4-μg/ml 
was used for all experiments (fig. B.5). 
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 Figure B.5. Thymidine incorporation assay of PHA-stimulated PBMC.  Human 
PBMC were stimulated with the indicated dose of PHA in a 96-well plate for 48-, 72-, or 
3 idine was added to the 
culture and proliferation was determined by thymidine incorporation assay.  Data are the 
means of triplicate wells.   
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B.6. Determination of a sub-mitogenic dose of PMA 
 The experiments presented in Chapters 4, 5, and 6 measure the ability of a sub-
mitogenic dose of PMA to rescue activation marker expression in the RWV.  This dose 
was determined by stimulating PBMC with a range of PMA concentrations for 48-, 72-, 
and 96-hrs, and then measuring proliferation by thymidine incorporation assay as 
described in section B.1.  Based on these titrations a dose of 0.5-ng/ml was used in all 
experiments (fig. B.6).   
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Figure B.6. Thymidine incorporation assay of PMA-stimulated PBMC.  Human 
PBMC were stimulated with the indicated doses of PMA in a 96-well plate for 48-, 72-, 
or 96-hrs.  During the final 4-hrs of each timepoint 1-μCi of 3H-thymidine was added to 
the culture and proliferation was determined by measurement of 3H-thymidine 
incorporation using a scintillation counter.  Data are means of triplicate samples.   
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APPENDIX C: PROTOCOLS 
 
 
 
C.1 Purification of PBMC from buffycoats 
 The following protocol is for the isolation of peripheral blood mononuclear cells 
(PBMC) from buffycoats.  Buffycoats are typically purchased from a third party supplier.  
The total volume of one “unit” of buffycoat can vary considerably from donor to donor to 
donor, but will typically be between 25- and 50-ml.  The yield of PBMC is also highly 
variable between donors, but a single buffycoat should contain at least 400E6 PBMC (if 
you get less than this [and did not botch the isolation] complain to the supplier).  
Buffycoats may be stored overnight at room temperature for cell purification the
 up all 
ills and treat all waste material with 10-% bleach prior to disposal.   
ats prior to purification, and 
distributes the gradient centrifugation step between several 15-ml tubes.  This is a matter 
of personal preference and it should be noted that others have used higher dilutions and 
larger gradient volumes to get comparable yields.  Fifty-ml tubes can be used to scale up 
the procedure; however, in my experience this makes it harder to remove the PBMC from 
the histopaque gradient after centrifugation.     
 
following day; however, never store buffycoats at 4 °C as this will adversely affect 
yields.  All human blood (screened and unscreened) should be treated as infectious, and 
only personnel who have received the appropriate training should be allowed to work 
with human blood.  Always where appropriate personal protective equipment and work 
within a BL-2 certified laminar flow hood when working with human blood.  Clean
sp
 This protocol calls for a 2-fold dilution of buffyco
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Materials required 
 RPMI 
 Histopaque 1077 
 50- and 15-ml disposable centrifuge tubes 
at 400xg            
•
•
•
• A centrifuge capable of spinning 15-ml tubes 
 
Abbreviated protocol 
• Dilute the buffycoat 1:2 with RPMI 
• Pipette 9.5-ml of the diluted buffycoat over 5-ml of histopaque 1077 in a 15-ml tube 
• Centrifuge for 30-minutes at 400xg in a room temperature centrifuge  
• Remove the PBMC-containing interphase from the histopaque gradient and transfer 
to a new 15-ml centrifuge tube 
• Wash the cells twice with RPMI 
• Resuspend the cells in RPMI or culture media 
• Treat the cells as required for experiments 
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Detailed protocol 
• Prior to beginning pipette 5-ml of histopaque 1077 into a 15-ml centrifuge tube and 
perature.  Prepare one tube of histopaque for every 5-ml of 
ix each cell 
suspension 1:1 with RPMI  
l of suspension to a 15-ml tube containing 5-ml of histopaque 
erlay the histopaque with minimal mixing 
results in 
 
 for 30-minutes at room temperature  
d cells (which are denser than histopaque 1077) 
llet at the bottom of the tube, while 
nse than the histopaque will collect at 
• Using a glass Pasteur pipette remove the PBMC and transfer to a 50-ml centrifuge 
tube 
o Expect ~2-ml of PBMC per gradient.  I generally pool the PBMC from up to 5-
gradients into a single 50-ml tube for washing.  For more than 5-gradients split 
evenly between two 50-ml tubes.     
• From this point on all solutions and centrifugation steps should be at 4 °C 
• Bring the volume of the cell suspension up to approximately 50-ml with RPMI 
• Pellet the cells by centrifugation for 10-minutes at 300xg   
• Repeat the wash step above once more for a total of two washes 
• After the final wash, remove the supernatant and resuspend the cells in RPMI.  The 
cells are now ready to be used in experiments 
o I typically resuspend in 30- to 40-ml of RPMI per 50-ml tube, which will 
typically result in cell densities between five and ten million cells per ml 
o Count a 1:10 or 1:20 dilution of the cells on a hemacytometer using trypan 
exclusion to verify cell viability (should be close to 100-%) 
  
  
warm to room tem
buffycoat. 
• Split the buffycoat equally between two 50-ml centrifuge tubes and m
• Gently transfer 9.5-m
1077.  The cell suspension should ov
between the two solutions.   
o In my experience placing more than 14.5-ml in the centrifuge tube 
leakage during centrifugation, so try to avoid completely filling the 15-ml tubes.  
• Centrifuge the gradient at 400xg
o During centrifugation red bloo
will pass through the gradient and form a pe
 demononuclear cells (PBMC) that are less
the histopaque-RPMI interface.   
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C.2 Phalloidin staining of f-actin for analysis by flow cytometry 
ctin (f-
 
ighly dynamic rearrangements of the actin cytoskeleton 
 
al2.   
1) 
lates  
cf of at least 800xg 
 
  
                                                
 Phalloidin is a fungal-derived toxin that specifically binds to filamentous-a
actin).  This protocol describes a method for using fluorescently labeled phalloidin to 
stain f-actin in suspension-cultured cells for analysis by flow cytometry.  This procedure
is typically used to measure the h
of T cells stimulated through their TCRs, and experiments are therefore of short duration 
and require immediate fixation to avoid processing artifacts.  Experiments are therefore
carried out in PBS (w/Ca2+ & Mg2+) or naked media (e.g. RPMI), and concentrated 
fixative is added directly to the cell suspension to terminate the experiment.  Direct 
addition of fixative to cells cultured in serum-containing media is not recommended.  
Note that phalloidin is highly toxic and should be handled with gloves at all times.  This 
protocol was adapted from procedures published by Flaishon et al  and Uttayarat et 1
Materials 
• PBS-both w/and w/o Ca2+ & Mg2+ 
• S + 0.1-% Triton X-100  PB
• A fluorescent-conjugate of phalloidin  
o We currently use TRITC-labeled phalloidin from Sigma-Aldrich (cat# P195
• 4-% paraformaldehyde (PFA) 
 fresh weekly; store at 4 °C protected from light o  Prepare
• 96-well microtiter p
• A centrifuge capable of spinning microtiter plates to an r
 
 
1 Flaishon L; et al. J Biol Chem. 2001; 276(50):46701. 
2 Uttayarat, P; et al. J Biomed Mater Res A. 2005; 75(3):668. 
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Abbreviated Procedure 
1. Fix cells 20-minutes at 37 °C in 2-% PFA 
. Tra
3. Wash 3 times with PBS 
5. Wash 3 times with PBS 
7. Wash 3 times with PBS 
 
Detailed Procedure 
2. Add concentrated PFA pre-warmed to 37 °C directly to the cell suspension for a final 
e 
cells 
a. Storage of the cells overnight prior to staining may be beneficial in that the extra 
is 
has not been methodically tested though.   
durations have not been tested 
at ~800xg (2000- to 2500-rpm in a standard tabletop centrifuge) 
5. Pellet the cells and transfer to a 96-well plate 
 best way w/o losing cells is to decant the supernatant and resuspend the 
A that remains in the tube (100- to 200-μl) for 
late 
spend the pellet in PBS 
 PBS + 0.1-% Triton X-100 to permeabilize the cells.  
h PBS as in step 6 
ropriate 
concentration.  Incubate 30-minutes protected from light 
a. Phalloidin concentration should be optimized beforehand, but for single-color 
flow cytometry I typically use TRITC-phalloidin at 0.5-μg/ml   
11. Wash the cells 3 times with PBS as in step 6 
13. Store the cells in PBS at 4 °C protected from light until analysis by flow cytometry 
a. I have always analyzed the cells immediately after staining (within 2-hrs), so the 
affects of storing the samples after staining are unknown 
 
  
2 nsfer cells to a 96-well plate  
4. Permeabilize the cells 5-minutes in PBS + 0.1-% Triton X-100 
6. Stain 30-minutes with Phalloidin diluted in PBS (w/Ca2+ & Mg2+) 
8. Analyze the cells by flow cytometry 
1. Stimulate cells as appropriate for your experiment 
concentration of 2-%, mix, and incubate at 37 °C for 20-minutes to rapidly fix th
3. At this point, the cells may be stored in the PFA at 4 °C  
fixation time helps maintain the integrity of the cells after permeabilization—th
b. Cells may be stored in this manner for at least as long as overnight, longer 
4. All subsequent steps are carried out at room temperature.  All centrifugation steps are 
a. The
pellet in the small volume of PF
transfer to the 96-well p
6. Pellet the cells, aspirate the supernatant, and resu
7. Repeat twice more for a total of 3 washes 
8. Pellet the cells and resuspend in
Incubate for 5-minutes prior to continuing to the next step. 
9. Wash the cells 3 times wit
10. Pellet the cells and resuspend in PBS (w/Ca2+ & Mg2+) + phalloidin at an app
12. Pellet the cells and resuspend in PBS 
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C.3 Surface staining of cells for flow cytometry 
 antibodies 
s 
• entrifuge capable of spinning microtiter plates at 400xg 
 
-ul 
ell micro-titer plate 
3-washes 
t the appropriate dilution 
d cells in 200-ul of 
d immediately, they may be resuspended in PBS and 
idual flow tubes.  Cells are ready for flow 
Materials 
• PBS + 1-% FBS or BSA (FACSwash) 
• 1-% Paraformaldehyde 
o Store at 4º C, light sensitive 
• Fluorescently conjugated
• 96-well round bottom microtiter plate
 C
Procedure 
All of the following steps should be carried out on ice.  All centrifugation steps should be 
carried out at 4 ºC.  Typically 0.5E6 to 2E6 cells are stained per test, in a volume of 50
 
1. Transfer the desired number of cells for staining to a 96-w
2. Pellet cells 5-minutes at 400xg remove supernatant and resuspend cells in 200-ul of 
FACSwash  
3. Repeat the above step twice more for a total of 
4. After the last wash remove the supernatant and resuspend the cells in 50-ul of 
FACSwash containing antibodies a
5. Incubate 30-minutes on ice in the dark  
6. Pellet cells 5-minutes at 400xg, remove supernatant and resuspen
wash buffer 
7. Repeat the above step twice more for a total of 3-washes 
8. After the last wash resuspend the cells in 200-ul of 1-% paraformaldehyde 
a. If the samples will be analyze
analyzed un-fixed.   
9. Transfer the cells from each well into indiv
cytometry.  Store at 4º C in the dark until use.  Samples should be analyzed no more 
than one week after staining.    
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C.4 BrdU and surface staining for flow cytometry 
5-bromo-2´-deoxyuridine (BrdU) is a thymidine analog that can be incorporated 
f the cell cycle, and detection of BrdU-labeled 
ell proliferation by flow cytometry.  This technique 
corporated into cellular DNA and therefore 
quires that (1) the cells are adequately permeabilized to allow antibody to reach the 
(2) the cellular DNA be denatured (i.e. unwound) to expose the incorporated 
o been 
e DNA can be denatured by heat, low pH, or enzymatic treatment with 
tection of BrdU in conjunction with surface 
sis by flow cytometry.  To preserve the antigenicity of surface markers 
 following 
essed for BrdU detection.  All washes, incubations, and 
f 
e DNAse I digestion buffer, all solutions should be used ice-cold.  Stain 1E6-2E6 cells 
med for 5-minutes at 400xg 
(~1500-rpm).  Post-fixation centrifugation steps should be performed at 800xg (~2000-
rpm) for 10-minutes. 
   
 
  
into cellular DNA by cells in the S-phase o
cells is commonly used to assess c
make use of antibodies that bind to BrdU in
re
nucleus and 
BrdU.  Permeabilization is achieved through the use of non-ionic detergents (0.2-% 
Triton X-100 is used here, but 0.2-% Tween-20 and 0.5-% NP-40 have als
reported), and th
DNAse I.   
This protocol is intended for the de
staining for analy
this protocol proceeds in two steps.  The cells are first surface-stained and
fixation the cells are proc
centrifugation steps are performed at 4 °C unless stated otherwise.  With the exception o
th
per sample.  Prior to fixation, centrifugation can be perfor
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Materials 
• BrdU (molecular probes: B23151)  
• antibody against BrdU (molecular probes: A21303)     
• PBS (w/o Ca2+, Mg2+)  
• PBS (w/o) + 0.5-% BSA + 0.2-% Triton X-100 (BrdUwash)  
• BSA (Fisher: BP1605-100
• PBS (w/Ca2+, Mg2+) 
) 
• Triton X-100 
• DNAse I (Sigma: DN25) 
 
Procedure           
1. Culture cells in the presence of 20-ug/ml BrdU for at least 4-hrs 
2. Transfer the required number of cells for staining to a 15-ml centrifuge tube 
3. Pellet the cells and surface-stain according to standard protocol, in brief: 
a. Wash 3X w/PBS + 1-% FBS  
b. Stain the cells for 30-minutes on ice  
c. Wash 3X w/PBS + 1-% FBS 
d. After the final wash resuspend the cells in 200-ul of 1-% PFA 
e. Fix o
i. No
vernight at 4 °C 
te:  Adequate fixation is essential for stabilizing the cells so that they are not 
2+ 2+
lysed by the permeabilization buffer (BrdUwash).  This step can probably be 
shortened to as little as 30-minutes, but this has never been verified  
4. Pellet the cells and wash 1X w/PBS and 1X w/BrdU wash 
5. Permeabilize the cells by incubation for 15-minutes on ice in BrdU wash 
6. Pellet the cells and denature cellular DNA by resuspension in PBS (w/Ca  and Mg ) 
+ 50-KU/1E6 cells DNAse I (at 0.5-KU/ul) 
a. DNAse activity is typically reported in Kunitz Units (KU) 
7. Incubate in DNAse I for 30-minutes at 37 °C   
8. Pellet the cells and wash 2X w/BrdU wash 
9. Block non-specific protein binding by incubating the cells 30- to 60-minutes on ice in 
BrdU wash 
10. Pellet the cells, resuspend in 200-ul/1E6 cells BrdU wash + Alexa488 anti-BrdU 
antibody at 1:200, and incubate 30-minutes on ice protected from light 
11. Pellet the cells and wash 1X w/BrdU wash and 1X w/PBS  
12. Following the final wash, resuspend the cells in 200-ul of PBS and store at 4 °C 
protected from light until analysis by flow cytometry 
 
 
